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INTRODUCTION
Chapter 1 Introduction
1ABSTRACT
Targeted genome editing has become a powerful genetic tool for modification of DNA 
sequences in their natural chromosomal context. 
CRISPR RNA-guided nucleases have recently 
emerged as an efficient targeted editing tool for 
multiple organisms. Hereby a double strand break 
is introduced at a targeted DNA site. During DNA 
repair genomic alterations are introduced which can 
change the function of the DNA code. However, our 
understanding of how CRISPR works is incomplete 
and it is still hard to predict the CRISPR activity at 
the precise target sites. The highly ordered structure 
of the eukaryotic genome may play a role in this. The 
organization of the genome is controlled by dynamic 
changes of DNA methylation, histone modification, 
histone variant incorporation and nucleosome 
remodelling. The influence of nuclear organization 
and chromatin structure on transcription is 
reasonably well known, but we are just beginning to 
understand its effect on genome editing by CRISPR.
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PART 1: General Introduction
GENOME EDITING 
Genome editing technologies make it possible to make precise changes in a DNA 
sequence, regardless of cell type or organisms. This gives an almost unlimited number of 
potential applications in the field of life sciences, for example to design model organisms 
with specific genotypes or to develop gene therapy strategies for use in health care or to 
improve crops and livestock for agriculture. A particular active area of genetic editing is 
that of patient-derived stem cells to create models for diseases including polycystic kidney 
disease (PKD) (1) or long QT syndrome (2). In the latter, patient-derived pluripotent stem 
cells were isolated to create isogenic cell lines. These cells can be differentiated to any 
cell type of interest to study or correct the disease. With these cell lines, it is possible to 
investigate the effect of gene mutations to a disease phenotype. Although genome editing 
strategies for disease therapies or plant breeding are making great progress, many hurdles 
still need to be overcome. Also, legislation and social acceptance are under active debate.
For the effective modification or regulation of genomic information a molecular machine 
is required with a DNA binding domain linked to an effector domain. The DNA binding 
domain is designed to bind specifically to a DNA sequence of a target gene. Several 
approaches for genome editing have been developed using targeted nucleases. The 
nuclease is directed to specific sequences in the genome where DNA modification is 
desired and introduces a DNA double-stranded break (DSB). Subsequently, the break 
activates the endogenous repair machinery of the host to restore the genome. In this 
process errors can be introduced that modify the targeted sequence (3-5). 
Established targeted nucleases are meganucleases, zinc-finger nucleases (ZFNs), 
transcription activator-like effector nucleases (TALENs) and clustered regularly 
interspaced short palindromic repeats (CRISPR) with CRISPR associated nucleases (Cas9). 
Meganucleases are generated by engineering existing restriction enzymes, typically 
enzymes with a long DNA recognition sequence (e.g., 14-40 bp) (3, 6). The large recognition 
site provides the specificity to the target site to occur only once in the genome (Figure 1a). 
ZFNs and TALENs are recombinant proteins constructed of a customized DNA binding 
domain fused to the nuclease domain of the FokI restriction enzyme (Figure 1b-c). The DNA 
binding domain consists of a series of repeats that are only variable at a few residues. Each 
repeat region has specificity for a specific DNA motif. The various repeats moieties can 
be connected to each other into an array that binds at a dedicated DNA sequence (7-11). 
These platforms have made it possible to make significant progress, but each has its own 
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drawbacks. The generation of a meganuclease/ZFN/TALEN is a demanding and/or time-
consuming process, making these approaches less suitable for multiplexing many targeted 
nucleases in a single cell.
More recently, a platform based on the bacterial CRISPR/Cas9 nuclease has been widely 
adopted by the scientific community for genome editing, largely because of the ease with 
which the target specificity can be generated (Figure 1d). This enables the performance 
of large scale, high throughput studies. In contrast to most known DNA-binding proteins, 
Cas9 is an RNA-guided nuclease and is targeted to a specific location in the DNA where 
its guide RNA base pairs with complementary DNA. Cas9 can be reprogrammed to target 
new sites by changing the sequence composition of the guide RNA. To serve as a genome 
editing tool, the natural endonuclease activity of Cas9 has been codon optimized for 
sequence-specific editing of the DNA in a wide range of organisms, including bacteria (12), 
fungi (13), plants (14) and animals (15-20).
The success of targeted nuclease genome editing tools is dependent on two processes. 
First, the specificity and efficiency of the generation of a DSB at a desired location in the 
genome by the targeted nuclease. Second, the efficacy and fidelity of the endogenous DNA 
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target DNA
target DNA
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C  Transcription activator-like effector nucleases (TALEN) D  CRISPR-Cas system
Figure 1: Targeted nucleases. Adapted from Thermo Fisher Scientific Inc. Schematics summarizing various 
approaches of genome engineering. (A) The meganuclease bound to its DNA target. The catalytic domain is shown 
in grey, which determines DNA sequence specificity and contains nuclease activity. (B) Zinc-finger nucleases (ZFNs) 
recognize DNA using three base pair recognition motifs. Three-four motifs are fused in tandem recognizing adjacent 
sequences to give unique specificity to a particular genomic locus. The motifs are linked to FokI nuclease that digests 
the DNA as a dimer. (C) Transcription activator-like effector nucleases (TALENs) recognize DNA through modules 
that include repeat-variable di-residues. As with ZFNs, two TALENs are used that cut DNA using the FokI nuclease 
dimer. (D) CRISPR/Cas9 system recognizes specific DNA using a guide RNA that brings Cas9 to its complementary 
DNA around a protospacer adjacent motif. Two domains of Cas9 are responsible for DNA cleavage on either stand of 
double strand DNA: the HNH domain cleaves the complementary DNA strand, whereas the RuvC-like domain cleaves 
the non-complementary DNA strand.
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repair mechanism in the cell. Here, we will outline the influence of nuclear organization and 
chromatin structure on both these processes necessary for CRISPR/Cas9 genome editing. 
PART 2: CRISPR/Cas9 
CRISPR
The functions of CRISPR and CRISPR-associated (Cas) genes (nucleases) are essential in adaptive 
immunity of many bacteria and in the majority of characterized Archaea to protect them against 
viruses and plasmids (21-24) (Figure 2). As the name suggests the CRISPR system incorporates 
sequences from foreign DNA in its own genome in arrays of repeat sequences. These repeat 
arrays are transcribed into CRISPR RNAs (crRNAs). Each crRNA consist of a constant part of 
the repeat and the specific incorporated foreign DNA, which is known as the ‘protospacer’ 
sequence. The crRNAs associate with a second RNA, the transactivating CRISPR RNA 
(tracrRNA) (25). crRNA-tracrRNA hybrids together from a guide RNA that recruits Cas enzymes 
to bind and cleave incoming pathogenic DNA carrying the complementary sequence of the 
protospacer (26-31). To prevent cleavage of the protospacer sequences which are incorporated 
in its own bacterial or archaeal DNA, the Cas nuclease needs to have a direct interaction with an 
additional short motif. This motif is positioned in the target DNA right next to the protospacer-
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Figure 2: CRISPR/Cas9 bacterial immune system. Adapted from the Doudna lab. Bacteria 
and archaea possess adaptive immunity against foreign genetic elements using CRISPR–Cas 
systems. Upon infection, new foreign DNA sequences are captured and integrated into the host 
CRISPR locus as new spacers. The CRISPR locus is transcribed and processed to generate mature 
CRISPR RNAs (crRNAs), each encoding a unique spacer sequence. Each crRNA associates with 
Cas effector proteins that use crRNAs as guides to silence foreign genetic elements that match 
the crRNA sequence.
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encoded sequence called protospacer adjacent motif (PAM) (26-28, 32). These PAMs are absent 
in the CRISPR repeat arrays of the bacterial or archaeal genome (Figure 1d).
Exploring the Cas9 nuclease from Streptococcus pyogenes led to a system that is now 
worldwide employed as a genome editing tool (26). The DNA target sequence is specified 
by a 20-nt target recognition segment in the guide RNA. Cas9 is guided to the site and 
upon binding; Cas9 uses its HNH and RuvC catalytic domains to create a precise DSB three 
nucleotides before the end of the target sequence (26, 32). This break occurs only when 
the target site is located adjacent to a PAM sequence that matches 5'-NGG. To simplify the 
system, the crRNA–tracrRNA duplex was fused into a chimeric single guide RNA (sgRNA) (26). 
Thus, any desired DNA sequence of the form N
20
-NGG can recruit the Cas9 nuclease by 
simply customizing the first 20 nucleotides of the guide RNA.
A large variety of Cas9 proteins exists in different bacteria and they efficiently induce 
genome editing (32-34). In addition to Streptococcus pyogenes (SpCas9), these include 
Neisseria meningitidis (NmCas9), Staphylococcus aureus (SaCas9) and Streptococcus 
thermophiles (StCas9). The various orthologues increase the usability of the CRISPR 
systems, because these Cas9 enzymes recognize alternative PAM sequences and use 
distinct crRNAs and tracrRNAs. Another interesting outlook is the combinatorial use 
of orthologous Cas9. Targeted gene knockout and targeted transcription activation 
become possible in a single cell. Recently, the first combinatorial CRISPR screen was 
demonstrated as a proof-of-principle (35). However, with such an approach, the number of 
gRNA combinations is increasing exponentially when adding more target genes. Thus, it is 
limited to a preselected group of gRNAs to keep the strategy feasible. 
APPLICATIONS OF CRISPR
CRISPR as a targeted nuclease
The CRISPR system has made it possible to knock-out target genes in various cell 
types and organisms more quickly and more efficiently. The main advantage of CRISPR 
technologies is the ease with which only ~80-nt sgRNAs need to be synthesized to direct 
Cas9 to unique target sequences and cut the DNA effectively. This gives the possibility 
to use the Cas9 platform for large-scale genome-wide knockout screens in a search of 
genes that contribute to a biological process of interest (Figure 3a). With the previously 
available techniques, this was not feasible (36-39). Researchers were only able to 
perform large-scale with RNA interference (RNAi)-based screens with pooled-RNA 
libraries (40). The RNAi molecules inhibit gene expression by pairing to complementary 
mRNA molecules (36, 41-44).
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Analogous to RNAi screens, sgRNA libraries have been generated for CRISPR/Cas9 targeting 
gene coding regions. This approach generates mutations at the targeted loci that may cause 
complete loss of gene function. Sequencing of the sgRNAs in the library treated cell pool 
show gains or losses of particular sgRNAs that identify genes of interest (Figure 3a) (45). 
A CRISPR/Cas9 screen usually results in a knockout and a more pronounced phenotype due 
to a complete loss of function instead of a knock-down seen in a RNAi screen. CRISPR-based 
screens have already successfully identified essential genes (46, 47) and drug targets (48, 49). 
In addition to targeting the coding DNA, CRISPR-based screening is also used to 
characterize enhancer elements and regulatory sequences (50, 51). This type of analysis is 
important to clarify the role of the non-coding genome.
CRISPR as a targeted modifier
Beyond targeted genome editing, the CRISPR/Cas9 system can also be employed to 
monitor specific chromosomal loci or to regulate endogenous gene expression in living 
cells. For that purpose a nuclease-deactivated Cas9 (dCas9) variant was engineered. It 
carries D10A and H840A mutations that disrupt the HNH and RuvC cleavage domains. 
dCas9 has been fused to effector domains such as GFP, transcriptional activators, 
repressors, and epigenetic modifiers (41, 52-55) that can subsequently be targeted by 
sgRNAs to specific sites in the genome (26, 32). For example, an eGFP-dCas9 fusion has 
been used to visualize DNA with repetitive sequences, such as telomeres, using a single 
sgRNA. For a locus without repetitive sequences 26 to 36 tiled sgRNAs across a 5-kb stretch 
of DNA were required to visualize a locus in vivo (56) (Figure 3c). This imaging strategy 
provides a new possibility to study the conformation and dynamics of chromosomes 
in vivo. Furthermore, it has been demonstrated that dCas9 fused to the transcriptional 
activation domain VP64 or the transcriptional repression domain KRAB (the Krüppel-
associated box domain) can respectively upregulate and downregulate the expression of 
targeted genes in human (52, 57-59) and mouse cells (60) (Figure 3d-e). The use of dCas9 
fusions is exciting because it offers the opportunity to regulate multiple genes in multiple 
ways (i.e. using activation and repression) in a single cell without with overexpression 
constructs. This bring us closer to the possibility to reprogram cells by tuning defined sets 
of genes with high precision and thereby controlling cell behaviour and identity.
CHALLENGES IN CRISPR-MEDIATED GENOME EDITING
Success of this technique is dependent on two processes; targeting the nuclease to the 
correct place and mutagenesis by imperfect repair of the DSB. Although Cas9 has great 
potential for both research and therapeutics, improvements can still be made. In contrast 
to RNAi, ZFN or TALEN which in principle can target any sequence, the target sites for 
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Figure 3: CRISPR/Cas9 System Applications. (A) Adapted from Lopes et al. (190). The sgRNA oligonucleotides 
targeting suitable Cas9 cleavage sites are synthesized, annealed with 3' and 5' cloning primers, pooled and cloned into 
viral constructs to produce a sgRNA expression library, from which viruses are produced to confer stable expression 
of sgRNAs in cells. Virus transduction of cells should ideally be performed such that each cell expresses only one 
sgRNA, but that all the sgRNAs are expressed in the transduced cell population, to maintain the complexity of the 
library. The transduced cells are subjected to a proliferation-based screening selection to identify sgRNAs that confer 
cell growth advantage or disadvantage according to the designed assay, and next-generation sequencing is used 
to assess which sgRNAs were enriched or depleted (shown in red) in the selected cell population. (B) A pair of Cas9 
nickases (Cas9n). A mutation in one of the cleave domains of Cas9 results in a site specific single-strand nick. A pair 
of Cas9n/sgRNA complexes can nick both strands simultaneously and introduce a staggered double-stranded break. 
(legend continued on next page)
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CRISPR/Cas9 are limited to DNA stretches adjacent to a PAM sequence (NGG). With the 
development of Cas9 orthologues, a much broader spectrum of target sites in the genome 
became available already. Additionally, it should be noted that for a complete gene 
knockout it is mandatory that all copies of a particular gene are mutated by CRISPR/Cas9. 
This makes a knock out screen more challenging as normal cells usually have two alleles. 
More than two alleles are often found in cancer cells (61). 
A more significant challenge lies in the specificity and efficacy of the method, especially for 
use in clinical applications. A big concern is potential off-target cleavage activity where a 
designed Cas9/sgRNA also induces a DSB elsewhere in the genome other than the intended 
target site, resulting in unwanted mutations (62-64). Reducing the concentration of either 
the Cas9 or sgRNA in the cells or minimalizing the duration of exposure of the CRISPR 
complex using inducible systems will diminish this problem (62, 65). Yet, these strategies 
often come at the cost of efficiency, which is important to successfully obtain a desired 
model system without having to screen hundreds of cells. In screens only efficient gRNAs 
are detected with a clear phenotype above the background. For clinical applications, one 
should keep in mind that an enormous number of affected cells have to be effectively 
mutated to influence the disease in a patient with for example Duchenne Muscular 
Dystrophy or Retinitis Pigmentosa. This emphasizes the importance of an efficient system. 
Specificity
To assess CRISPR specificity, guide RNA variants containing one to four mismatches in 
the protospacer region have been generated and tested for their capability to guide Cas9 
nuclease to a reporter-gene (63) or endogenous gene target sites (15, 62). Mismatches 
at the 5' end often appeared to be harmless for the recognition of the intended target. 
In contrast substitutions in the 3' end are less tolerated. Therefore, it was concluded 
that the stretch of 8-12 base pairs at the 3 'end (seed area) is very important for target 
recognition (12, 15, 26, 66, 67). However, this rule does not apply to all single or double 
mismatches; it has been reported that some mismatches in the 5 'end decreased the 
specificity, while other mismatches in the 3' end did not have a marked effect (63). 
A complementary approach to study the specificity was to investigate the activity of 
Cas9 to target potential off-target sites, (i.e. loci that have few nucleotide mismatches 
compared to the designed gRNA target sequence). Algorithms were developed to find 
possible off-target sites in the human genome that differ 1–6 nucleotides with the 
on-target site (62, 63, 68-71). Sequence analysis revealed that off-target sites that differ 
The D10A mutation (RuvC-mutant) renders cleavage of only the strand complementary to the sgRNA and generated 
a 5’ overhang. The H840A/N863A mutation (HNH-mutant) cuts only the strand similar to the sgRNA and leaves a break with 
a 3’ overhang. (C-E) Nuclease-deficient Cas9 with mutations in both cleavages domains can be fused with various effector 
domains allowing specific localization. For example with fluorescent proteins (C) transcriptional activators (D) and repressors (E).
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by as many as five positions in the protospacer region, can still be edited by the CRISPR 
system (63). In addition the alternative PAM sequence, NAG, appeared to be effective 
for targeting by the sgRNA-Cas9 complex (62). Surprisingly, some research groups 
observed that the resulting insertion and deletion (indel) mutations at these off-target 
sites have sometimes comparable frequencies as those for the on-target site (63, 70, 71). 
Another whole-exome sequence study of three CRISPR treated K562 cell lines did not 
find evidence for Cas9-induced off-target mutations (72). Overall, these results suggest 
that the contribution of off-target editing is variable for diverse guide RNAs and that it 
is possible to target locations in the genome with high specificity. Based on published 
studies it is still difficult to predict the precision of a particular guide RNA. 
Efficiency
Like the variability in cleaved off-target sites, there is also a high variability of 
on-target efficacy. Several research groups have published web-based software for the 
identification of CRISPR target sites and potential off-target sites in the organism of 
interest (e.g., CHOPCHOP (http://chopchop.cbu.uib.no/) (73) and the CRISPR Design Tool 
(http://crispr.mit.edu/) (62)). Nevertheless there is a lack of knowledge regarding the 
underlying rules that determine whether the CRISPR/Cas9 system will effectively target 
a given region of interest. To obtain an effective guide that introduces indels normally a 
few gRNAs should be tested per target site. For the incorporation of designed mutations 
by donor template-mediated HDR various guide and template combinations should be 
tested to find an efficient one.
To improve gRNA design for nuclease Cas9 to maximize the predictability of efficiency, 
several groups extracted information from large data sets to find correlations for specific 
sequence compositions (74, 75). Doench et al. constructed a library of sgRNAs targeting all 
possible sites across a handful of genes and tested their ability to make full gene knockout 
using antibody staining and flow cytometry readout (39). Sequence features were revealed 
that make sgRNAs most effective in various contexts. For example, a sgRNA expressed from 
a U6 promoter in mammalian cells should not contain a stretch of four or more uracils (U's) 
in a row otherwise RNA polymerase III will prematurely terminate the transcript (76). Also a 
stretch of U's near the 3' end of the guide sequence is unfavourable for Cas9–sgRNA binding (36). 
In general long stretches of the same nucleotide greatly decrease sgRNA activity (41). 
The results are mixed concerning the effect of GC content. A paper by Wang et al. 
suggests that sgRNAs with a very high or low GC content are less effective when combined 
with nuclease Cas9 (36). Another study reported that variations in GC content did not 
significantly change the effectiveness of dCas9 fused to effectors (41). Although progress 
has been made in predicting more effective gRNAs, it is obvious that more factors than 
gRNA sequence alone affect CRISPR/Cas9 efficacy.
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IMPROVED CRISPR MOLECULES
To improve the specificity and efficiency of the CRISPR system a closer look has been 
taken at the SpCas9 protein structure, guide RNA secondary structure, spacer sequence 
composition and length.
Optimization at the Cas9 level
To reduce the off-target effect of Cas9, Cas9 nickase mutants were developed with mutations 
of the catalytic residues (D10A in RuvC or H840A in HNH) (15, 17, 32) (Figure 3b). In contrast 
to wild-type Cas9, the nickase variants introduce gRNA-targeted single-strand breaks in DNA 
instead of the double-strand breaks. By using two Cas9 nicking enzymes directed by a pair 
of gRNAs targeting opposite strands of a locus results in a DSB while minimizing off-target 
activity (15, 69, 77, 78). Alternatively, protein engineering of SpCas9 produced a high fidelity 
variant with reduced non-specific DNA contact while retaining on-target activity (79, 80). 
Therefore, substitutions were introduced into the Cas9 domain that interacts with the gRNA 
and the target DNA resulting in the variants with high specificity called eCas9(1.1) (79) and 
Cas9-HF1 (80). It is thought that the substitutions diminished the stability of the Cas9–gRNA 
interaction that introduces conformation changes necessary for active cleavage, thereby 
favouring the on-target cleavage (79, 80). An alternative explanation is that the engineered 
Cas9 molecules are unable to undergo conformational change to activate the NHN nuclease 
domain when bound to mismatched targets (81). Based on this hypothesis, new Cas9 
variants were developed with high specificity: HypaCas9 (81) and evoCas9 (82). Both carried 
mutations in the REC3 domain. This domain binds to the RNA-DNA duplex and is believed to 
be important for linking the active part of the NHN domain (81). 
Optimization at guide RNA level
At the RNA level, it was shown that off-target effects were minimized by decreasing the 
length of the gRNA-DNA pairing to 17-18 bp. Longer constructs can compensate for 
mismatches and still retain robust binding, while shorter gRNAs have less complementary 
RNA to bind the DNA and as a result are more sensitive to mismatches. gRNAs with 
decreased pairing length generally functioned efficiently at the intended target site and 
provides a simple flexible approach to minimize the off-target effects. The use of shorter 
gRNA does not impair the targeting range because a site of 17 or 18 nt of complementarity 
is equally unique in the human genome as those target site of 20 nt (70). 
gRNAs were studied that comply with the above mentioned rules to improve efficiency, but 
it resulted in poor cleavage activity in vitro and in vivo. These impaired gRNA sequences 
revealed that potentially hairpin structures could be formed in the protospacer region of 
the gRNA. Substitutions that disrupt these predicted hairpins improved cleavage whereas 
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control substitutions in different areas of the gRNA were neutral (83). A model was 
proposed where the constant scaffold of the gRNA binds strongly to the Cas9 protein while 
the protospacer sequence has more conformational freedom. This allows the protospacer 
sequence to invade the target DNA strand, but also to form potentially harmful secondary 
RNA structures, which explains why secondary structure of the protospacer sequence 
affects Cas9 activity (84). Considering that the RNA structure has a key role for the binding 
of the complex to the target DNA, it should be noted that the chimeric sgRNA is 10 bp 
shorter than the native crRNA-tracrRNA duplex (26). It was shown that this does not 
reduce functionally in vitro, while conflicting results are found in vivo. Dang et al. showed 
enhanced efficiently when extending the sgRNA, while Hsu et al. do not find an effect 
of extension (62, 85). Probably, the enhanced effect is dependent on the target site, but 
the extension of sgRNA has no reported negative effect. The Cas9/sgRNA complex seems 
optimal when it is stable enough to form a complex, but flexible enough to engage at 
target site to form a subtle ‘weak-ish’ interaction that is sensitive for mismatches. 
PART 3: DNA Repair
DNA CLEAVAGE FOLLOWED BY DNA REPAIR
In order to perform successful targeted genome editing, a DSB is first introduced at the to-
be-modified genomic location as explained above. Second, repair of the break has to occur 
whereby the DNA is edited. The break can be repaired by intrinsic cellular mechanisms, 
such as non-homologous end joining (NHEJ) or homology directed repair (HDR). 
In addition to these, other (back up) DNA repair pathways have been described and are 
grouped under the name of alternative end joining (A-EJ) (86). The roles of the latter are 
less well understood. Moreover, the choice of pathway is also not completely clear. The 
relative usage of the various pathways may depend on species, cell type, phase of the 
cell cycle and chromatin state in which the DNA damage is encountered.
DNA damage response
Cells have evolved mechanisms that act upon damage of the DNA, collectively referred to 
as DNA damage response (DDR). Sensors detect DNA lesions after which a series of signal 
transductions is initiated by protein kinases (87). The initial activated kinases are the ataxia 
telangiectasia-mutated protein (ATM), the ATM and Rad3-related kinase (ATR) and the 
DNA-dependent protein kinase (DNA-PK). These kinases have the ability to phosphorylate 
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residue 139 of histone variant H2AX (γH2AX) at the chromatin flanking the breakage site (88, 89). 
Proteins involved in repair and checkpoint activation are then recruited to the DSB site, 
visible as foci in immunofluorescence (Figure 4). ATM, MDC1, the MRN complex and the 
RING finger E3 ubiquitin ligases RNF8 and RNF168 are among the earliest factors found 
in DNA damage foci (90). 53BP1 and BRCA1 appear later and their recruitment depends 
on the aforementioned upstream factors (91). Phosphorylation of 53BP1 or BRCA1 by ATM 
plays a role in the selection of the repair pathway to control resection of the DNA ends. It 
has become clear that the degree of 5' to 3' resection has a major impact on the choice of 
repair pathway. DNA-ends with long 3' overhanging tails are destined for HR repair (92, 93). 
53BP1 is a negative regulator of resection (94) while BRCA1 promotes the removal of 
53BP1 to enable resection (95), but how cells switch from a preferred NHEJ to a resection-
dependent pathway is unclear.
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Figure 4: DNA damage response. Figure elements adapted from (191-193). Schematic representation of 
DNA damage response signalling pathway. ATM responds to DNA double-strand breaks and is activated, 
this is followed by the phosphorylation of H2AX and localization of MDC1 to the break. Then several 
repair proteins are recruited to the site of damage e.g. via ubiquitination of H2AX by RNF8 and RNF168 E3 
ubiquitin ligases precedes recruitment of repair proteins such as BRCA1 and 53BP1. ATM also regulates 
cell-cycle checkpoints through the activation of CHK2 and p53. See text for further details.
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Canonical nonhomologous end-joining
The canonical form of NHEJ ensures that the broken DNA ends are joined together. In this 
process, the first protein that responds to double-strand breakage is Ku70/Ku80, which is 
present in very high concentrations in cells (Figure 5a). Once bound, the Ku-heterodimer 
serves as a scaffold to recruit other NHEJ factors to the damage site including DNA-PKcs (96), 
X-ray cross-complementing protein 4 (XRCC4) (97-99), DNA ligase 4 (98), XRCC4-like 
factor (XLF) (100) and end-processing enzymes (polymerases μ and λ, and the 
Artemis nuclease). Upon binding of DNA-PKcs to the DNA-Ku complex, the Ku-heterodimer 
translocates further on the DNA strand (101, 102). At the DNA ends, the DNA-PKcs 
molecule forms a specific structure that holds the two sites close together (103-105). This 
complex of Ku and DNA-PKs prevents access to nucleases and ligases to process the DNA 
termini (105, 106). Subsequently, DNA-PKcs is activated, which in turn mediates auto-
phosphorylation as well as phosphorylation of other NHEJ factors (107). Autophosphorylated 
DNA-PKcs causes a large conformational change that is thought to promote its dissociation 
from the DNA ends. Access of end-processing enzymes to the termini of the double strand 
break is then allowed (108-110). End-processing includes the removal of mismatched 
nucleotides by nucleases and/or resynthesis by DNA polymerases to create ends that are 
compatible for ligation. Different end-processing enzymes are active, depending on the 
status of the DNA termini. Ligase 4 and its co-factor XRCC4 anneal the DNA ends. Although 
the exact role of XLF is unknown, it interacts with the XRCC4/DNA ligase 4 complex and is 
therefore thought to participate in the ligation step (111).
Homology directed repair
Higher eukaryotes are also capable of repairing DSBs by using the sister chromatid as 
a homologous template (Figure 5b). As consequence this homologous recombination 
pathway (HR) is limited to the S and G2 phases of the cell cycle, in which the sister chromatid 
copy is generated by DNA replication. The initial step in HR is DNA nucleolytic end 
resection at the break site by the MRN complex (comprising Mre11, Rad50, Nbs1). The MRN 
complex is an important sensor of DNA DSBs and promotes long-distance resection by the 
endo/exonucleases Exo1 and Dna2 together with additional proteins such as BLM helicase, 
CtIP and the tumour suppressor protein BRCA1 (112-117). During resection, nucleotides 
are removed from the 5 'ends leaving long 3' single-stranded DNA (ssDNA) overhangs on 
both sides of the fracture. These 3' ssDNA tails are coated and stabilized by the replication 
protein A (RPA) complex. This complex is then displaced by Rad51 recombinase, forming 
Rad51 nucleoprotein filament. BRCA1 promotes the recruitment of BRCA2 (118, 119) which 
assists loading of Rad51 (120). The Rad51 recombinase then performs strand invasion by 
pairing with the complementary strand of the sister chromatid, thereby forming a D-loop. 
The invading strand is extended by DNA polymerase using the sister chromatid as a 
template until it reaches the area homologous to other side of the fracture. The lagging 
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strand also has a 3' overhang and can recover by either forming another junction with the 
homologous chromatid followed by gap filling or by extension along the receiving DNA 
duplex. DNA ligation links the DNA ends and newly synthesized sequences together.
Alternative and microhomology-mediated end joining
Studies have shown that in addition to C-NHEJ and HR a different pathway of DSB 
processing is operational. It is based on the simple end joining principles, but slower than 
C-NHEJ (half-lives from 30 minutes to 20 hours) (121-124). This repair route, commonly 
named alternative end joining (A-EJ) is Ku or ligase 4 independent (125). Proteins involved 
in A-EJ are PARP1, the MRN complex and CtIP that perform DNA end processing. PARP1 
accumulates factors to promote ligation including the ligation complex XRCC1/Lig3 (86) 
(Figure 5c). Occasionally, microhomologies are utilized in this pathway to process the 
DSB, although the use of microhomologies is not an exclusive feature of A-EJ. Therefore, 
this subset of A-EJ is also termed microhomology-mediated end joining (MMEJ) (125-127). 
It is thought that A-EJ will engage at DSBs when either C-NHEJ or HR have attempted to 
process the DSB but somehow failed. Thus, at these DNA ends, factors of either C-NHEJ or 
HR can be present when A-EJ takes over the DSB processing. 
DNA REPAIR IN CHROMATIN CONTEXT
There is increasing evidence that the chromatin micro-environment and specific histone marks 
around DSBs are crucial for the efficiency and fidelity of DNA repair pathways. Monitoring 
of chromosomally integrated fluorescent reporter substrates demonstrate that C-NHEJ and 
HR are strongly influenced by chromosomal location (128). This variation of pathway usage 
may be explained that direct repair of DSBs in compact structures like heterochromatin 
is a challenge that cells need to overcome to preserve genome integrity (129-132). 
It has been proposed that after damage in compacted DNA, the chromatin needs to 
decondense first before repair proteins have access to the lesions (129, 130). ATM 
kinase seems to play a role in this process. It has been reported that in ATM null cells 
the majority of DSBs (~85%) is repaired with normal kinetics while the remaining breaks 
stay unrepaired for longer times after damage (133). However, inhibition of ATM in 
parallel with knockdown of the heterochromatin proteins KRAB-associated protein 1 
(KAP-1) or heterochromatin protein 1 (HP-1) rescues these persistent DSBs (129). This 
finding supports the idea that phosphorylation of KAP-1 at residue Ser824 by ATM drives 
the relaxation of heterochromatin (129-131). In addition, decreasing the chromatin 
compaction by histone deacetylases (HDACs) or by reducing the levels of linker histone 
H1, enhances DDR signalling (134, 135). In euchromatin, ATM inhibition had no major 
effect on the repair of DSBs (129). 
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Repair kinetics
Chromatin complexity and the need for relaxation upon damage has been suggested to 
delay repair kinetics in an effort to concentrate effector proteins to the damage site (130). 
DSB repair within heterochromatin was found to be roughly 2-fold slower than repair 
within regions of euchromatin (129). Inhibition of ATM lowered the rate of heterochromatic 
DSB repair further, while having little effect on repair of euchromatin (129). In contrast to 
this observation, Janssen et al. noticed similar kinetics for DSB repair in euchromatin and 
heterochromatin of Drosophila (136). Live cell imaging assays revealed that cells can use 
either C-NHEJ or HR to repair DSBs in heterochromatic and euchromatic regions of the 
genome with similar kinetics. A difference in the spatial displacement of the majority of 
the heterochromatin breaks is observed, but the movement is absent in the euchromatin 
breaks (136, 137). The relocation of foci has been shown to require the presence of resection 
proteins (137). It seems that breaks and their repair in heterochromatin behave differently 
when compared to euchromatin breaks and that the kinetics of chromatin decompaction 
may differ in various model systems.
DNA mobility 
It has been suggested that there is a connection between the compaction state of the 
chromatin and the ability of a damaged locus to relocate (136, 137). In the absence of 
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damage, movements of the DNA are constrained by multiple cellular and physical 
properties leading to the retention of chromosomes within defined regions of the 
nucleus called ‘chromatin territories’ (138). In yeast, there is clear evidence that DSBs 
induce chromatin mobility (139). In higher eukaryotes, the issue of DSB is controversial 
due to conflicting results (140-144). As mentioned above, in Drosophila, single and global 
DNA damage leads to expansion of pericentromeric heterochromatin and relocation of 
heterochromatic foci to the periphery of the heterochromatin domains (136, 137). A similar 
relocation was observed upon single ion micro-irradiation of mouse chromocenters that 
represent constitutive heterochromatin (140). Conversely, UV or γ-rays induced DSBs 
were found to have only limited mobility, but did lead to a localized decondensation of 
chromatin (141, 142). Moreover, induction of multiply damaged sites (including DSBs, 
single strand breaks and base damages) did not cause relocation nor did nuclease induced 
DSBs in a heterochromatic transgene locus carrying >100 repeats (143, 144). 
In yeast, resection of DNA ends was found to be key in regulating the mobility of breaks in the 
process of homology search (145). In mammalian cells, the constraint on mobility was shown 
to be dependent on Ku80, a component of C-NHEJ repair pathway. It appeared that the 
C-NHEJ machinery is tethered to the DSB ends for rapid repair, thereby limiting mobility (143). 
From these findings it was proposed that DSB relocalization in heterochromatin depends 
on resection and DNA repair pathway choice (137). But how this choice is made in 
heterochromatin remains unclear. It is clear that a simple model where euchromatin or 
heterochromatin determines the type of damage repair pathway is an oversimplification.
Organizing DNA repair in the nucleus 
The classic definition of transcriptionally active, open euchromatin, and compacted, 
silent heterochromatin, understates the high diversity of chromatin states. For example 
heterochromatin can have various different chromatin make-ups (146). The most compacted 
form of heterochromatin is typically rich in deacetylated histones and histone H3 
trimethylation on lysine 9 (H3K9me3). This mark can be bound by repressive proteins such 
as KAP-1 and HP-1 (147-149). Another form of heterochromatin is more flexible and its level 
of compaction can change, for example during differentiation. This state is represented by 
histone H3 trimethylation on lysine 27 (H3K27me3) and polycomb-repressive complexes (146). 
Moreover, chromatin that is often found in genomic regions associated to nuclear lamina 
(lamina associated domains) is abundant in H3K9me2 and the boundaries are enriched with 
H3K27me3 (150). The majority of genes in these regions are silenced (146). 
 
Several studies investigating DSB repair show that kinetics and choice of repair pathway 
may vary between the different heterochromatic compartments. It was found that DSBs 
induced by I-SceI in a mammalian locus that was experimentally tethered to the nuclear 
lamina could not recruit the HR associated factors BRCA1 and Rad51. Instead the breaks 
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were mainly repaired by C-NHEJ. Also the A-EJ pathway appeared to be active at these DSBs, 
possibly repairing breaks in which resection already had taken place (151). Interestingly, 
these breaks induced near the nuclear membrane did not relocate to areas that were more 
permissive for HR and were rather repaired by alternative end joining (151). 
In contrast, DSBs introduced near nuclear pores, where the chromatin microenvironment 
is more open when compared to that at the lamina, use both C-NHEJ and HR pathway for 
repair (151). Also breaks in centromeric and pericentric heterochromatin Ku80 was able 
to recruit both the C-NHEJ protein Ku80 as well as the HR protein Rad51. Recruitment of 
Ku80 to the break occurs throughout the cell cycle and leaves locus positionally stable. 
Recruitment of Rad51 seems to be domain specific, centromeric lesions tether Rad51 protein 
at all stages of the cell cycle and relocate the foci toward euchromatin. DSBs in pericentric 
heterochromatin however recruit Rad51 exclusively at post-replicative chromatin at the 
periphery of the heterochromatin domain. The recruitment of Rad51 throughout the cell 
cycle in centromeric breaks is surprising since HR normally requires a sister chromatid for 
DNA repair, though the Rad51 recruitment is enhanced in G2. One might speculate that 
this could account for HR being licensed throughout the cell cycle and perhaps uses its 
own repeats in cis as a template or persist until it passes through S-phase (152, 153).
Although both types of heterochromatic domains are condensed, they are unique in 
chromatin modifications, DNA sequence and histone variant composition. Pericentric 
heterochromatin is enriched in H3K9me3 and HP-1s, while in the centromere core domain 
no H3K9me3 could be detected. The centromere core domain consists of nucleosomes 
carrying H3 and the H3 variant, CENP-A (154). The H3 nucleosomes comprise marks for 
active chromatin including H3K4me2, H3K36 methylation and H3 acetylation, (154). It was 
shown that H3K36me3 promote DNA ends resection and HR (155, 156). Possibly only the 
marks present at the centromere make the chromatin permissive for resection in G1.
In pericentric heterochromatin, DSBs are positionally stable in G1 and can recruit C-NHEJ 
factors. In S/G2, resection takes place and the DSBs are relocated to the periphery of the 
heterochromatin, where they are retained by Rad51. It has been proposed that the spatial 
movement of the break site prevents the activation of mutagenic pathways and illegitimate 
recombination between repetitive sequences in trans. As centromeres from different 
chromosomes are spatially separated within the nucleus and do not cluster together, the 
risk of chromosomal translocations is minimal in the presence of active HR. 
Along the same line of thought two studies were performed in which DSBs were generated 
within repeats of nucleoli of mammalian cells using endonucleases and showed that the 
choice of repair pathways regulates the spatial movement of the break (153, 157). In both 
cases the DSBs and the rDNA chromatin itself were detected at the periphery of nucleoli 
indicating that relocation had occurred. The relocation was associated with transcriptional 
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silencing. Inhibition of ATM blocked the transcriptional silencing and prevented the 
reorganization of nucleoli and the rDNA. In addition, blocking of C-NHEJ resulted in 
enhanced nucleolar reorganization and transcriptional silencing, which was not observed 
by blocking HR. Repair of rDNA by HR was also found to generate a loss of rDNA repeats; 
this effect was increased by loss of C-NHEJ (158). These complementary studies suggest that 
C-NHEJ occurs rapidly within nucleoli to maintain rDNA transcription. However, when these 
breaks remain unrepaired by C-NHEJ they are transcriptionally silenced and relocalized to 
the nucleolar periphery where they can be recognized by the HR machinery. Altogether, 
different forms of chromatin regulate DNA repair pathway choice in a unique fashion. 
Communication between DSB response and transcription 
Although most heterochromatin is not transcribed, breaks in rDNA repeats indicated a link 
between DSB response and transcription silencing. A system was developed in U2OS cells to 
visualize the DSB response and the effect on nascent transcription simultaneously. Multiple 
breaks are introduced in a LacO cassette 4 kb upstream of an inducible YFP transcription 
unit in which the 3'-UTR (untranslated region) contains 24 repeats of a stem loop structure 
that is recognized by phage coat protein MS2 (159, 160). This enables real time visualization 
of the DSB introduced by mCherry-LacI-FokI and the nascent transcription through the 
expression of YPF-MS2. Introduction of a DSB upstream of the transcriptional start site 
effectively silences RNA Pol II-dependent transcription in an ATM and ubiquitin-dependent 
manner. Transcription was rapidly restored upon removal of FokI and DSB repair (161). 
This transcriptional reporter system also revealed that ATM-dependent silencing 
suppressed transcriptionally induced chromatin decondensation (160). The finding that 
the DSB response can suppress transcription associated chromatin decompaction seems 
contradictory, since DSBs themselves induce decompaction. However, it is likely that the 
pre-existing state of chromatin at the time of DSB induction influences the nature of the 
DSB response and the outcome of ATM signalling. Transcriptionally active regions are 
often more open as compared to inactive compacted DNA.
After transcription silencing, DNA repair occurs. Regions with actively transcribed genes 
were found to only associate with recruitment of the HR-protein Rad51 and not with the 
C-NHEJ protein XRCC4 using chromatin immunoprecipitation-sequencing (ChIP-seq). In 
these areas the transcription-elongation associated histone mark, histone H3 lysine 36 
tri-methylation (H3K36me3) was present. In agreement with this, the methyltransferase 
placing this mark, SETD2, has been shown to be required for the recruitment of CtIP (CtBP-
interacting protein) which in turn promotes DNA end resection and HR (162). 
In a subset of these HR-prone regions, DSBs cluster together. Clustering of damaged 
genes occurs primarily during the G1 cell-cycle phase and coincides with delayed repair 
as has been shown by capture Hi-C. The study revealed that DSBs induced in active genes 
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are prone to be repaired by HR in post replicative cells, but to be refractory for repair in 
the G1 phase (163). Interestingly, this behaviour is similar to other large scale DSB mobility 
events in heterochromatin mentioned before that are associated with persistent or 
‘difficult’ DSBs (137, 139, 152, 153, 164). The reasons underlying repair deficiency at active 
genes in G1 remain unknown. Maybe, DSBs cluster to be prepared for faithful repair. Since 
the other available pathway that can accommodate resected/processed ends in G1 is A-EJ, 
this might be too detrimental for the cell given the high mutation rate associated with this 
pathway. Clustering may help to inhibit such error prone repair pathway to sequester DSBs 
from the rest of the genome, while awaiting a more appropriated cell cycle phase (163). 
Overall it emerges that spatial positioning of DSBs in the highly compartmentalized 
nucleus may have significant implications for fidelity and choice of repair pathways.
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Figure 6: Genome editing with CRISPR/Cas9. The Cas9 nuclease is directed to target site by its 
sgRNA and introduces a double stranded break. The break is repaired by one of two mechanisms: 
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PART 4: CRISPR/Cas9 – DSB Repair – Chromatin Interplay
REPAIR FIDELITY OF CRISPR INDUCED BREAKS 
How can repair by endogenous pathways result in edits in the DNA after a Cas9-induced 
DSB? The C-NHEJ pathway ligates the two broken ends together and has no built-in 
mechanism of restoring the original sequence around the DSB. Therefore, small mistakes 
such as insertion or deletion mutations of various lengths can be introduced at the targeted 
location during repair. When these indels land in the coding or regulatory region of a gene 
they may lead to functional knockouts due to disruption of the reading frame of a gene, 
the promotor region, binding sites for transcription factors or enhancer regions (165). 
Using the homology directed repair (HDR) pathway, designed (point) mutations or 
specific sequences can be inserted by recombination of the target locus with exogenously 
delivered DNA donor templates (166, 167) (Figure 6).
Several methods have been developed to monitor the induction and re-joining of DNA 
DSBs in the genome. Direct detection of DSBs includes comet assay (168) or pulsed-
field gel electrophoresis (121). These techniques lack sensitivity and are unable to 
monitor DSB repair where only a few DSBs are induced or remain. Other strategies use 
immunofluorescence against DSB markers such as γH2AX, combined with microscopy, flow 
cytometry or chromatin immunoprecipitation (169-171). These techniques are limited by 
the requirement to use fluorescent proteins or luciferase-based readouts as a substitute 
for DSB repair activity. The difficulty with tracking of molecular components is that it is 
unknown how their accumulation and dissociation at the break site relates to the actual 
process of repairing of the DNA break. Recently, an alternative approach was reported in 
which next-generation sequencing was used to study DSB formation and DNA repair. This 
method does not depend on the expression of reporter genes and provides a direct read-
out for repair and has the power to study multiple sites at the same time (172-176). Several 
computational tools have become available to analyse the sequence data (177-179).
In a systematic study, the repair outcomes of 223 CRISPR targets were monitored in the 
human genome. It was shown that at some sites one or two repair events were dominant, 
while at other locations a wide variety of repair events took place at lower frequency. 
After Cas9-induced DSB the pattern of DNA repair at each target site appeared not 
to be random and was consistent between experimental replicates, cell lines or 
reagent delivery methods (180). Using different reporter cell lines and inhibitors it was 
demonstrated that multiple repair pathways can resolve a single Cas9-mediated DSB. 
From these experiments, it has been suggested that the presence and polarity of the 
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overhanging structure is a critical determining factor for the pathway choice of double-
strand break repair (180-182). This assumption was supported by the observation that 
where a Cas9 nickase mutant produced a staggered DSB, it resulted in different repair 
products (181) (Figure 3b). In addition, micro-homologies were found in the DNA sequence 
neighbouring the DSB where larger deletions were introduced during repair in the absence 
of DNA-PKcs (180). The presence of microhomologies and the type of DNA ends clearly have 
implications for the choice of repair pathway and offer opportunities to improve the ability to 
steer genome editing outcome. However, for a particular target site or CRISPR variant, the repair 
outcome results in a complex mixture of multiple mutations. It is a matter of balancing between 
the preferences for repair pathways in order to optimize the desired DNA editing outcome.
CRISPR IN CHROMATIN CONTEXT 
Although the CRISPR system has been optimized in vitro in test tubes, most applications 
of the CRISPR are in vivo in cells and animals. There are still discrepancies between the 
activity of CRISPR/Cas9 on episomal targeted DNA or genomic DNA, suggesting that like 
for DNA repair, chromatin structure influences the working of CRISPR. 
Accessibility 
Cas9 nuclease activity has been shown to correlate with the absence of repressive 
histone marks and increased accessibility. This was demonstrated by a reporter locus 
construct harbouring an array of tetO elements that can switch from compact to 
relaxed chromatin through doxycycline (Dox) dependent release of tTR-KRAB fusion 
protein. Binding of KRAB proteins triggers recruitment of chromatin remodelling 
factors such as KAP-1 and HP-1 resulting in epigenetic silencing. This system and 
similar reporter assays revealed that in a closed chromatin conformation CRISPR/Cas9 
nuclease yields less edited target sites than in relaxed chromatin (183, 184).
A library-on-library approach demonstrates a similar correlation. Hereby the activity 
of CRISPR/Cas9 was evaluated with a library of sgRNAs of ~1400 endogenous target 
sites, compared to CRISPR/Cas9 activity of a lenti virus library of corresponding target 
sites integrated mostly in open chromatin. The target sites that had different editing 
frequencies in the two libraries were often found in region of low DNAseI accessibility (185). 
Furthermore, in zebrafish CRISPR/Cas9 mutagenesis efficiency was found to be positively 
correlated with chromatin accessibility at different stages of development (186).
Additionally, single molecule imaging studies have demonstrated that dCas9 
explores euchromatin more frequently than it does heterochromatin (187). All 
these studies together indicate that Cas9 nuclease is less active in more compacted 
chromatin.
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At a smaller scale, chromatin folding by the nucleosomes restricts the activity of CRISPR/Cas9. 
Detailed biochemical studies with a variety of nucleosomal templates and in vivo studies 
using Mnase occupancy, demonstrated that the intrinsic stability of the histone-DNA 
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Figure 7: Nuclear architecture and DNA damage. (A) A scheme illustrating the hierarchical structure of interphase 
chromatin adapted from Razin et al. (195). Chromosome territories (at the top of the picture) are partitioned into A- and 
B-compartments formed by long-range spatial interactions between distant genome loci and containing active and 
repressed genome regions, respectively. At a sub-megabase level, chromatin is folded into topologically-associating 
domains, TADs, commonly interpreted as self-interacting globular structures the positions of which are largely 
conserved across cell types. The internal structure of TADs is represented by arrays of so-called loop domains formed 
by spatial contacts between CTCF/cohesin-binding sites. (B) Figure elements adapted from (191, 196, 197). Several 
epigenetic regulators define the chromatin state of cells. Relevant epigenetic marks include histone modifications, 
DNA methylation and incorporation of different core histone variants (yellow and orange cylinders) that alter 
accessibility of the DNA (dark blue line). The main histone marks, the active H3K4me3 and the repressive H3K9me3 
are positively regulated by specific histone methyltransferases (HMTs; including SETDB1) and negatively regulated 
by the respective histone demethylases (HDMs). The methyl group is indicated as a green hexagon (Me). Histone 
acetylation also marks active chromatin, and the acetyl group (the red triangle, Ac) can be added through histone 
acetyltransferease (HATs) and removed by histone deacetylases (HDACs). Phosphorylated histone residues are often 
associated with gene activation (yellow circle, P). DNA methylation (yellow stars) is typically present in heterochromatin 
(marked by H3K9me3 and HP-1). DNA can be hypermethylated, as a result of the action of DNA methyltransferases 
(DNMTs). In euchromatic regions DNA is generally unmethylated. The chromatin make-up of a region can influence 
the efficiency of CRISPR guide RNA. (C) Adapted from Stratigi et al. (198). DNA double strand breaks and repair in 
various structures in the nucleus that affect the DNA mobility and repair kinetics, e.g. damage in lamin associated 
domains, near nuclear pore or at the nucleolus. The radial distribution of chromosome territories in the nucleus 
as well as the level of chromatin compaction affect the DNA accessibility to damage and the DNA repair kinetics.
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interactions, the location of the target site within the nucleosome and the action of 
chromatin remodelling enzymes play critical roles in regulating the activity of SpCas9 
(Figure 7b). Target sites located in DNA that is wrapped around a nucleosome are subjected 
less to digestion than sites in the linker DNA between nucleosomes. The activity could be 
recovered when the nucleosome was relocated by remodelling enzymes (188, 189). 
To improve CRISPR/Cas9 activity in compact chromatin regions, chromatin decondensation 
or derepression by chromatin-factor drugs such as histone deacetylase (HDAC) inhibitors or 
DNA methyltransferase could be a strategy. However, such an approach may affect the cells 
in unintentional or undesired ways. A localized approach could be beneficial, for example 
in combination with a Cas9 orthologue or TALE fused to a decondensation effector protein.
PART 5: Outline of Thesis 
CRISPR/Cas9 is powerful technology that has greatly changed the scientific field for genome 
editing and has the potential to have an impact on gene therapy/genome modification 
in future. Despite the broad application, the process of repair of Cas9-induced DSBs has 
been only partially characterized. It is clear that both the sequence and location are in 
important for guide efficacy, but it is not known how long it takes before an individual 
Cas9-induced DSB is repaired, how error-prone this process is and what the influence of 
chromatin is on these aspects. To reconcile current discrepancies it will be important to 
develop systems whereby DSBs can be induced within different chromatin states in the 
same biological system to determine how this influences chromatin dynamics. However, 
at present methods to track CRISPR/Cas9 induced DSB repair with high specificity and 
resolution throughout the genome in time are lacking. Therefore a toolbox of methods is 
developed to study the fidelity and kinetics of repair CRISPR/Cas9 induced DSBs; which 
repair pathways are involved and how the chromatin status affect these processes. 
Chapter 2 introduces TIDE, a method for quantitative detection of insertions and deletions 
after repair of a targeted DSB. 
Chapter 3 describes TIDER, a method based on the TIDE algorithm to quantitate the 
number of homologous directed repair events driven by a donor template.
Chapter 4 specifies the major procedures and nuances that help improve the TIDE and 
TIDER methods.
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Chapter 5 presents quantitative modelling of the accumulating indels after Cas9-induced 
DSB at a single locus in the genome to study the kinetics and fidelity of cutting and repair. 
Chapter 6 describes a strategy to monitor the chromatin effect on CRISPR/Cas9 induced 
DSB repair. A variant of the TRIP assay was designed to track DSB repair at multiple loci in 
the genome in parallel.
Chapter 7 closes with a general discussion of results presented in this thesis and highlights 
the direction of future research.
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2ABSTRACT
The efficacy and the mutation spectrum of genome editing methods can vary substantially 
depending on the targeted sequence. A simple, 
quick assay to accurately characterize and quantify 
the induced mutations is therefore needed. Here 
we present TIDE, a method for this purpose that 
requires only a pair of PCR reactions and two 
standard capillary sequencing runs. The sequence 
traces are then analysed by a specially developed 
decomposition algorithm that identifies the major 
induced mutations in the projected editing site 
and accurately determines their frequency in a cell 
population. This method is cost-effective and quick, 
and it provides much more detailed information than 
current enzyme-based assays. An interactive web 
tool for automated decomposition of the sequence 
traces is available. TIDE greatly facilitates the testing 
and rational design of genome editing strategies. 
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INTRODUCTION
Genome editing tools such as TAL effector nucleases, zinc finger nucleases and RNA-guided 
endonucleases (RGENs) enable targeted mutagenesis of a selected DNA sequence in 
genomes of many species (1, 2). In each of these methods, introduction of an endonuclease 
with programmable sequence specificity into a pool of cells leads to a precisely defined 
DNA double-strand break (DSB), which, when repaired by non-homologous end joining, 
results in a mixture of unaltered and mutated DNA. The latter consists primarily of a 
diversity of short deletions and (more rarely) short insertions that are centered round 
the break site (3-5). Cells with a mutation of interest then need to be cloned in order to 
establish a stable mutant line. 
In order to implement this approach, it is usually necessary to test the efficacy of the 
programmable nuclease, which can vary dramatically depending on the sequence that is 
targeted. For example, with RGENs one typically needs to test several single-guide RNAs 
(sgRNAs) that are predicted to target the endonuclease to a gene of interest (6). Commonly 
used assays to verify the efficacy of programmable nucleases are the enzymatic Surveyor 
and T7 endonuclease I cleavage assays (7, 8), which detect small sequence changes. These 
methods are, however, semi-quantitative and suffer from high background signals when 
sequence polymorphisms are present. More importantly, these enzymatic assays do not 
provide insight into the nature and the diversity of the mutations that are introduced. This 
information is particularly useful if one needs to establish a clonal cell line with a specific 
editing outcome, such as a defined deletion size that causes a specific frame shift in an 
open reading frame of interest, or that generates a subtle sequence change in a regulatory 
element. To determine the frequency of the desired editing event in the pool of cells, 
one can amplify the targeted genomic region by PCR, clone individual DNA molecules 
in a bacterial vector, and analyse 50-100 clones by sequencing. This approach is labour-
intensive, time-consuming and relatively costly. Next generation sequencing around the 
induced break site (9) is a powerful alternative, but is also expensive and usually takes 
several weeks in most research environments.
Here, we present a simple, rapid and cost-effective strategy that accurately quantifies the 
editing efficacy and simultaneously identifies the predominant types of insertions and 
deletions (indels) in the targeted pool of cells. The method, named TIDE (Tracking of Indels 
by DEcomposition), requires only two parallel PCR reactions followed by a pair of standard 
capillary sequencing analyses. The two resulting sequencing traces are then analysed 
using specially designed software that we provide as a simple web tool (http://tide.nki.nl). 
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RESULTS
The TIDE method
In the first step of TIDE, a stretch of about 500-1500 basepairs around the editing site 
is PCR amplified from genomic DNA isolated from the cell pool that was treated with 
the targeted nuclease. A parallel PCR amplifies the same stretch of DNA from a control 
cell pool lacking the nuclease or sgRNA. Both PCR products are then directly subjected 
to conventional capillary (‘Sanger’) sequencing, a basic technology that is available in 
most laboratories. In the DNA sample from the cells expressing the targeted nuclease, the 
sequence trace after the break site consists of a mixture of signals derived from unmodified 
DNA and sequences that are each shifted by a different number of nucleotides due to 
insertions and deletions (Figure 1a). 
Based on the quantitative sequence trace data, the TIDE software first visualizes the 
proportion of aberrant base signals along the sequence traces in an intuitive graph 
(Figure 1b, step 1). This enables the user to visually inspect the sequence deviation caused 
by the targeted nuclease, and verify that the break site is located as expected. 
Subsequently, the TIDE software decomposes the composite sequence trace into its 
individual components by means of multivariate non-negative linear modelling, with the 
control sequence trace serving as a template to model the individual indel components. 
This decomposition results in an estimate of the relative abundance of every possible 
indel within a chosen size range (Figure 1b, step 2). The software provides the R2 value as 
a goodness-of-fit measure, and calculates the statistical significance for each indel. In 
the TIDE webtool, the sequence segment used for decomposition can be interactively 
adjusted, which is helpful in case the sequence traces are locally of poor quality. 
Finally, for insertions of a single basepair, the relative frequency of the four possible bases 
is deduced from the model, which is of interest if one wishes to obtain a +1 mutation 
of a particular sequence (Figure 1b, step 3). For longer insertions this base-calling is 
computationally more complicated and currently not implemented. 
In vitro proof of principle
In order to test our approach, we first constructed a series of artificial samples consisting 
of wild-type DNA mixed with DNA carrying various indels in a broad range of relative 
concentrations. We then performed standard capillary sequencing and fed the resulting 
data into the TIDE algorithm. The constituents of the mixes could be identified and 
quantified with great accuracy. In a mixture of wild-type and +1 insertion DNA our 
algorithm was able to detect the insertion quantitatively with a sensitivity down to ~2.5% 
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(Figure 2a; Supplementary Figure S1), and generally predicted the correct base (Figure 2a, inset; 
Supplementary Figure S1). Even a -15 deletion could be reliably detected when mixed 1:10 
with wild-type DNA. (Figure 2b; Supplementary Figure S2a). All constituents in mixtures 
of wild-type DNA with either five or eight different indels were identified by TIDE 
(Figure 2b; Supplementary Figure S2b-c). These in vitro simulations show that sequence trace 
decomposition can accurately identify and quantify the constituent indels in a mixture. 
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Figure 1: Assessment of genome editing by sequence trace decomposition. (A) Due to imperfect repair after cutting 
by a targeted nuclease, the DNA in the cell pool consists of a mixture of indels, which yields a composite sequence trace 
after the break site. (B) Overview of TIDE algorithm and output, which consists of three main steps: 1) Visualization 
of aberrant sequence signal in control (black) and treated sample (green), the expected break site (vertical dotted 
line) and the region used for decomposition (grey bar); 2) Decomposition yielding the spectrum of indels and their 
frequencies; 3) Inference of the base composition of +1 insertions. See main text and http://tide.nki.nl for explanation. 
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Application of TIDE to CRISPR/Cas9 edited DNA sequences
We then tested this approach on a pool of human K562 cells carrying random integrations 
of the green fluorescent protein (GFP) reporter gene. We transfected these cells with the 
RGEN Cas9 together with a sgRNA designed to target the GFP gene, or without the sgRNA 
as a control. TIDE determined that 34.2% of GFP sequences in the sgRNA-treated cell 
pool carried an indel, with 23.2% being a -1 deletion (Figure 3a). The composite sequence 
started at the expected break site (Figure 3b), confirming correct targeting by the sgRNA. 
The +1 insertions consisted almost exclusively of a G nucleotide on the forward strand 
(Figure 3a, inset), indicating that the choice of the inserted nucleotide is non-random. 
Sequencing of the opposite DNA strand yielded virtually identical quantitative results 
(Supplementary Figure S3a), indicating that the assay is highly robust. 
To independently validate these results, we cloned and sequenced 84 individual DNA 
molecules from the same PCR product. This revealed a similar spectrum of indels, in 
which the frequency of each indel is generally not significantly different from the TIDE 
calculations (Figure 3c). However, some larger indels with frequencies below ~2% were 
not significantly detected by TIDE. All +1 insertions of the individual clones consisted of a 
G nucleotide in the forward strand, confirming the computational inference. 
All the significant mutations found by TIDE are predicted to lead to frame shifts yielding a 
non-functional truncated GFP protein. In agreement with this finding FACS analysis shows a 
38.4% loss of GFP-positive cells in the pool of cells expressing the sgRNA compared to the pool 
lacking the sgRNA (Figure 3d). Thus, the calculation of gene editing efficiency by sequence 
trace decomposition is in close agreement with the observed frequency of the phenotype.
Figure 2: Proof-of-principle of TIDE. (A) A DNA fragment carrying a +1 insertion was mixed in indicated relative 
amounts with a corresponding wild-type DNA fragment (horizontal axis), after which the +1 insertion content 
was determined by TIDE (vertical axis) using the default search for indels with a size range of 0..10. Inset: relative 
abundance of the inserted nucleotide in a wt, +1 mix (90%:10%). See Supplementary Figure S1 for the complete 
decomposition results. (B) TIDE decomposition of various complex mixtures of wild-type DNA with DNA carrying a 
range of indels. See also Supplementary Figure S2a-c. 
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Finally, we used our approach to test different sgRNAs designed to target endogenous 
genes in human or Drosophila cell lines (Figure 3e-h). Interestingly, the results show that 
different sgRNAs resulted in distinct indel spectra. For example, a sgRNA targeting the 
NDC1 gene produces roughly equal amounts of +1 and -1 indels, while a sgRNA targeting 
the LBR gene produces mainly +1 insertions and a few bigger deletions including a more 
pronounced -7 deletion. Overall, small indels (+1 and -1) appear to be the most common 
mutations induced by Cas9, which is in agreement with other studies (3-5). Individual 
indels were detected at estimated frequencies down to ~1%. Again, the results were 
nearly identical when the opposite strand was sequenced (Supplementary Figure S3b-c). 
In addition, +1 insertions were typically dominated by one specific nucleotide, which 
was identical to one of the two terminal nucleotides of the break site. Which of the two 
neighbouring nucleotides is duplicated appears to vary. For example, one sgRNA guide 
targeting NDC1 resulted in different +1 insertions in K562 and RPE cells (Figure 3e-f). How 
the DSB repair machinery chooses the inserted bases remains to be further elucidated.
DISCUSSION
Advantages of TIDE
Genome editing techniques like CRISPR, TALENs and ZFPs are now widely used to alter 
specific sequences in genomes of cultured cells. However, the efficacy and the spectrum 
of mutations vary greatly depending on the RGEN target site and cells used (10, 11 and 
this report). Hence, a fast and cost-effective approach to determine the efficacy of RGENs 
is essential to optimize the genome editing strategies. TIDE takes advantage of the fact 
that non-homologous end joining repair of DNA DSBs leaves an indel at the break site. By 
decomposition of the quantitative sequence trace data, the TIDE software identifies and 
quantifies these indels. This allows researchers to quickly determine the efficiency of the 
RGENs and rationally estimate the number of cell clones that must be picked and screened 
in order to obtain a clonal line with a particular indel of interest. 
Figure 3: Application of TIDE to in vivo edited DNA sequences. (A-D) A pool of human K562 cells expressing GFP 
treated with Cas9 alone (control) and cells treated with Cas9 and a GFP targeting sgRNA (sample) were analysed by: 
TIDE (A-B), sequence analysis of 84 cloned DNA fragments (C) and flow cytometry (D). (A) Indel spectrum determined 
by TIDE. Inset shows the estimated composition of the inserted base for the +1 insertion. (B) Aberrant nucleotide 
signal of the sample (green) compared to that of the control (black). Blue dotted line indicates the expected cutting 
site. Grey horizontal bar shows the region used for decomposition. (C) Comparison of indel occurrences in cloned 
DNA fragments (n = 84) to frequencies estimated by TIDE, with p-values according to Pearson's chi-squared test. 
Decomposition was limited to indels of size 0..10, hence larger indels could not be detected. (D) Distributions of 
GFP fluorescence intensities of Cas9 and Cas9+sgRNA treated cells, measured by flow cytometry. The percentage of 
GFP-positive cells is indicated in the top right corner within indicated histogram gate. (E-H) TIDE analysis of various 
endogenous genes (NDC1, LBR, LMN) targeted with RGENs in human cell lines (K562, RPE) and in a Drosophila cell 
line (Kc167). Insets: prediction of the inserted base for +1 insertions. 
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Attractive features of TIDE are the low costs and the fact that it requires only two standard 
PCRs and two capillary sequencing runs. Hands-on time is therefore limited, and results 
can be obtained in one or two days. We found that TIDE is capable of detecting insertions 
and deletions with a sensitivity up to ~1-2% across various target regions in a pool of 
cells. The method is highly robust, as indicated by the strong correspondence between 
the decomposition results from forward and reverse sequence traces. Good agreement of 
TIDE results with the sequence composition of a set of individually cloned DNA molecules 
underscores the reliability.
Comparison to other methods
Several other methods have been used to assess genome editing efficacies. Cloning and 
sequencing of 50-100 individual DNA molecules provides an accurate characterization 
of the indel spectrum, but this is obviously more labor-intensive and 25-50 times more 
expensive than TIDE. Next-generation sequencing (NGS) of bulk PCR products, followed 
by analysis using software such as CRISPR-GA (9) provides a highly detailed estimate of 
the indel spectrum, but this method is only cost-effective if a large number of samples are 
multiplexed; moreover, in most research institutes NGS takes several weeks. 
For the creation of gene knockouts, homology based integration of a selectable marker 
gene at the induced break site can facilitate the isolation of the desired clonal line (12). 
This approach is time-consuming and still requires moderately effective DSB induction 
and hence prior characterization of the efficacy of the genome editing tool is desirable. 
Finally, assays that employ mismatch-detecting enzymes (7, 8) require a similar amount 
of hands-on time as TIDE, but only estimate the overall mutation frequency and do not 
characterize the spectrum of indels. Moreover, polymorphisms in the vicinity of the break 
site are expected to cause high background signals in these enzymatic assays, unlike TIDE. 
Thus, TIDE offers a cost-effective and accurate alternative strategy for the rapid testing of 
genome editing efficacy.
Potential limitations of TIDE
Naturally, the reliability of TIDE depends on the purity of the PCR products and the quality 
of the sequence reads. Decomposition results with a low R2 must be interpreted with 
caution. As a rule of thumb, we recommend to aim for a background signal of aberrant 
sequences before the break site <10% (both control and test sample), and R2>0.9 for the 
decomposition result. Sequencing of the opposite strand is recommended to confirm the 
results. Highly repetitive sequences around the target site may in some instances hamper 
the decomposition. Incorrect alignments can be detected when the quality plot shows an 
aberrant sequence signal that is not located at the expected break site. The decomposition 
window can be adjusted in order to avoid repetitive regions. 
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Additional applications
While we demonstrated the utility here for Cas9-based mutagenesis, TIDE should also be 
applicable to other genome editing tools that are based on targeted DSB induction (1, 2). 
Because of the quantitative nature of the results, TIDE may also be used to study 
mechanisms of DSB repair. For example, we observed that the spectrum of insertions and 
deletions varies among various target sites and cell types. It will be interesting to employ 
TIDE to investigate how DSB repair is affected by sequence context or local chromatin 
environment. Another application would be to determine differential effects of various 
indels at a gene of interest on cellular fitness. With TIDE, the relative abundance of indels 
can be followed over time in a growing population of cells treated with RGENs. An increase 
or decrease of wild-type sequence or particular indel over time could be an indication 
that the targeted sequence is lethal. In summary, TIDE will be a valuable tool for a broad 
diversity of research involving genome editing methods.
MATERIAL & METHODS
Cell culture and transfection
K562 cells (ATCC) were cultured in RPMI 1640 (Gibco) supplemented with 10% fetal bovine 
serum (FBS, HyClone®), 1% penicillin/streptomycin. A pool of K562 cells stably expressing GFP 
was generated by transduction with the lentivirus construct pCCLsin.PPT.hPGK.GFP.pre (13). 
Because the lentiviral construct integrates randomly, the distribution of GFP expression 
levels is broad. This cell pool also includes cells that that were not transduced and do 
not express GFP at all. For transient transfection with CRISPR vectors, 1 x 106 K562 cells 
were resuspended in Nucleofector® Solution V (Lonza) with 1 µg plasmid DNA, and 
electroporated in an Amaxa 2D Nucleofector using program T-016. In case of LBR editing, 
a clonal K562 line stably transformed with Cas9 was used.
Human retinal pigment epithelial (RPE) cells were cultured in a 1:1 mixture of DMEM (Gibco) 
with Nutrient F12 (Gibco) supplemented with 10% fetal bovine serum (FBS, HyClone®), 
1% penicillin/streptomycin. CRISPR vectors were transfected with 5 μL Lipofectamine® 
2000 Reagent (Invitrogen) and 2.5 μg plasmid DNA in 250 μL antibiotic-free medium (Gibco).
Kc167 cells were cultured in BPYE media with 5% heat-inactivated FBS and 1% penicillin/
streptomycin. 1 x 106 cells were electroporated with 1 μg each of Cas9 and sgRNA 
expression plasmid using a BioRad Gene Pulser II (450µF, 86V).
Constructs
For human cells, expression vector PX330 (Addgene plasmid 42230) encoding Cas9 
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and chimeric guide RNA was used (14). The LBR guides were cloned into expression 
vector pBluescript with the sgRNA cassette of PX330 and transfected into the K562 
line stably transformed with Cas9. For Drosophila cells, Cas9 expression vector 
pBS-Hsp70-Cas9 (Addgene plasmid 46294) was used in combination with pU6-BbsI-chiRNA 
construct (Addgene plasmid 45946) (15). The sgRNAs were designed using CRISPR design 
(http://crispr.mit.edu/) (16) and CHOPCHOP (https://chopchop.rc.fas.harvard.edu/) (17).
The following sgRNA sequences were used:
GFP guide 5’ CATGCCGAGAGTGATCCCGG 3’
NCD1 guide 5’ GGATAGTTGCAAGTATTGTT 3’
CD59 guide 5’ CAAGGAGGGTCTGTCCTGTT 3’
LMN guide 5’ GTCTGCTCGATGACACAGCT 3’
LBR guide #1 5’ GAAATTTGCCGATGGTGAAG 3’
LBR guide #2 5’ GCCGATGGTGAAGTGGTAAG 3’
For the cloning of individual DNA fragments from the edited GFP gene, PCR products 
were ligated in Zero Blunt® vector (Invitrogen) using standard procedures.
PCR 
Genomic DNA (~1 x 106 cells) was isolated three days after transfection using the ISOLATE II 
Genomic DNA Kit of Bioline. PCR reactions were carried out with 50 ng genomic DNA in 
MyTaqTM Red mix (Bioline) according to manufacture instructions. PCR conditions were 
1 min at 95°C (1x), followed by 15 sec at 95°C, 15 sec at 55°C, and 1 min 72°C (25-30x). The 
PCR products were purified using the ISOLATE II PCR and Gel Kit (Bioline). 
The following primer pairs spanning the target site were used (FW: forward; RV: reverse):
GFP FW 5’ GCAGAAGAACGGCATCAAGGT  3’
GFP RV 5’ AGCAGCGTATCCACATAGCG   3’
NCD1 FW 5’ CCACCACCCCTCATACAAAG   3’
NCD1 RV 5’ CTGCCCAAAGGAAAAACAAA   3’ 
LMN FW 5’ ACATGTCGAGCAAATCCCGA   3’
LMN RV 5’ CTCTGTCTGTTTGATGCGGC   3’
LBR FW 5’ GTAGCCTTTCTGGCCCTAAAAT 3’
LBR RV 5’ AAATGGCTGTCTTTCCCAGTAA 3’
Sanger sequencing
Purified PCR samples (100ng) were prepared for sequencing using 4 µL of BigDye® terminator v3.1 
(Applied Biosystems®) and 5pM primer in final volume of 20 μL. PCR program: 1 min at 96°C (1x), 
followed by 30 sec at 96°C, 15 sec at 50°C, and 4 min at 60°C (30x), and finishing with 1 min 
incubation at 4°C (1x). Samples were analysed by an Applied Biosystems 3730xl DNA Analyzer. 
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Flow cytometry
K562-GFP cells were collected 8d after nucleofection and directly analysed for fluorescence 
using a BD FACSCalibur. Viable cells were gated on size and shape using forward and side 
scatter. The GFP expression was measured using a 488 nm laser for excitation. 
TIDE software 
TIDE code was written in R, version 3.1.1. TIDE requires as input a control sequence data 
file (e.g. obtained from cells transfected without RGEN Cas9), a sample sequence data file 
(e.g. DNA from a pool of cell treated with RGEN Cas9) and a character string representing 
the sgRNA sequence (20 nt). The sequencing data files (.abif or .scf format) are imported 
into TIDE using the R Bioconductor package sangerseqR (version 1.0.0) (18). Additional 
parameters have default settings but can be adjusted if necessary. The web interface was 
constructed using the shiny R package, with some code adapted from the Poly Peak Parser 
web tool (http://spark.rstudio.com/yostlab/PolyPeakParser/). The latter is a genotyping 
tool that can identify heterozygous short indels in sequence traces, but it cannot resolve 
sequences with complex indel mixtures (19).
TIDE first aligns the sgRNA sequence to the control sequence to determine the position 
of the expected Cas9 break site. Next, the control sequence region upstream of the break 
site is aligned to the experimental sample sequence in order to determine any offset 
between the two sequence reads. Alignments are done using standard Smith-Waterman 
local alignment implemented in the BioStrings package in Bioconductor. From here on, 
the software uses the peak heights for each base, as determined by the sequence analysis 
software provided by the manufacturer of the capillary sequencing equipment (we used 
3730 Series Data Collection Software V4 and Sequencing Analysis Software V6). TIDE uses 
these peak heights to determine the relative abundance of aberrant nucleotides over the 
length of the whole sequence trace.
Note that there is a 25% chance that an identical nucleotide will be found in the composite 
sequence trace when compared to the wild-type sequence at the same position, since 
only 4 different nucleotides are available. This means that the average maximum aberrant 
sequence signal of 75% actually represents 100% of aberrant sequence trace. The plot of 
this aberrant sequence signal allows the user to gauge the quality of the sequence data, 
verify the expected cut site, and interactively select the region used for decomposition.
The decomposition is conducted on a sequence segment downstream of the break site. By 
default it spans from s+5bp downstream of the break to s+5bp from the end of the shortest 
sequence read, with s being the maximum indel size in bp. Sequence trace models of all 
possible deletions and insertions of sizes {0..n} (n is by default set to 10) are constructed 
from the control sample trace by shifting all peaks by the appropriate number of positions 
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to the left or right, respectively. This is done for each of the four bases, after which the 
vectors of the four bases are concatenated so that the decomposition is done for all bases 
combined. Next, the sequence trace from the mutated DNA sample is assumed to be a 
linear combination of the wild-type and the modelled  indel traces. This combination is then 
resolved by standard non-negative linear modelling, for which we used the R package nnls. 
R2 is calculated to assess the goodness of fit. The p-value associated with the estimated 
abundance of each indel is calculated by a two-tailed t-test of the variance-covariance 
matrix of the standard errors. In order to account for systematic differences between the 
sequence trace intensities of the control and mutated DNA, the fitting parameters are 
then multiplied by a constant factor such that their sum equals R2.
Lastly, to model insertions, the TIDE software estimates the relative frequency with which 
each of the four nucleotides is introduced immediately after the break site. This is done 
by removal of the aggregate of estimated signals of mutants that have smaller number 
of insertions (including non-mutated and deletions). While this can be done for all insert 
sizes, TIDE currently only estimates the nucleotide composition of +1 insertions, which are 
the most frequently observed insertions.
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Supplementary Figure S1: Specificity of TIDE indel detection of in vitro mixed samples. TIDE indel spectra of 
several samples consisting of wild-type DNA mixed with DNA with a +1 insertion in different ratios. See also Figure 2a.
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Supplementary Figure S2: TIDE indel spectra of in vitro composite samples. TIDE was applied to several 
artificial samples consisting of wild-type DNA mixed with DNA carrying various indels in a broad range of 
relative concentrations. (A) Mix of (-15, 0) with ratio 1:9. (B) Mix of (+1, 0, -1, -2, -3, -7) with ratios 4:6:5:3:2:1. 
(C) Mix of (+1, 0, -1, -2, -3, -7, -8, -10, -15) all with the same concentration. See also Figure 2b. 
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Supplementary Figure S3: Comparison of TIDE indel decomposition of forward and reverse sequence reads.
Indel spectra for targeted mutation in the genes (A) GFP, (B) NDC1 and (C) LBR guide#2 (D) LBR guide#1, based on 
sequence reads from the either the forward (left panels) or reverse (right panels) strand. Insets: estimated nucleotide 
composition of +1 insertions; note that the forward and reverse reads should yield complementary nucleotides.
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Chapter 3 Easy Quantification of Template-Directed CRISPR/Cas9 Editing
3ABSTRACT
Template-directed CRISPR/Cas9 editing is a powerful tool for introducing subtle mutations in 
genomes. However, the success rate of incorporation 
of the desired mutations at the target site is difficult 
to predict and therefore must be empirically 
determined. Here, we adapted the widely used TIDE 
method for quantification of templated editing 
events, including point mutations. The resulting 
TIDER method is a rapid, cheap and accessible tool 
for testing and optimization of template-directed 
genome editing strategies. A free web tool for TIDER 
data analysis is available at http://tide.nki.nl.
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INTRODUCTION
The CRISPR system for genome editing has become one of the most popular techniques 
in molecular biology. CRISPR endonucleases such as Cas9 can cleave genomic DNA with 
high precision, and due to error-prone repair mechanisms this can result in small insertions 
or deletions (indels) (1-3). Alternatively, precisely designed small nucleotide changes can 
be incorporated near the break site by providing a donor template (4, 5), such as a single-
stranded oligodeoxynucleotide (ssODN) (4, 6). By homology directed repair (HDR), the 
DNA of the donor template is exchanged with the genomic DNA, and thereby the desired 
mutations are introduced (7, 8). Such precise editing offers the possibility to create and 
study specific mutations, or to correct disease-causing nucleotide variants (5, 9). 
A current limitation of this template-directed strategy is that the efficacy is unpredictable 
and often low. Because error-prone non-templated repair pathways are active besides 
HDR, various indels are often introduced at the target site instead of the desired mutation. 
Moreover, a substantial fraction of the target sequence may remain unaltered. Thus, 
exposing a pool of cells to CRISPR and a donor template yields a complex mixture of cells 
with wild-type DNA, indels and the designed mutation, with unpredictable ratios (10-12). 
A quick and easy assay to determine these ratios is of key importance, particularly if one 
wants to estimate how many cells are to be cloned from the pool in order to obtain at least 
one clonal line with the desired mutation. 
High throughput sequencing of DNA around the induced break site is a powerful tool 
to analyse the mutation spectrum (13), but is also expensive and requires substantial 
computational analysis. The frequently used Tracking of Indels by DEcomposition (TIDE) 
method (14) is much simpler and cheaper, as it requires only two standard Sanger capillary 
sequencing reactions and an easy-to-use web tool for data analysis. However, in its 
present form TIDE is not suitable for templated genome editing, because it can only detect 
overall indel frequencies and no nucleotide substitutions or specifically designed indels. 
To overcome this limitation we developed TIDER (Tracking of Insertions, DEletions and 
Recombination events), a redesigned version of TIDE. TIDER can estimate the incorporation 
frequency of any type of template-directed mutations (including point mutations) and 
separate it from the background spectrum of additional indels. The corresponding TIDER 
web tool is freely accessible at http://tide.nki.nl.
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RESULTS
Quantification of template-directed CRISPR/Cas9 editing - the TIDER method.
To positively identify and quantify template-directed editing, we redesigned the TIDE 
method. The original TIDE protocol requires two capillary sequencing traces from a DNA 
stretch around the editing site: one test sample (DNA from cells treated with targeted 
nuclease) and one control (e.g. DNA from mock transfected cells). Indels are then quantified 
by computational decomposition of the mixture of sequences in the test sequence trace, 
using the control sequence for comparison. TIDER requires one additional capillary 
sequencing trace. This ‘reference’ trace is derived from a pure DNA sample that carries the 
designed base pair changes as present in the donor template. Such a reference trace can 
be generated readily from commercially synthesized DNA or from DNA obtained by a 
simple two-step PCR procedure as outlined in Methods section. The latter approach 
requires slightly more hands-on time, but is typically quicker and cheaper. Sequence traces 
derived from either source performed equally well in TIDER (see below). In addition, a text 
string representing the sequence of the sgRNA is used as input to determine the expected 
break site. To determine the individual sequence variants in the DNA of a cell pool, the 
algorithm decomposes the sequence trace of the experimental sample by multivariate 
non-negative linear modelling (Figure 1). For this, it uses the control and reference traces 
to construct a set of models of all likely outcomes of the cutting and repair process: 
wild-type sequence, all possible random indels at the break site, and the desired sequence 
as result of HDR. All of these models are collectively fitted to the experimental sample 
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Figure 1: Assessment of homologous direct repair by sequence trace decomposition. Overview of TIDER 
algorithm and output. The introduction of designed mutations by homology directed repair with a donor template 
results in defined changes in a sequence trace. Due to NHEJ repair also insertions and deletions arise at the targeted 
break site. All these mutations yield in a composite sequence trace. As input a sgRNA sequence string and three 
sequences are required: 1) wild-type control, 2) reference file with designed mutations in the used donor template 
and 3) composite test sample. Trace decomposition yields the spectrum of indels and the HDR events with their 
frequencies (See main text and http://tide.nki.nl for explanation).
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trace. As the construction of the models and the fitting of the data are more complicated 
than for TIDE, the software code was extensively modified for TIDER and subjected to a 
large series of tests (see below). The TIDER software provides an R2 value as a goodness-
of-fit measure, and calculates the statistical significance of the detected HDR events. 
Additionally, it generates a set of quality control plots that enable the user to verify the 
expected break site, and to visually inspect the sequence changes resulting from the 
editing process  (Supplementary Figure S1).
In vitro validation of TIDER.
To test the performance of TIDER, we initially mimicked the occurrence of HDR events in vitro 
by mixing DNA carrying defined sequence variants. First, we combined ‘wild-type’ DNA with 
‘mutant’ DNA carrying a single base pair change in various ratios. We performed standard 
capillary sequencing and analysed the resulting data with the TIDER software. The algorithm 
was able to detect the single base pair change quantitatively with a sensitivity down to ~5% at 
a p-value cut-off of 0.01 (Figure 2a, b; Supplementary Figure S2a). Only very small amounts of 
false-positive indels were scored across the entire range of mixing ratios (Supplementary Figure S3). 
No statistically significant signal was detected when a reference sequence with a different point 
mutation was used, attesting to the specificity of TIDER for one particular mutation (Figure 2b, 
purple triangles). More complex mixtures consisting of wild-type DNA, DNA carrying various 
indels and DNA with a single base pair change could also be resolved accurately (Figure 2a, c; 
Supplementary Figure S4). In this particular experiment the proportion of the designed mutant 
was somewhat overestimated at low mixing ratios, but with increasing ratios the estimates 
were accurate. Results were nearly identical for reference DNA generated by full synthesis or by 
the two-step PCR procedure (compare Figure 2b-c & Supplementary Figure S2b-c). In another 
mixing experiment with a different complex pool and a different mutant, the accuracy was 
substantially higher (Supplementary Figure S2d-f), presumably because this mutant differed at 
four base pair positions from the wild-type DNA instead of one position. 
A potentially more challenging scenario is when the templated mutation is a small 
deletion. During the repair process, other (non-templated) deletions of the same size may 
arise. We tested the ability of TIDER to discriminate the designed deletion from alternative 
deletions of the same size. When we mixed wild-type DNA with varying amounts of a 
-4 deletion, TIDER correctly determined the deletion with high specificity as ‘designed’ 
when DNA carrying this deletion was used for the reference trace (Figure 2a, d). Similar 
results were obtained with four different ‘designed’ -1 deletions, although in two 
instances a small fraction was scored as non-templated deletion (Figure 2a, e). Therefore, 
in the presence of only a small designed deletion (-1, -2) near the expected break site the 
designed mutation may be underestimated somewhat. In general, however, TIDER does 
not mistake a ‘designed’ deletion for a non-templated deletion of the same size. 
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As a more stringent in vitro test, we generated several mutant sequences with a +1 insertion 
at various positions relative to the break site (Figure 2a), and mixed each of these ‘designed’ 
mutant DNAs with a complex pool of DNA that contained ~39% of ‘natural’ +1 insertions. 
TIDER analysis resolved the composition of the mixtures with high accuracy (Figure 2a, f). 
Sequencing of the opposite DNA strand yielded very similar results (Supplementary Figure S5), 
illustrating the robustness of the approach. This experiment illustrates that the presence of 
a non-templated insertion generally does not compromise the detection of the designed 
insertion of the same size. Together, these in vitro mixing experiments show that sequence 
trace decomposition can in most cases accurately identify and quantify ‘designed’ 
mutations (base pair substitutions as well as small deletions and insertions) in a complex 
background of indels caused by imperfect repair. 
Comparison of TIDER to next generation sequencing.
We tested TIDER in a series of in vivo experiments in which we subjected specific genomic 
sequences to templated editing in mouse embryonic stem (mES) cells and human retinal 
pigment epithelium (RPE-1) cells. We co-transfected these cells with Cas9, a sgRNA and a 
corresponding ssODN carrying three or four nucleotide substitutions. As control the ssODN 
was omitted. To verify the TIDER results, we sequenced the same samples by next generation 
sequencing (NGS). For 5 out of 5 tested sgRNA/ssODN combinations we found that the NGS 
results are similar to the TIDER estimations (Figure 3a-e). Moreover, in cells treated with 
sgRNA in the absence of a donor template, TIDER detects almost no HDR events, while the 
non-templated indel spectra are again highly similar to those determined by NGS (Figure 3f; 
Supplementary Figure S6). Furthermore, in one set of editing experiments involving a 
complex set of templated nucleotide substitutions, application of TIDER with different 
window settings, combined with the data visualization tool, reproducibly revealed that one 
nucleotide substitution 40 bp upstream of the break site was less efficiently incorporated than 
the more proximal substitutions; this result was confirmed by NGS (Supplementary Figure S7). 
We conclude that TIDER can reliably estimate the frequency of HDR events in a background 
of non-templated indels in genomic DNA from pools of cells. 
DISCUSSION
Advantages of TIDER. 
TIDER is a simple and rapid assay to evaluate the efficacy of templated editing. Like 
TIDE, TIDER requires only standard capillary sequencing, thereby offering a widely 
accessible, cheap and rapid alternative to NGS. TIDER is much more quantitative and 
informative than the Surveyor and T7 endonuclease I cleavage assays (15, 16), which are 
unable to discriminate between the designed mutation and randomly induced indels. 
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Figure 2: TIDER decomposition of in vitro mixes of DNA. Template-directed genome editing experiments in a pool of 
cells were simulated by in vitro mixing of DNA fragments carrying specific mutations with a corresponding wild-type 
DNA fragment, or with a complex pool of DNA fragments carrying different indels. (A) DNA mixtures that were tested. 
Letters in parentheses refer to the panels that show the corresponding TIDER results. Only the relevant sequences of 
the tested DNA fragments are shown; the total length of the fragments was 529 bp. ‘Designed’ mutations are indicated 
in green, ‘natural’ indels in red. Virtual Cas9 break sites used in these analyses are marked in dark blue. The complex 
pool is DNA from a pool of cells treated with Cas9 and sgRNA; it contains wild-type DNA as well as various indels 
introduced by NHEJ, of which the relative amounts are indicated. (B-C) PCR product with mutation1 was mixed in 
indicated relative amounts (horizontal axis) with wild-type DNA or with the complex pool. The proportion of mutant 
DNA was determined by TIDER (vertical axis) using either correct reference (mutant1, green squares) or incorrect 
reference (mutant2, purple triangles). See Supplementary FigureS S3 and S4 for the complete decomposition results. 
(figure and legend continued on next page)
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(D) Same as (B-C), but for wild-type2 mixed at various ratios with mutant7 that carries a -4 deletion. Green 
diamonds: estimated ‘designed’ -4 deletions as in the reference file. Red squares: estimated ‘natural’ -4 deletions 
(i.e. all deletions of size 4 that overlap with or are immediately adjacent to the break site). (E) 1:1 mixtures of mutant8 
and wild-type3-6. For the TIDER analysis mutant8 was used as reference and the respective break sites were chosen 
as indicated in (A); hence in each analysis mutant8 carries a ‘designed’ -1 deletion relative to the wild-type DNA. 
The percentages of the designed -1, natural -1 (other deletions of size 1) and wild-type DNA as estimated by TIDER 
are shown. The expected percentages are depicted in the last column. (F) TIDER analyses of mixtures of the complex 
DNA pool with each of mutant3-6 at three different ratios (9:1, 1:1, and 1:4). Bar graphs show percentages of the 
designed +1, natural +1 (other insertions of size 1) and wild-type DNA as estimated by TIDER. Expected percentages 
are depicted in the last column of each mixture set. In all analyses in (B-F) default TIDER settings were used (size 
range 0-10 for deletions and 0-5 for insertions). 
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Next-generation sequencing of bulk PCR products, followed by analysis using software 
such as CRISPResso (17) provides a highly detailed estimate of the introduced mutations, 
but this method is only cost-effective when large numbers of samples are multiplexed. 
Moreover, in many research institutes NGS is only available through a shared facility that 
may have turn-around times that are much longer than Sanger sequencing. 
TIDER is primarily designed to determine the efficacy of templated genome editing. It 
complements TIDE, which can only detect non-templated indels. TIDER can estimate 
the incorporation frequency of any type of template-directed mutations, including point 
mutations, and distinguish them from the background spectrum of additional indels. 
While TIDER can also quantify the latter, TIDE is more suitable for the assessment of non-
templated editing experiments because it is slightly simpler in experimental design. The 
TIDER web tool is freely available through http://tide.nki.nl/. 
Possible limitations.
Because the TIDER algorithm analyses individual peak heights in the input sequence 
traces, the accuracy of TIDER relies on the quality of the PCR products and the sequence 
reads. This is particularly relevant when the difference between the wild-type and 
reference sequence is small, e.g., in case of single-nucleotide differences. In such cases we 
recommend that the results are verified with a sequence trace of the opposite strand. The 
TIDER web tool provides graphical feedback as well as an R2 value as means to estimate 
the reliability of the analysis. We generally recommend that R2 is above 0.9. While the 
default settings of the web tool are suited for most purposes, parameter settings can be 
adjusted interactively to optimize the performance. Note that the TIDER algorithm cannot 
resolve HDR events that have acquired an additional non-templated indel. However, it has 
been reported that the frequency of such double templated/non-templated mutations is 
low when a PAM disrupting mutation is included (17, 18).
MATERIAL & METHODS
Cell culture and transfection
Human retinal pigment epithelial (hTERT RPE-1, ATCC CRL-4000) cells were cultured in DMEM 
(Gibco 31966) supplemented with 10% fetal bovine serum (FBS, HyClone®). Mouse embryonic 
stem cells (mESCs) were cultured as described (19). Briefly, mESCs were expanded and maintained 
on sub-lethally irradiated mouse embryonic fibroblast feeder cells in LIF supplemented medium. 
Prior to transfection, cells were seeded on gelatin-coated plates and cultured in Buffalo Rat 
Liver cell (BRL) conditioned medium supplemented with LIF (ESG1107, Merck (Millipore)). 
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Figure 3: Application of TIDER to in vivo edited DNA sequences. Comparison of TIDER and NGS analyses of 
various mutations introduced by template-directed Cas9 editing in human cell line RPE (A-D,F) and mouse ES cells 
(E). In each panel (A-E), a pool of cells was treated with Cas9, a targeting sgRNA and a ssODN carrying three to four 
mutations. Panel (F) shows a control experiment corresponding to (D) in which the ssODN was omitted. Additional 
control experiments corresponding to (A-C) are shown in Supplementary Figure S6. In each panel, the top sequence 
corresponds to wild-type, with the sgRNA sequence highlighted in grey and the expected cut site marked by a vertical 
line; the bottom sequence indicates the designed mutant, with mutated nucleotides highlighted in green. Bar graphs 
show the estimated percentage of successfully edited DNA molecules (right-hand plot; ‘HDR’) and of indels of the 
indicated size (left-hand plot). Upward axes show TIDER estimates; downward axes show the NGS estimates based 
on the same DNA sample. Pale red and blue bars indicate proportions of wild-type (non-mutated) sequence. R2 values 
indicate the goodness-of-fit score for the TIDER estimates; ‘total eff’ indicates the total according to TIDER (top) and 
NGS (bottom); ‘other mutations’ are all non-indel, non-designed mutations as detected by NGS (and which cannot be 
detected by TIDER). For TIDER, the decomposition was limited to deletions of sizes 0-15 and insertions of sizes 0-5. 
For NGS, at least 2 x 104 reads were analysed in each experiment.
68
Chapter 3
The desired mutations were introduced in hTERT RPE-1 according to the RNP CRISPR 
approach of IDT. The sgRNAs were designed using CRISPR design tools of Benchling 
or MIT tool (20). In brief, 1 x 105 cells were seeded out the day before transfection in 
12-well dish in 750 µL medium with 1 µM final concentration DNA-PKcs inhibitor NU7441 
(Cayman). 3 µL of 10 µM sgRNA and 3 µL of 10 µM Cas9 protein were mixed in optiMEM 
(Life Technologies) to final volume of 125 µL and incubated in for 5 min at RT. 4.5 µL of 
this Cas9/sgRNA mix, 1.5 µL of 10 µM ssODN (Ultramer IDT) and 4.5 µL Lipofectamine 
RNAiMAX (Invitrogen) were added to 240 µL optiMEM. Mixture was incubated at RT for 
20 min before adding to the cells. The next day the medium was changed, and 2 days after 
transfection the cells were harvested for analysis of the genomic DNA. 
mESCs were seeded 2 days before transfection at a density of 5 x 104 cells in each well of a 
6-well dish. 250ng of a PX330 derived vector (Addgene #42230, with an added puromycin 
resistance cassette) and 2.25 µg of ssODN were added to 250 µL optiMEM. 6.25 µL of Mirus 
TransIT LT-1 was added to this mixture and mixed by pipetting. After incubation for 15 min 
at RT, the solution was added dropwise to the cells. One day after transfection, the cells 
were reseeded on gelatin coated plates in BRL medium containing 3.6 µg/mL puromycin. 
2 days after reseeding, the medium was replaced without puromycin, and 4 days later the 
cells were harvested for genomic DNA extraction.
PCR control & test sample
Genomic DNA was isolated 2 days (RPE cells) or 7 days (mESC cells) after transfection 
using either the ISOLATE II Genomic DNA Kit (Bioline) or lysis buffer (100 mM Tris (pH 8.5), 
50 mM EDTA, 40 mM NaCl, 0.2% SDS and 100 µg/mL proteinase K) for 2 hours at 55°C 
followed by 45 min incubation at 85°C and DNA precipitation by addition of 2.5 volumes of 
100% ethanol, followed by 30 min centrifugation at 14,000 RPM at 4°C. After washing of 
pellets with 70% ethanol, pellets were dissolved in TE buffer by overnight incubation at 55°C. 
PCR reactions were carried out with 50 ng genomic DNA in MyTaqTM Red mix (Bioline) 
according to manufacturer’s instructions using primers a & b (10 µM) as listed below. 
PCR thermocycling scheme: 1 min at 95°C (1x), followed by 15 sec at 95°C, 10-20 sec at 
55-60°C, and 10-20 sec 72°C (25-35x). The PCR products were purified using the ISOLATE II 
PCR and Gel Kit (Bioline). The Msh2 target site was amplified with Taq polymerase (MRC 
Holland) using the following PCR program: 2 min 94°C (1x), followed by 30 sec at 94°C, 
3 sec at 53.8°C and 40 sec at 72°C (37x) and 5 min at 72°C (1x).
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The following sgRNA sequences were used:
guide_msh2 5’ GATCAGTTCTCCAATCTCG 3’
guide3 5’ TGTTTGTTGGAGAGTCCCAC 3’
guide5 5’ TGCTTCCAGTAAATAAGGTG 3’
guide7 5’ AAGCTTTTTCCACTTCCTGT 3’
guide8 5’ TAAGCTTTTTCCACTTCCTG 3’
guide12 5’ AAAGTTATCTGCTAAGAAAC 3’
guide_lbr2 5’ GCCGATGGTGAAGTGGTAAG 3’
The following ssODNs sequences were used:
guide_msh2 960 mmsh2-
l187r-rflp-s
5’ TAGTCTCTCCTCCTGGTAAAACGCATTCCTTTGGTCCAATCTGA
ATCAGAAGAGCCTGGATCCTGGAGAACTGATCATTCTCGGGGAACTC
ACACAAGCTTAGCTTCCTCTGGGTGGA*A*T 3’
guide3 ssODN9 5’ GTGTTCATAGATTCTCAGAGGATTAAACAGCAAGCAACATTGTT
TGTTGGAGAGTCCCTGATGAAGTGGAAAAAGCTTAGCCTTACTTTGT
TCTGCTTTAGCATGGCAACAATCTCTTAG 3’
guide5 ssODN7 5’ CATCTTCCACAAAATTTTCTGGTGATAGATGACTTGCTGCTTCC
AGTAAATAAGGTGGATCCGGTACTGTACTTTAAAGATGTCACTTCAA
GTGTAGACTCATTGTCCTGTATATTGGTT 3’
guide7, 
guide8
ssODN8 5’ ACTACTTACCACTAAGAGATTGTTGCCATGCTAAAGCAGAACAA
AGTAAGGCTAAGCTCCGTCCACTTCCTGTTGGACTCTCCAACAAACA
ATGTTGCTTGCTGTTTAATCCTCTGAGAA 3’
guide12 ssODN13 5’ TAAATTACTTATATAAGACTCCCCTGAAAAAACCACTCTGGCTG
CAAAGTTATCTGCTGCGGCACAGGCATCCATATACAGAGATGAAAAT
GATGATTTTCAAGTAGAGAAGAAAAGAAT 3’
* denote PTO linkages
The following primer pairs spanning the target site were used (a: forward; b: reverse):
primer a primer b
guide msh2 5’ TCTTTCTCAGTTTGAAGACATCC 3’ 5’ GGGGTATTTTACATGAAGG 3’
guide3, 
guide7,  
guide8
5’ GAGCTGGGCATCTTCACTTTA 3’ 5’ CCAGGCTGCCAAGTCTTTAT 3’ 
guide5 5’ TTTCCCTGGGTTTACCTTT3’ 5’ CCCATTACAGTACACCATACT 3’
guide12 5’ AGAAGGAGCTTTCAGGATTATGG 3’ 5’ CCATGCAGTTTCACTTGAACG 3’
guidelbr2 5’ GTAGCCTTTCTGGCCCTAAAAT3’ 5’ AAATGGCTGTCTTTCCCAGTAA 3’
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The following primer pairs spanning the to be edited site were used (c: reverse; d: forward):
primer c* primer d*
guide_msh2 5’ TAGTCTCTCCTCCTGGTAAAACGCATTCC
TTTGGTCCAATCTGAATCAGAGAGCCTGGATC
CTGGAGAACTGATCATTCTCGGGGAACTCACA
CAAGCTTAGCTTCCTCTGGGTGGAAT 3’
5’ ATTCCACCCAGAGGAAGCTAAGCTTGTGT
GAGTTCCCCGAGAATGATCAGTTCTCCAGGAT
CCAGGCTCTTCTGATTCAGATTGGACCAAAGG
AATGCGTTTTACCAGGAGGAGAGACTA 3’
guide3 5’ CTAAGCTTTTTCCACTTCATCAGGGACTC
TCCAACAAACAATGTT 3’
5’ GTGTTCATAGATTCTCAGAGGATTAAACA
GCAAGCAACATTGTTTGTTGGAGAGTCCCTGA
TGAAGTGGAAAAAGCTTAGCCTTACTTTGTTC
TGCTTTAGCATGGCAACAATCTCTTAG 3’ 
guide7, 
guide8
5’ ACTACTTACCACTAAGAGATTGTTGCCAT
GCTAAAGCAGAACAAAGTAAGGCTAAGCTCCG
TCCACTTCCTGTTGGACTCTCCAACAAACAAT
GTTGCTTGCTGTTTAATCCTCTGAGAA 3’
5’ GTTGGAGAGTCCAACAGGAAGTGGACGGA
GCTTAGCCTTACTTTG 3’
guide5 5’ CATCTTCCACAAAATTTTCTGGTGATAGA
TGACTTGCTGCTTCCAGTAAATAAGGTGGATC
CGGTACTGTACTTTAAAGATGTCACTTCAAGT
GTAGACTCATTGTCCTGTATATTGGTT 3’ 
5’ GTGACCTCTTTAAAGTACAGTACATCACC
TTATTTACTGGAAGC 3’ 
guide12 5’ CTGTATATGGATGCCTGTGCCGCAGCAGA
TAACTTTGCAGCCAG 3’
5’ TAAATTACTTATATAAGACTCCCCTGAAA
AAACCACTCTGGCTGCAAAGTTATCTGCTGCG
GCACAGGCATCCATATACAGAGATGAAAATGA
TGATTTTCAAGTAGAGAAGAAAAGAAT 3’ 
guide_lbr2_1 5’ GCCATCGACGCTCTTACCACT 3’ 5’ AGTGGTAAGAGCGTCGATGGC 3’
guide_lbr2_2 5’ CTTACCACTTCTACCATCGGCAAAT 3’ 5’ ATTTGCCGATGGTAGAAGTGGTAAG 3’
guide_lbr2_3 5’ CGACCTCTTACCAACTTCACCATCG 3’ 5’ CGATGGTGAAGTTGGTAAGAGGTCG 3’
guide_lbr2_4 5’ GCCATCGACCTCTTCACCACT 3’ 5’ AGTGGTGAAGAGGTCGATGGCC 3’
*Note that some of primers c,d are similar to the used ssODN oligo
PCR Reference sample 
The reference sequence was generally generated in a 2-step PCR reaction. Two complementary 
primers (primers c & d) were designed that carried the designed mutations as present in 
the donor template. Two standard PCR reactions were done with 50 ng wild-type genomic 
DNA in MyTaqTM Red mix (Bioline) using primers a & c and primers b & d. PCR thermocycling 
scheme: 1 min at 95°C (1x), followed by 15 sec at 95°C, 15 sec at 55°C, and 20 sec 72°C (25-
30x). The two PCR products were purified using the ISOLATE II PCR and Gel Kit (Bioline). Next, 
the resulting two PCR amplicons (each 1 µL) were combined with 48 µL buffer (10 mM Tris, 
50 mM NaCl, 1 mM EDTA) and denatured for 5 min 95°C and cooled down to 25°C (0.1 °C/sec). 
Of this mixture 3 µL was subsequently used as template in a PCR reaction with MyTaqTM 
Red mix (Bioline) with primers a & b, starting with an extension step as follows: 
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15 sec at 72°C (1x), followed by 15 sec at 95°C, 15 sec at 55°C, and 20 sec 72°C (25-30x). The 
PCR products were purified using the ISOLATE II PCR and Gel Kit (Bioline).
Sanger sequencing
Purified PCR samples (100 ng) were prepared for sequencing using 4 µL of BigDye® 
terminator v3.1 (Applied Biosystems®) and 5 pmol primer in final volume of 20 μL. 
Thermocycling program: 1 min at 96°C (1x), followed by 30 sec at 96°C, 15 sec at 50°C, 
and 4 min at 60°C (30x), and finishing with 1 min incubation at 4°C (1x). Sequence traces 
were generated on an Applied Biosystems 3730xl DNA Analyzer, running 3730 Series Data 
Collection Software V4 and Sequencing Analysis Software V6.
Next generation sequencing
The following primers sequences were used for NGS:
msh2_F EB514 5’ ACACTCTTTCCCTACACGACGCTCTTCCGATCTTAACGCTGTTGGAGTTGG
GTATGTGG 3’
msh2_R EB515 5’ GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTTCAAGGAAATACAGGGG
AAGG 3’
guide5_F EB524 5’ ACACTCTTTCCCTACACGACGCTCTTCCGATCTATAGGCGGACAGAACCAA
TATACAGGACAA 3’
guide5_R EB525 5’ GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTACAAACCACCATATTTA
AGGAATTA 3’
guide12_F EB532 5’ ACACTCTTTCCCTACACGACGCTCTTCCGATCTCTACGTAAATTGCCTACC
TGTAAGTTATTTATG 3’
guide12_R EB533 5’ GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTCATGCAGTTTCACTTGA
ACGA 3’
guide3_7_8_F EB534 5’ ACACTCTTTCCCTACACGACGCTCTTCCGATCTACGGATTTTTCATTGGTT
TCTGTGTTCA 3’
guide3_7_8_R EB535 5’ GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTTTTTGCTATATTGAAAC
TCTTTTGGA 3’
PCR was performed in two steps with genomic DNA as template; PCR1 with ~50 ng genomic 
DNA and site specific barcoded primers. PCR2 used 2 µL of each PCR1 product with Illumina 
PCR Index Primers Sequences 1-12. Each sample was generated with a unique combination 
of a barcode and index. Both PCR reactions were carried out with 25 µL MyTaqTM Red mix 
(Bioline), 4 µM of each primer and 50 µL final volume in a 96 well plate. PCR conditions were 
1 min at 95°C, followed by 15 sec at 95°C, 15 sec at 58°C and 1 min at 72°C (15x). 20 µL of 8 
samples were pooled and 100 µL was loaded onto a 1% agarose gel. PCR product was cut 
from gel to remove the primer dimers and cleaned with ISOLATE II PCR and Gel Kit (Bioline). 
The isolated samples were sequenced by Illumina MiSeq. 
72
Chapter 3
NGS data analysis
In order to identify insertions and deletions, the distance between a fixed sequence 
~50 nt upstream of the break site and ~50 nt downstream of the break site was determined. 
Insertions and deletions have a distance longer or shorter than wild-type, respectively. For 
each of the remaining reads a window of 50 nucleotides (from -25 to +25 relative to the 
expected break site) was compared to the corresponding nucleotide sequence strings of 
the control and reference sequences. Windows with zero or one mismatches compared 
to the control sequence were counted as wild-type reads. Subsequently, remaining reads 
with zero or one mismatches compared to the reference sequence were counted as HDR 
reads. All other reads are counted as other mutations. Reads in which we could not find 
a match with the constant parts are discarded. Finally, for each sample, the ratio of each 
mutation type over the total of reads is calculated. 
TIDER software 
TIDER is built upon the previous published TIDE software (14). TIDER code was written in 
R, version 3.3.2. TIDER requires as input a control sequence trace file (e.g. obtained from 
cells transfected without Cas9), a sample sequence trace file (e.g. DNA from a pool of cell 
treated with Cas9 and donor template), a reference sequence trace file (e.g. DNA from the 
donor template) and a character string representing the sgRNA sequence (20 nt). 
We advise to sequence a stretch of DNA ~700 bp enclosing the designed editing site. 
The projected break site should be located preferably ~200 bp downstream from the 
sequencing start site. The sequencing data files (.abif or .scf format) are parsed using 
R Bioconductor package sangerseqR (version 1.10.0) (21). Additional parameters have 
default settings but can be adjusted if necessary. The web interface was constructed using 
the shiny R package (version 1.0.0). 
Briefly, the algorithm consists of the following steps. Both the test sample and the 
reference sequence are first aligned to the control sample sequence using standard 
Smith-Waterman local alignment implemented in the BioStrings package (version 2.42.1) 
in Bioconductor (22). Subsequent calculations are done using the peak heights of the four 
bases for each position in the aligned sequence trace data. Next, for each position, the 
absolute peak height of each base is converted to a relative peak height by dividing it by 
the sum of the peak heights of all four bases at that position. All subsequent calculations 
are done using these relative peak heights.
In contrast to TIDE, the decomposition window of TIDER spans by default from 20 bp 
upstream of the break to 80 bp downstream from the break. This window can be 
interactively adjusted, but it should contain all nucleotides that are edited. Within this 
window, sequence trace models are constructed of all possible indel occurrences that 
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may realistically be expected, i.e, deletions of sizes {0..n} and insertions of sizes {0...m} 
that overlap with or are immediately adjacent to the break site. For example, to model all 
possible -4 deletions, 5 different sequence trace models are constructed; and to simulate all 
possible insertions of size 3, 43 = 64 trace models are constructed. By default, n is set to 10, 
and m to 5. For deletions, the model traces are simply constructed from the control trace 
by deleting the values at the corresponding positions. For insertions, the average value of 
the same nucleotide occurrence within the whole sequence trace is used. The break site is 
assumed to be between the 17th and 18th bases in the sgRNA target sequence (3 bp before 
the PAM) (23). The sequence trace models are constructed accordingly for each of the 
four bases, after which the vectors of the four bases are concatenated, so that each model 
consists of a single vector. Subsequently, control sequence model, all indel models and 
the reference sequence model are combined into a single decomposition matrix. To avoid 
doublet models, in case the reference consists of an insertion or deletion at the break site, 
the identical simulated insertion or deletion is removed from the decomposition matrix.
The decomposition is subsequently performed in two iterations. First, the sequence 
trace from the test sample is assumed to be a linear combination of the wild-type trace, 
the modelled indel traces and the reference trace. This combination is decomposed by 
standard non-negative linear modelling, for which we used the R package nnls (version 1.4). 
After this first trace decomposition, all sequence variants with an estimated frequency 
of exactly 0 are removed, and the decomposition is repeated with the remaining models.  
Next, the frequencies of the various traces of same deletion or insertion size are summed. 
R2 is calculated to assess the goodness of fit. The p-value associated with the estimated 
abundance of the reference trace is calculated by a two-tailed t-test of the variance-
covariance matrix of the standard errors. Finally, the fitting coefficients (frequencies) are 
multiplied by a constant factor such that their sum equals R2.
Plots for visual inspection of sequence traces
TIDER uses the relative peak heights to determine the abundance of aberrant nucleotides 
by subtracting the peak heights of the highest control nucleotide over the length of the 
whole sequence trace of either the test sample or reference. Then, the highest peaks in 
the reference and the peaks in the control at the same location that are not the highest 
are identified (the designed base pair changes). Of these positions the corresponding 
nucleotide peak signal in the control and test sample are plotted to show the relative 
incorporation of the donor template. The plots of these sequence signals allows the user 
to check the quality of the sequence data, inspect proper alignment, verify the expected 
cut site, and interactively select the region used for decomposition.
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TIDER settings and constrains 
For TIDER, we have empirically determined an optimal decomposition window of 100 bp 
for most applications, but this can be interactively adjusted.
In case the designed mutation consists of an insertion larger than +1, TIDER does not 
consider natural insertions of the same size, because we found the decomposition to 
become less robust, and because we and others have rarely observed natural insertions 
larger than +1 (14, 24). 
It has been reported that the incorporation of donor template is less efficient when the 
designed point mutations are further away from the break site (25). This may confound 
TIDER estimates when such distal mutations are combined with mutations close to the 
break site. This is also what we observed (Supplementary Figure S7). By comparing different 
settings for the decomposition window and by visual inspection of the TIDER plots it is 
possible to infer such biases. 
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Supplementary Figure S1: Plots for visual 
inspection of TIDER analysis. Plots show 
for each position around the expected break 
site (vertical blue dashed line) how much 
the nucleotide signals in the sequencing 
traces deviate from the expected signals 
according to the control sample sequence. 
For each position, a value of 0% indicates 
that the detected nucleotide did not deviate 
from the control sequence; a value of 100% 
indicates that the expected nucleotide was 
not detected at all (and instead only one or 
more of the other three nucleotides). Vertical 
dashed blue line marks the expected break 
site; arrowheads mark nucleotides that are 
expected to be substituted. (A) Comparison 
of the reference (red) and control (black) 
traces. Note the high scores at the positions 
of the altered nucleotides. Near the end of 
the sequencing trace are also high scores, but 
these are typically due to the lower quality 
of the trace towards the end. Fluctuations in 
the control signal reflect local variation in the 
quality of the sequence trace. (B) Comparison 
of the experimental test sample (green) and 
control (black) traces. Immediately after 
the break site a consistently elevated signal 
is observed in the experimental sample 
(horizontal green dashed line), which is due 
to insertions and deletions at the break site. 
The starting position of this elevated signal 
may be used to verify that breaks were 
induced at the expected location. (C) Masked 
plot of (B), showing only the expected mutated 
nucleotide(s) in the experimental test sample. 
The substituted nucleotide (arrowhead) again 
shows elevated signals, but not as much as in (A) 
because the editing efficiency is not 100%.
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Supplementary Figure S2: TIDER analyses of additional in vitro mixes. (A-C) Proportions of mutant DNA as 
determined by TIDER for various mixtures of DNA as indicated. Reference DNA was generated from fully synthetic 
DNA, rather than by the 2-step PCR mutagenesis procedure. Mixtures in (B-C) correspond to those in Figure 2b-c. 
(D) Estimate of the reproducibility of TIDER: mixtures with low ratios of reference, similar as in (C) were independently 
sequenced 6 times, divided over two separate sequencing runs. Mean ± SD is plotted. (E-G) Additional mixing 
experiment with a different mutant and a different complex DNA pool. (E) Sequences, mutations and break site. 
(F) Indel spectrum of complex pool2 as determined by conventional TIDE. (G) TIDER estimates from samples 
with various mixing ratios.
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Supplementary Figure S3: Specificity of TIDER indel detection in in vitro mixed samples. TIDER indel 
and HDR spectra of samples consisting of wild-type DNA mixed with DNA with a HDR reference in different 
ratios. Samples correspond to individual data points in Figure 2b; input mixing ratios are indicated. In each 
panel, bar graphs show the estimated percentage of successfully edited DNA molecules (right-hand plot; 
‘HDR’) and of indels of the indicated size (left-hand plot). R2 values indicate the goodness-of-fit score for 
the TIDER estimates; ‘total eff’ indicates all mutations combined (HDR plus indels).
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Supplementary Figure S4: Specificity of TIDER indel detection in in vitro mixed samples with 
complex DNA pool. TIDER spectra of samples corresponding to individual data points in Figure 2c. 
See legend of Supplementary Figure S3 for explanation.
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Supplementary Figure S5: TIDER analysis of reverse complement sequencing data. Wild-type and mutant 
sequences with +1 insertion at or surrounding break site. Mutant sequences of a were mixed in vitro with DNA 
carrying various indels including natural +1 insertion in different ratios. Reverse complement reads of same in vitro 
mixtures as shown in Figure 2h. The used reference is indicated and the expected ratio is plotted in the last column of 
each mixture. Designed +1, natural +1 and wild-type as determined by TIDER are shown.
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Supplementary Figure S6. 
Negative controls confirm 
specificity of TIDER estimates. 
(A-C) TIDER (red) and NGS (blue) 
analyses of negative control 
experiments corresponding to 
Figure 3a-c. Here, cells were 
transfected with Cas9 and 
indicated sgRNAs, but without 
ssODN donor template. As 
expected, indels are detected 
but virtually no HDR. For NGS, 
at least 5 x 104 reads were 
analysed in each experiment. 
(D) Three technical TIDER replicates 
of the sample shown in Figure 3e.
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(figure and legend continued on next page)
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Supplementary Figure S7: 
Reproducible and robust TIDER 
analysis of a complex mutagenesis 
design. Three additional biological 
replicates and further analysis of 
the mutagenesis experiment of 
Figure 3e. (A) Extended sequences 
showing an additional designed 
substitution 40 bp upstream of the 
break site (B-D) Comparison of 
TIDER and NGS analyses of three 
independent biological replicates 
when analysis is restricted to 
decomposition window 133..233. 
Data representation as in Figure 3e. 
For NGS, at least 2 x 105 reads 
were analysed in each experiment. 
(E-G) Comparison of TIDER and 
NGS estimates of HDR frequency 
based the same data as in 
(B-D), but with a decomposition 
window of 110..130. TIDER and 
NGS consistently indicate that 
the incorporation of the distal 
mutation is ~2.5-fold less frequent 
than that of the designed mutations 
near the break site. (H-J) Quality 
plots of the test sample depicted 
in (B). Grey bar: decomposition 
window 133..233; purple bar: 
110..130. TIDER visualization of the 
sequence trace data confirms this 
interpretation, as the distal (purple 
arrowhead) and proximal (grey 
arrowheads) mutated nucleotide 
peaks are present in the reference 
sample (H, red), but the distal 
peak is weaker compared to the 
proximal mutated nucleotide peaks 
in the test sample (I J, green). See 
legend of Supplementary Figure S1 
for explanation quality plots. In 
all panels the decomposition was 
limited to deletions of sizes 0-10 and 
insertions of sizes 0-5.
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4ABSTRACT
Current genome editing tools enable targeted mutagenesis of selected DNA sequences in 
many species. However, the efficiency and the type 
of introduced mutations by the genome editing 
method is largely dependent on the target site. As a 
consequence, the outcome of the editing operation 
is difficult to predict. Therefore, a quick assay to 
quantify the frequency of mutations is vital for a 
proper assessment of genome editing actions. We 
developed two methods that are rapid, cost–effective 
and readily applicable: 1) TIDE, which can accurately 
identify and quantify insertions and deletions (indels) 
that arise after introduction of double strands breaks 
(DSBs); 2) TIDER, which is suited for template-
mediated editing events including point mutations. 
Both methods only require a set of PCR reactions 
and standard Sanger sequencing runs. The sequence 
traces are analysed by the TIDE or TIDER algorithm 
(available at http://tide.nki.nl). The routine is easy, 
fast and provides much more detailed information 
than current enzyme-based assays. TIDE and TIDER 
accelerate testing and designing of DSB based 
genome editing strategies. 
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INTRODUCTION
CRISPR based systems are popular and widely used for genome editing in the field of 
molecular biology. CRISPR endonuclease Cas9 introduces a DSB into the genomic DNA 
with high precision. Due to the error-prone repair mechanisms of the cell this often results 
in insertions or deletions at the targeted site (1). This is exploited to make functional knock-
outs of specific genes and regulatory elements (2-4). Alternatively, to gain more control 
over the nature of the mutations, strategies have been developed that introduce small 
nucleotide changes around a precisely targeted site by using a donor template (5, 6). In 
the latter approach the genomic DNA around de DSB break is replaced by the DNA of the 
donor template through homology directed repair (HDR), resulting in the introduction of 
a designed mutation with high accuracy (7, 8). This precise editing creates the possibility 
to generate and study specific disease-causing nucleotide variants (6, 9). Typically, one 
starts with a homogeneous cell line and ends up with a pool of cells with a complex mix 
of indels and/or designer mutations (10-12). To study a mutation of interest, clonal mutant 
lines need to be isolated from the cell pool. Because this is a very labour-intensive process 
it is important to know a priori the efficiency in which the desired mutation(s) have been 
introduced. However, a complicating factor is that the efficacy of the programmable 
nucleases can vary dramatically depending on the sequence that is targeted. In addition, 
different cell types have a varying performance in transfection capability. These factors 
make the efficacy of CRISPR experiment difficult to predict. For this reason it is usually 
necessary to test several guide RNAs (gRNAs) that lead the endonuclease to the site of 
interest. This is even more critical when a template–directed strategy is applied, which 
often has a low efficiency because HDR repair pathways are generally less active than 
error-prone non-templated repair (10, 12). Hence, a quick and easy assay to estimate the 
frequencies of the diverse introduced mutations in the cell pool is of key importance.
We developed two methods that can accurately quantify the efficiency of either indels or template-
directed mutations in a pool of cells. Both methods are rapid and cost-effective. The method TIDE 
(Tracking of Indels by DEcomposition) identifies and quantifies indels. It requires only a pair of 
standard Sanger sequence traces of two PCR products (13). The sequence traces are then analysed 
using an easy-to-use web tool. Note that TIDE can only detect overall indel frequencies, but not 
nucleotide substitutions or specifically designed indels. For the latter purpose we developed 
TIDER (Tracking of Insertions, DEletions and Recombination events) (14). This method can estimate 
the incorporation frequency of template-directed mutations, including point mutations, and 
distinguish them from a background of additional indels that originate from competing erroneous 
repair pathways. Although TIDER can also quantify indels alone, TIDE is slightly simpler to 
implement and therefore more suited for the assessment of non-templated editing experiments. 
The corresponding web tools for both TIDE and TIDER are freely accessible at http://tide.nki.nl.
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MATERIALS
Guide RNA design
TIDE and TIDER are suitable for any species in which genomic editing experiments can be 
performed. CRISPR guide RNAs can be designed using various online design webtools (e.g. 
http://crispr.mit.edu/, https://chopchop.rc.fas.harvard.edu/, https://www.deskgen.com/). 
DNA Purification Buffers and Solutions
Usually, one to three days after transfection genomic DNA is isolated. Genomic DNA 
of a minimum of 1000 cells should be isolated to get a comprehensive sampling of the 
complexity of the mutations that are introduced by the repair of the CRISPR-Cas9 
double strand break. A standard genomic DNA isolation Kit (e.g. BioLine ISOLATE II 
Genomic DNA Kit , BIO-52067) can be used according to the manufacturer’s protocol. 
DNA can also be isolated with the protocol for isolation of high-molecular-weight DNA 
from mammalian cells using proteinase K and phenol/chloroform extraction (15). 
PCR amplification of control & experimental sample DNA 
PCR reactions are carried out with primers surrounding the expected break site. We advise to amplify 
and sequence a stretch of DNA 500-1500bp enclosing the designed editing site. The projected break 
site should be located preferably ~200 bp downstream from the sequencing start site.
1. Genomic DNA 
2. PCR primers 
3. PCR mastermix (example makes 50 μL):
21-x μL H
2
O
2 μL primer a (10 µM stock)
2 μL primer b (10 µM stock)
x uL genomic DNA (~50 ng)
25 μL 2x pre-mix of buffer, Taq polymerase and dNTPs (e.g. BioLine MyTaqTM, BIO-25044)
PCR program:
Step Temperature Time (min:sec) Number of cycles
Initial denaturation 95 °C 1:00 1
Denaturation 95 °C 0:15
Annealing 55-58 °C 0:15 25-30
Extension 72 °C 0:10
Final Extension 72 °C 1:00 1
4 °C hold
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4. Check an aliquot of the PCR product on 1-2% agarose gel. A sharp single band should 
be visible.
5. Purify the PCR product using a kit according to manufacturer's instructions 
(e.g. BioLine ISOLATE II PCR and Gel Kit, BIO-52060).
Two-step PCR amplification of reference DNA (TIDER only)
1. Genomic DNA 
2. PCR primers. Similar primers as used for control & experimental sample plus two 
specific primers carrying the designed mutation(s) as present in the donor template 
(See Note 13). For the primers carrying the mutation(s), it is advised to include at least 
10 complementary nucleotides on the 3' side of the mutation(s). 
3. PCR mastermix (example makes 50 μL):
PCR mix1 PCR mix2
21-x μL H
2
O H
2
O
2 μL primer a (10 µM stock) primer d (10 µM stock)
2 μL primer c (10 µM stock) primer b (10 µM stock)
x uL genomic DNA (~50 ng) genomic DNA (~50 ng)
25 μL 2x pre-mix of buffer, Taq polymerase and dNTPs 
(e.g. BioLine MyTaqTM, BIO-25044)
2x pre-mix of buffer
PCR program:
Step Temperature Time (min:sec) Number of cycles
Initial denaturation 95 °C 1:00 1
Denaturation 95 °C 0:15
Annealing 55-58 °C 0:15 25
Extension 72 °C 0:10
Final Extension 72 °C 1:00 1
4 °C hold
4. Purify PCR product using kit and manufacture instructions (e.g. BioLine ISOLATE II 
PCR and Gel Kit, BIO-52060)
5. Anneal the following two PCR products for 1 minute 95°C, cool down to 20°C 
(0.1 °C/sec).
48 µL annealing buffer (=10 mM Tris, 50mM NaCl, 1mM EDTA)
1 µL PCR mix1
1 µL PCR mix2
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6. Extend the annealed products and amplify the joined product.
18 µL H
2
O
2 µL primer a (10 µM stock) 
2 µL primer b (10 µM stock)
3 µL annealed oligo mix
25 µL 2x pre-mix of buffer, Taq polymerase and dNTPs (e.g. BioLine MyTaqTM, BIO-25044)
PCR program:
Step Temperature Time (min:sec) Number of cycles
Initial denaturation 95 °C 1:00 1
Denaturation 95 °C 0:15
Annealing 55-58 °C 0:15 25
Extension 72 °C 0:10
Final Extension 72 °C 1:00 1
4 °C hold
7. Check the PCR product on 1-2% agarose gel. A sharp single band should be visible.
8. Purify the PCR product using a kit and manufacturer’s instructions (e.g. BioLine 
ISOLATE II PCR and Gel Kit, BIO-52060).
Sanger sequencing
We strongly recommend that all PCR products (control, experimental sample(s) and for 
TIDER also the reference) are sequenced in parallel. Purified PCR samples are prepared 
for Sanger sequencing with the following protocol or can be send for commercial Sanger 
sequencing.
1. Purified PCR samples (100 ng) 
2. PCR primers. Similar primers can be used as for the amplification of control & 
experimental sample
3. PCR mastermix (example makes 20 μL):
15.5-x μL H2O
0.5 μL primer a or primer b (10 µM stock)
x uL Purified PCR samples (100 ng)
4 μL BigDye (e.g. BigDye® terminator v3.1 of Applied Biosystems, 4337456)
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PCR program:
Step Temperature Time (min:sec) Number of cycles
Initial denaturation 96 °C 1:00 1
Denaturation 96 °C 0:30
Annealing 50 °C 0:15 30
Extension 60 °C 4:00
4 °C hold
4. Samples are analyzed by a Sanger sequence instrument (e.g. Applied Biosystems 
3730xl DNA Analyzer). Sequence trace files must be saved in .ab1 or .scf format. 
Equipment
1. Cell counter
2. Microcentrifuge 
3. PCR cycler
4. Nanodrop
Software
The TIDE and TIDER web tools are both available at https://tide.nki.nl/. 
METHODS
Control and experimental sample generation
For both methods genomic DNA is isolated from the cell pool that was transfected with 
the nuclease or guide RNA alone (control) and from cells exposed to both Cas9 and guide 
RNA (experimental sample). For TIDER the experimental sample is also co-transfected with 
the donor template. Then a region of about 500-1500 base pairs around the target site is 
amplified by PCR from DNA of the control and experimental sample (Figure 1a,b). Next, 
the PCR amplicons are subjected to conventional Sanger sequencing. In the PCR product 
of the experimental sample the sequence trace may consist of a combination of multiple 
sequences derived from unmodified DNA and DNA that has acquired a mutation (Figure 2a). 
Reference sample generation (TIDER only)
TIDER is required for genome editing experiments in the presence of a donor template. In 
addition to the control and experimental sample trace, TIDER requires one extra Sanger 
sequencing trace called ‘reference’. The reference is similar to the control sequence, 
except that it carries the desired base pair changes as designed in the donor template 
(Figure 2e). There are two paths to obtained the reference sequence as described below. 
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2-step PCR
The reference sequence can be easily created in a 2-step PCR protocol based on 
site-directed mutagenesis (16). Here, two additional primers are required that overlap 
and carry the desired mutation(s) (mutated primers c,d, which are reverse complement 
of each other) (Figure 1c). These primers are used in combination with the primers used 
for the amplification of the control and experimental sample (control primers a,b). The 
control forward primer a is combined with the reverse mutated primer c and the forward 
mutated primer d with the control reverse primer b, resulting in two PCR amplicons 
that incorporate the designed mutations. Then the two amplicons are denatured and 
hybridized at the complementary ends in an annealing reaction. The second PCR uses the 
annealing mixture as a template and the control forward and reverse (primers a and b) as 
primers. This PCR starts with an extension step followed by exponential amplification. This 
results in a PCR product carrying the designed mutations (See Note 13).
DNA synthesis
Alternatively, the reference DNA can be ordered as synthesized DNA. The design should 
include a similar DNA code as the PCR product of the control sample, except that it should 
carry the designed mutation(s) as in the donor template. The annealing sequences for the 
forward and reverse primers (a,b) should also be present in the synthesized fragment. Similar 
to the control and test sample, the reference can be amplified with primer a,b (See Note 13). 
primer a
primer b
sample = mixed pool
primer a
primer b
primer c
primer d
reference = designed mutations
primer a
primer b
primer a
primer b
control = wild-type
mutations after DSB repair
designed bp changes
gDNA
PCR PCRPCR
mix, denature,
anneal, extend
PCR
+
PCR
TIDER
TIDE
1 2 3
Figure 1 Method to generate the required input samples for TIDE and TIDER. Control and test samples can 
be obtained by PCR using primers spanning the CRISPR target site (primers a,b). The reference sequence (TIDER 
only) can be created in a similar way as site directed mutagenesis (16) (See Methods for detailed explanation).
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Web tool
The PCR products of the control, optional reference, and experimental sample are 
processed by conventional Sanger sequencing. The resulting sequence trace files (.ab1 
or .scf format) are then uploaded into the TIDE or TIDER web tool (both available at 
http://tide.nki.nl). In addition, a character string representing the guide RNA sequence (20 nt) 
is required as input (See Note 2,9). Then, the software will perform several calculations. 
First, the guide RNA sequence is aligned to the control sequence in order to determine the 
position of the expected Cas9 break site. Next, in all Sanger sequence traces an alignment 
window is automatically selected that runs from 100 to 15 bp upstream of the break site. 
The sequence segment in this window of the experimental sample (and the optional 
reference) is aligned to that of the control in order to determine any offset between the 
sequence reads. Users may change the default settings for these calculations, which is 
necessary when alignment problems occur with these settings (See Note 3,4). Subsequently, 
two output plots are generated: one plot that can help with quality control, and one that 
displays the indel/HDR spectrum.
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Figure 2: Overview of TIDE and TIDER algorithm. Due to imperfect repair (and repair by homology directed 
repair with a donor template) after cutting by a targeted nuclease, the DNA in the cell pool consists of a mixture of 
indels (and designed mutations). The various introduced mutations in the pool are disentangled by TIDE or TIDER. 
(A) TIDE requires as input a guide RNA sequence string and two sequences are required: 1) wild-type control, 
2) composite test sample. (B) For quality control the aberrant sequence signal is visualized in control (black) and 
treated sample (green), the expected break site (vertical dotted line), region used for alignment (pink bar) and the 
region used for decomposition (grey bar). A constant composite sequence signal is yielded after the break site. 
(C) Trace decomposition yields the spectrum of indels with their frequencies (D) In presence of +1 insertions, the base 
composition is estimated. (E) Input files for TIDER are identical to TIDE and one additional sequence file with designed 
mutations in the used donor template. (F). Quality plot showing only the proportion of desired mutated nucleotide(s) 
as designed in donor template that is/are present in the control (black) and treated sample (green). The region for 
alignment (pink bar) and decomposition (grey bar) as used in TIDER are represented. (G-H) Decomposition gives the 
spectrum of indels (G) and the HDR events (H) with their frequencies.
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Quality control
For generation of the quality control plot the signals of all nucleotides: A, G, T, C at each 
position in the sequence file are used. In general, each position in the sequence trace is 
represented by one predominant nucleotide signal indicative of the actual nucleotide. The 
minor signals from the other three nucleotides are normally considered as background. In 
TIDE(R) the percentage of these aberrant nucleotides is plotted along the sequence trace 
of the control and the experimental sample. Thus, a value of 0% at a position indicates that 
the detected nucleotide does not differ from the control sequence while a value of 100% 
indicates that the expected nucleotide was not detected at all (and instead only one or 
more of the other three nucleotides) (Figure 2b). The percentages of aberrant nucleotides 
in the control should be low along the whole sequence trace. However, the experimental 
sample consists of mixture of multiple sequences due to the presence of indels and 
possible point mutations. Around the break site the sequences start to deviate from the 
control, which is visible with consistently elevated signal of the aberrant sequence signal. 
Note that there is a 25% chance that an identical nucleotide in a mutated sequence is 
found as is present in the control sequence at the same position, because there are 
only four different nucleotides available. This plot allows the user to visually inspect the 
sequence deviation caused by the targeted nuclease and enables to verify the alignments 
and quality of the data. It is important to confirm that 1) the break site is located as 
expected, 2) the aberrant signal is only increasing around the break site and 3) remains 
elevated downstream of the break site. The sequence trace downstream of the break site 
is decomposed into its individual sequence components. The region used for this purpose 
is marked as the decomposition window. All parameters in TIDE(R) have default settings 
but can be adjusted if necessary. The user can interactively change the alignment and 
decomposition windows. Choosing a different decomposition window is often a remedy 
to circumvent locally poor sequence traces, which should be avoided (See Note 1,5,8).
For TIDER two additional quality plots are generated. In one, the aberrant signal of the 
reference trace compared to the control trace is plotted. This can be used to verify whether 
the designed mutation(s) is/are present at the expected location. In the second one, the 
percentage of the designed mutation(s) present in the experimental sample is plotted, 
representing the relative incorporation of the donor template (Figure 2f).
Mutation detection by decomposition
For the detection of individual mutations with the corresponding frequencies, the TIDE and 
TIDER software perform a decomposition of the mixed sequence signal in the experimental 
sample. This composite sequence trace is a linear combination of the wild-type (control) 
and the mutated sequences. For TIDE, the decomposition is performed on a sequence 
segment downstream of the break site. As a rule of thumb, the larger the decomposition 
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window is chosen, the more robust the estimation of mutations is (See Note 5). To perform 
the decomposition, a set of sequence trace models are generated that contain all possible 
indels of size {0..n} (n is by default set to 10). The models are derived from the control 
trace and contain all nucleotide peaks signals of the decomposition window shifted by 
the appropriate number of positions to the left or right. A wild-type trace (shift 0) is also 
added as a model. Then, using non-negative linear modelling the combination of trace 
models that can best explain the composite sequence trace in the experimental sample 
is determined (Figure 2c) (See Note 6). An R2 value is calculated as a measure of the 
goodness of fit (See Note 7,8), and the statistical significance of the detection of each indel 
is calculated. 
For TIDER the mutation detection is more complex. It is mandatory that the decomposition 
window in TIDER covers the location of the designed mutation(s) in the donor template 
(See Note 5,12). In contrast to TIDE, the decomposition window of TIDER spans by 
default only 100 bp. In case only few base pair changes are introduced, the sequence 
with the designed mutation will be very similar to the wild-type sequence. The smaller 
decomposition window of TIDER emphasizes the difference between the control and 
reference better. Simulations of all possible insertions and deletions are generated from 
the control file and placed in a decomposition matrix together with the control and 
reference. Subsequently, decomposition of the experimental sample is performed thereby 
choosing the best combination of the models in the decomposition matrix. This results 
in an estimation of the incorporation frequency of template-directed mutation(s) and 
distinguishes these from the background of indels that are introduced by error prone 
repair (See Note 11).
The reliability of TIDE and TIDER depends on the quality of the input samples (See Note10). 
For an accurate TIDE(R) estimation it is recommended that 1) R2>0.9 and 2) aberrant 
signals upstream of the break site are below 10% in the quality plot. This applies to all 
files: control, reference and experimental sample. To verify the results the samples can be 
sequenced from the opposite strand (See Note 12).
Sequence determination of the +1 insertion (TIDE only)
During repair of CRISPR-Cas9 a single base pair is frequently inserted at one of the DNA 
ends of the break (13, 17, 18). TIDE provides an estimate of the base composition of this 
insertion. This may be of interest if one wishes to obtain a particular sequence variant 
(Figure 2d). For longer insertions this base-calling is computationally complicated and 
currently not implemented. 
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NOTES
1. Quality plot recommendations. In the experimental sample, around the break site a 
consistently elevated signal is expected, which is due to indels introduced at the 
break site. The starting position of this elevated signal may be used to verify that 
breaks were induced at the expected location. The control trace should have a 
low and equally distributed aberrant sequence signal along the whole trace. The 
reference trace in the case of TIDER, should only have high scores at the positions 
of the altered nucleotides. Fluctuations in the control and reference signal reflect 
local variation in the quality of the sequence trace. Near the end of the sequencing 
traces the aberrant signal is often high, typically due to the lower quality of the trace 
towards the end (Figure 3a). When a sequence stretch of poor local quality is present 
in the decomposition window the calculations of TIDE(R) are compromised. The 
boundaries of the decomposition window can be manually adjusted to remove the 
region that is of low quality; this will improve the estimations. Another area to avoid 
in the decomposition window is a stretch of repetitive sequences. These regions can 
be recognized in the quality plot as a sudden stretch without aberrant nucleotides 
(Figure 3b). Such region might confound the decomposition of the sequence trace.  
2. Nuclease type. TIDE(R) is currently designed for regular Cas9. But it can be used to 
analyse data from another nuclease, by entering in the webtool the DNA sequence 
around the expected cut site. The TIDE(R) web tool assumes that the DSB is induced 
between nucleotides 17 and 18 of the guide RNA sequence string (Figure 3f). Note 
that if the exact breakpoint is unknown, TIDE will estimate the amount of the indels 
correctly, but the nucleotide composition of the +1 insertion will not be reliable. 
TIDER will only work when the exact cutting position is known and when the 
nuclease is a blunt cutter. 
3. Alignment cannot be performed. By default, the alignment window begins at 
nucleotide number 100, because the first part of the sequence read tends to be of 
low quality. The end of the alignment window is set automatically at 15 bp upstream 
of the break site. When this window is too small or when the break site is located 
upstream of nucleotide 100, the alignment cannot be performed correctly. Then 
the start of the alignment window should be set manually closer to nucleotide 
number 1 (Figure 3c). 
4. Incorrect alignment. When the beginning of the sequence trace is of poor quality, 
the alignment function can make a mistake. This results in a quality plot with a high 
aberrant sequence signal along the whole length of the sequence trace (Figure 3d). 
The aberrant sequence signal should only increase around the expected cut site (blue 
dashed line). In case of poor alignment, the start of the alignment window needs to be 
adjusted until a proper alignment is achieved (default of 100). 
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5. Decomposition window recommendations. For TIDE, the default decomposition window 
spans the entire sequence trace from the break site until the end of the sequence 
minus the size of the maximum indel. When the boundaries of the decomposition 
window cannot fulfil this constraint, the software will report that the boundaries 
are not acceptable. For example, this can occur when the break site is too close to 
the end of sequence trace. To address this,, the decomposition window boundaries 
should be set further apart or a smaller indel size should be chosen. Alternatively, 
new primers have to be designed according to Material section ‘PCR amplification 
of control & experimental sample DNA’. For TIDER the decomposition window is by 
default 20 bp upstream of the break to 80 bp downstream from the break. This smaller 
window compared to TIDE has more discriminatory power for subtle designed base 
pair changes.
6. Allele-specific indels. The different bars in the plot represent the insertions, deletions and/or 
template-directed mutations in the cell population. These mutations are not specific of 
an allele. To determine allele specific information a cell clone needs to be isolated and 
analysed again by TIDE(R). A diploid cell gives a percentage of ~50% per mutation.
7. Goodness of fit. R2 is a measure for the reliability of the estimated values. For example, 
if the R2 value is 0.95, it means that 95% of the variance can be explained by the model; 
the remainder 5% consists of random noise, very large indels, non-templated point 
mutations, and possibly more complex mutations. Decomposition results with a low 
R2 must be interpreted with caution. A low R2 can be caused when the settings are 
not optimal or when the sequence quality is not good (See Note 10). A low R2 value 
can also arise when a sequence stretch with a poor local quality is present in the 
decomposition window (See Note 1). Furthermore, the presence of indels larger than 
the maximum indel size that is considered can affect the R2 (default of 10). By default 
these are not modelled, which may result in a low R2 score. The size range of indels 
that are modelled can be manually changed to larger number to test if this improves 
the fit (Figure 3e).
8. Overall efficiency. The overall efficiency refers to the estimated total fraction of DNA 
with mutations around the break site. It is calculated as R2 x 100 - % wild-type. 
9. No guide RNA match. Sometimes a mismatch occurs in the control sequence at the 
location of the sgRNA. This will stop the TIDE(R) analysis. In this case, edit the base 
annotation in the chromatogram file into IUPAC nucleotides of the expected control 
sequence (Figure 3g). The peak signals in the chromatogram should not be altered. 
Viewing and editing of chromatogram files can be performed with Snapgene or 
Chromas software.
10. Poor sequence quality. When the sequence has poor quality overall, TIDE(R) will yield poor 
results with a low R2 value (See Note 8) since too much noise is present in the data. The quality 
plot will show an overall high aberrant sequence signal in the control, (the reference) and 
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the experimental sample, before and after the break site (See Note 1). It is recommended 
to check the chromatograms of the samples (Figure 3h) for poor sequencing quality. 
If so, these samples cannot be analysed reliably by TIDE(R). Note that sometimes the 
peak signals in the chromatogram appear normal, but the file can contain wrongly 
unannotated or additional annotated nucleotides (Figure 3i). TIDE(R) gives a warning 
when the spacing between the nucleotides in the chromatogram of the sequence trace 
are not consistent, which is often an indication for wrongly unannotated or additional 
annotated nucleotides. In case of this warning, the chromatograms should be carefully 
investigated (use Snapgene or Chromas software). 
11. Natural versus designed mutations. In general, TIDER is able to discriminate ‘naturally’ 
occurring deletions and insertions from templated ‘designed’ indels. Only in the 
presence of a small designed deletion (-1, -2) near the expected break site the designed 
mutation may be underestimated (14). In case the designed mutation consists of 
an insertion larger than +1, TIDER does not consider natural insertions of the same 
size, because the decomposition becomes less robust. This is generally acceptable, 
because natural insertions larger than +1 are rarely observed (13, 17).
12. Distal designed mutations. It has been reported that the incorporation of donor template 
sequence is less efficient when the designed point mutations are further away from the 
break site (19). This often leads to a variation in incorporation frequently of the distal and 
proximal designed mutations as can be observed in the quality plots. Such a situation 
may confound TIDER estimates. The decomposition window can be restricted to either 
the proximal or the distal mutations to resolve the individual efficiencies.
13. Donor plasmid contamination in isolated genomic DNA. Potentially, a donor template 
that was transfected into the cells could co-purify with genomic DNA and be co-
amplified in the PCR if it contains the primer sequences. This could result in an 
overestimation of the HDR events. This is generally not a problem with short ssODN 
donors, but with plasmid templates with long homology arms the primers a,b should 
be chosen outside of these homology arms. Alternatively, the donor plasmid may be 
cleared from the cells by a few passages of culturing.
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5ABSTRACT
The RNA-guided DNA endonuclease Cas9 is a powerful tool for genome editing. Little is known 
about the kinetics and fidelity of the double-strand 
break (DSB) repair process that follows a Cas9 cutting 
event in living cells. Here, we developed a strategy to 
measure the kinetics of DSB repair for single loci in 
human cells. Quantitative modelling of repaired DNA 
in time series after Cas9 activation reveals variable 
and often slow repair rates, with half-life times up 
to ~10 h. Furthermore, repair of the DSBs tends to 
be error-prone. Both classical and microhomology-
mediated end joining pathways contribute to the 
erroneous repair. Estimation of their individual rate 
constants indicates that the balance between these 
two pathways changes over time and can be altered 
by additional ionizing radiation. Our approach 
provides quantitative insights into DSB repair kinetics 
and fidelity in single loci, and indicates that Cas9-
induced DSBs are repaired in an unusual manner. 
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INTRODUCTION
The CRISPR/Cas9 nuclease system is a powerful tool for genome editing due to its efficient 
targeting of specific sequences in the genome (1). Cas9 endonuclease is directed by a guide 
RNA to a specific target site in the genome, where it induces a single double-strand break 
(DSB) (2-4). The break is subsequently repaired by the cellular DNA repair mechanisms that 
can introduce mutations in the target sequence (5). This application of Cas9 has become 
widely popular to generate mutant alleles of genes and regulatory elements of interest. 
Despite the broad application, the process of repair of Cas9-induced DSBs has been only 
partially characterized. For example, it is not known how long it takes before an individual 
Cas9-induced DSB is repaired, and how error-prone this process is.
Eukaryotic cells have two main pathways for DSB repair: classical non-homologous end 
joining (C-NHEJ) and homologous recombination (HR) (5). A large proportion of DSBs is 
repaired by C-NHEJ, which directly re-joins the two DNA ends. This type of repair is thought 
to be mostly perfect but may lead to insertions or deletions (indels) at the break site (6). 
However, estimates of the frequency at which these indels occur are a matter of debate. 
The accuracy of re-joining is subject of debate, and is thought to depend on the nature 
of the damaging agent and the end structures of the formed DSBs (6, 7). In contrast, HR 
is highly precise because it utilizes a homologous template sequence to restore the DNA 
sequences around the DSB (8). Apart from these two main pathways, there are alternative 
end joining (A-EJ) pathways that are thought to be highly mutagenic. One of these is 
microhomology-mediated end-joining (MMEJ), which uses short sequence homologies 
near the two ends, leading to characteristic small deletions (9). Current evidence indicates 
that multiple pathways can contribute to the repair of Cas9-induced DSBs (10, 11), but the 
interplay and the relative contributions have remained largely uncharacterized. Moreover, 
the fidelity of these pathways in the context of Cas9-induced breaks is still largely unclear. 
Related to this, it is still unknown how quickly a Cas9-induced break is repaired. DSBs have 
been measured by comet assays (12) or pulsed-field gel electrophoresis, typically (13) after 
exposure to high doses of ionizing radiation that cause hundreds of DSBs per cell. Time 
courses of such bulk measurements in mammalian cells have consistently shown that DSBs 
are generally repaired with a half-life of 10-60 minutes (13-18). Computational modelling 
of such datasets has indicated that a small sub-fraction of DSBs is re-joined more slowly, 
over several hours (14, 15, 19, 20). A-EJ pathways are thought to be largely responsible for 
this population of more slowly repaired DSBs (21, 22). However, such bulk measurements 
of DSBs lack the sensitivity that is required to follow DSB repair at single loci.
Repair rates have also been inferred from immunofluorescent labelling of DSB markers 
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such as γH2AX, which form transient foci at DSBs (23, 24). In irradiated mammalian cells, 
clearance of such foci typically takes on to three hours (24-26). Note that marker proteins 
at foci may linger at the DSB site after re-joining of the two DNA ends, hence the actual 
repair may be quicker, as is strongly suggested by the direct DSB measurements mentioned 
above. So far, the rate of repair of individual Cas9-induced DSBs has remained unknown 
due to limitations of the available methods. 
In principle, accumulation of mutations over time can be used to infer repair rates. A 
crude estimate based on indel detection suggested that about 15 hours were necessary 
to repair the majority of the Cas9-induced lesions (27). However, precise quantitative 
kinetics of actual re-joining of DNA ends after the induction of a DSB at a single defined 
genomic location are missing. One challenge is that perfectly repaired junctions are 
indistinguishable from DNA that was never broken, which may lead to systematic errors in 
the rate constants. Furthermore, when sequence-specific nucleases are used to create a 
break, indels may only arise after multiple cycles of breaking and perfect repair, and thus the 
final mutation rate may grossly overestimate the error rate of individual repair events (7). 
Finally, with such nucleases the accumulation of indels is also dependent on the cutting 
rate. Here, we tackle these problems by a combination of mathematical modelling and 
highly accurate measurements of indel accumulation, focusing on Cas9-induced DSBs. 
RESULTS
A kinetic model of DSB repair
We approached the process of repair of a Cas9-induced DSB as a simple three-state model 
(Figure 1a). In this model, the intact state is the original unbroken DNA sequence that can 
be recognized by the Cas9/sgRNA complex. After introduction of a DSB by this complex 
the DNA enters a reversible broken state. This state may be repaired perfectly, after which 
the DNA is susceptible to another round of cutting. Alternatively, an error-prone repair 
mechanism may introduce a small insertion or deletion (indel) at the break site. The 
latter results in an irreversible indel state that can no longer be recognized properly by 
the sgRNA and therefore cannot be cut again by Cas9 (see below for validation of this 
assumption). Hence, in this model there are three reaction steps: cutting, perfect repair, 
and mutagenic repair, each having a specific rate constant that we refer to as k
c
, k
p
 and k
m
, 
respectively (Figure 1a). 
Our aim was to determine these key descriptors of the repair process for individual Cas9/sgRNA 
target loci. For this purpose, we captured the model in a set of ordinary differential 
equations (ODEs) describing the three reaction steps, with the rate constants as 
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Figure 1: Quantitative analysis of Cas9-induced DSBs. (A) Proposed model of DSB repair based on stochastic 
transitions between intact, broken and indel states. k
p
 and k
m
 are rate constants of perfect and mutagenic repair, 
respectively; k
c
 is the rate constant of cutting by Cas9. The latter depends on Cas9 activation and is therefore 
denoted as k
c
(t). (B) ODEs describing the three reaction steps, with rate constants as parameters. (C) Outline of the 
experimental strategy; see main text. (D) Representative time course experiment, showing gradual accumulation 
of indels. A sigmoid curve was fitted to the data to determine the plateau level at late time points (dashed line), 
which reflects the transfection efficiency. (E) Relative proportions of intact (red) and indel (green) fractions at the 
LBR2 locus over time. The data points are normalized on to the total indel fraction to correct for the variation 
in transfection efficiency. Indel fraction in absence of Shield-1 is shown in grey. Average of 7 independent 
experiments; error bars represent the standard deviation and the dashed lines show fitted sigmoid curves.
(legend continued on next page)
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parameters (Figure 1b). With this ODE model it is possible to simulate the relative 
abundance of the three states over time in a pool of cells after activation of Cas9. Such 
simulations show that activation of Cas9 generally leads to a gradual loss of intact DNA, a 
transient increase in the broken DNA state, and a gradual increase in the indel state until 
virtually all DNA is converted to the latter. However, the shape of each curve is determined 
by the rate constants (Supplementary Figure S1a-c). We reasoned that it should therefore 
be possible to determine the rate constants by fitting the ODE model to actual time series 
measurements of one or all three states after Cas9 induction.
Quantification of Cas9 cutting and repair rates
We set out to measure the accumulation of indels in cells in which a specific DSB was 
introduced by Cas9. To control the timing of DSB formation we established a clonal K562 
cell line (K562#17) with a stably integrated construct that encodes a tightly controlled 
inducible Cas9 nuclease. To switch Cas9 activity on and off, we fused a ligand-responsive 
destabilizing domain (28) to Cas9. With the small ligand Shield-1, Cas9 can then be 
reversibly stabilized for transient DSB-induction. K562 cells are capable of activating DNA 
damage response upon DSBs, although the G1 checkpoint is affected due to a mutated 
TP53 gene (29).
We transiently transfected K562#17 with a plasmid encoding a sgRNA targeting the LBR gene 
(sgRNA-LBR2). We previously found that this sgRNA effectively induces indels (30). 
Twenty-four hours after transfection we stabilized Cas9 by adding Shield-1. Flow cytometry 
analysis showed that cells 16 hours after damage had an ~10% increase in G2 population 
suggesting a modest check point activation (Supplementary Figure S5). We collected cells 
at various time points up to 60 hours after Cas9 induction, amplified a ~300-bp region 
around the sgRNA target site by PCR and subjected the products to next generation 
sequencing (NGS) to determine the intact and indel fractions (Figure 1c). 
The results show a gradual accumulation of indels over time (Figure 1d), indicating that 
DSBs were introduced and repaired imperfectly. Towards the end of the time course the 
indel frequency reached a plateau of ~70%. This value corresponds approximately to 
the mean transfection efficiency (mean ± S.D. = 67.6 ± 11.9%, n=7), determined as the 
proportion of cells that express GFP after transfection with a GFP-expressing plasmid 
(Supplementary Figure S1d-e). We therefore assumed that the plateau value of ~70% 
is good representation of the total proportion of cells that received the sgRNA and 
underwent DSB induction and repair. After normalization for this transfection efficiency, 
(F) Western blot analysis of Cas9 presence as a function of time. Tubulin was used as loading control. (G) The 
intensities of Cas9 antibody signal were determined by densitometry from time points of three individual western 
blots and normalized to a sample incubated for 60 hours with Shield-1 (lanes labelled ‘K562#17+Shield-1’ in (F)). An 
ODE fit was performed to determine the activity score of Cas9 in time. 
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the data were highly reproducible over 7 independent replicate experiments (Figure 1e). 
Indel accumulation was dependent on stabilization of Cas9 by Shield-1 (Figure 1e).
The sigmoid appearance of the measured indel time curves suggested a delayed onset of 
indel accumulation. This may be explained by delayed activation of Cas9 at the beginning 
of the time series, as indicated by Western blot analysis of Cas9 (Figure 1f). Assuming 
that the cutting activity of Cas9 is proportional to its abundance, we modified the 
computational model to incorporate the gradual increase of Cas9 levels as determined 
from the Western blot signals (Figure 1g). We assume that the transfected cells continuously 
express sgRNA over the duration of the time courses, because after transfection with a 
GFP-expressing vector the proportion of GFP-positive cells did not decline for at least 
120 hours (Supplementary Figure S1f). 
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Figure 2: Estimation of cutting and repair rates. Representative time series traces of the intact (A), broken (B) 
and indel (C) fractions. Measured data (dots) are overlaid with the ODE model fit (solid lines). The percentage of 
intact and indel traces are relative to the total. The broken fraction is estimated by the model on the basis of the 
intact and indel measurements. τ indicates time of the largest amount of broken DNA. (D) Distributions of rate 
constants from 7 independent experiments (values indicate mean ± SD). (E) Estimate of the upper confidence bound 
of the proportion of perfect repair. Fitting residual errors are shown for various fixed k
p
/(k
p
+k
m
) ratios (7 combined 
time series). Black dashed line marks the optimal fit; red dashed line marks the k
p
/(k
p
+k
m
) ratio above which the fit 
becomes significantly worse than the optimal fit (P < 0.1, one-sided F-test). This corresponds to k
p
/(k
p
+k
m
) = 0.28. For 
each k
p
/(k
p
+k
m
) ratio, k
c,max
 and k
m
 were adjusted to produce the best fit. (F) Examples of model fitting with various 
combinations of k
p
 and k
m
 forced to values that would correspond to models of rapid cycling of cutting and perfect 
repair (dashed curves). Green dots are measured values, green curve shows unrestrained optimal fit.
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Cutting and repair rate constants in the LBR gene
Next, we fitted the set of ODEs to the measured indel curves for sgRNA-LBR2 (Figure 2a-d). 
Based on 7 independent replicate experiments, this yielded a cutting rate k
c
 = 0.11 ± 0.01 h-1 
at maximum Cas9 expression. This corresponds to a cutting half-life (i.e., the time that 
would be required to cut 50% of the available target sequences in the absence of repair) 
of ~6 hours. Cutting by Cas9/sgRNA-LBR2 in our system is thus a rather slow process.
Our model fit estimated the rate constant for imperfect repair to be k
m
 = 0.15 ± 0.11 h-1. 
This corresponds to a half-life of broken DNA of 4.6 hours. Surprisingly, the rate constant 
for perfect repair was estimated to be k
p
 = 1.6 ± 1.6 x 10-5 h-1, which is about ten thousand 
times slower than imperfect repair. This suggests that virtually all repair events at this 
locus result in the formation of indels, while perfect repair is very rare.
Robustness of the model
On average, the goodness of fit between the model and the measured data was R2 = 0.995. 
We considered that the parameter estimates could be strongly influenced by the modelling 
of the Cas9 induction. To test this, we also modelled a simple step function with various 
time delays of Cas9 activation. Although the results were quantitatively slightly different 
(Supplementary Figure S1g-j), the main conclusion remained that repair at this locus is slow 
and error-prone. 
While these results point to robustness of the modelling, we were surprised to find the 
extremely low rate of perfect repair. To check whether the model with the low perfect repair 
rate is indeed the most optimal fit to the data, we conducted a ‘parameter sweep’ survey 
in which we imposed different fixed perfect/mutagenic repair ratios. Analysis of the fitting 
residuals indicated that low k
p
/(k
p
+k
m
) ratios (~10-6) indeed yield the best fit (Figure 2e-f). 
However, the difference with higher ratios was rather minor, and statistical testing revealed 
that only at k
p
/(k
p
+k
m
) ratios > 0.28 the fit became significantly poorer (P < 0.1, F-test) than at 
the initially estimated ratio of 10-6. We therefore conservatively conclude that the contribution 
of perfect repair at this locus can be at most 28%, although lower ratios are more likely to 
be correct. The other parameter values (k
c
, k
m
 and the predicted broken fraction) showed 
only minor variation within this range (Supplementary Figure S2a-e), further attesting to the 
robustness of the model. 
From this parameter sweep analysis follows that the indel accumulation curve is not 
compatible with a very rapid cycle of cutting and perfect repair with only occasional 
imperfect repair. In such a scenario k
p
/(k
p
+k
m
) would be close to 1. As mentioned above, 
according to the F-test this yields a significantly poorer fit compared to lower k
p
/(k
p
+k
m
)ratios 
(Figure 2e-2f). Increased cutting rates also lead to poorer fits (Supplementary Figure S2f). 
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Experimental validation
We validated the underlying assumptions and results of the modelling with several 
independent biological assays. First, we tested our assumption that the reverse reaction 
from the indel state to the broken state cannot occur (Figure 1a). For this purpose we 
isolated several clonal cell lines that had acquired one or more indels in the target site 
and lacked wild-type sequences (Supplementary Figure S4a). We then re-transfected three 
of these cell clones with sgRNA-LBR2 and again activated Cas9. Despite prolonged re-
exposure to Cas9/sgRNA-LBR2, we could not detect any change in the indels present 
in each clone (Supplementary Figure S4b). We conclude that the target site, once it has 
acquired an indel, is not recognized again by the same sgRNA. 
Second, we verified the kinetics of the broken state as predicted by the computational model 
(which was based on intact and indel frequencies only). The model predicts that the broken 
fraction peaks at 16.4 ± 1.7 h, with a maximum of 19.9 ± 6.7% broken DNA (mean ± SD, n = 7; 
Figure 2b). To verify this, we established a variant of the ligation-mediated PCR assay (LM-PCR) 
for the quantification of DNA breaks at a defined location (31, 32). In this assay, we first denature 
the DNA and subject it to a primer extension reaction using a primer near the break site. This 
ensures that all cleavage sites are converted into blunt ends, even if resection of the broken 
ends has occurred. Next, an adaptor is ligated to the blunted DNA end, followed by PCR with 
one primer near the break site and a second primer that is complementary to the adaptor 
sequence (Figure 3a). When analysed on agarose gels, the samples from cells treated with 
sgRNA and Shield-1 yielded a band of the expected size (Figure 3b), and the band intensity 
was sufficiently linear with input across the measured range (Supplementary Figure S3f).
Analysis of several time series showed that the band intensity increased until 14.1 ± 2.0 h 
(mean ± SD, n = 4) hours after Cas9 induction, and then decreased again (Figure 3b-c). This is in 
agreement with the peak time of the broken state as predicted by the model fitting (cf. Figure 2b). 
As expected, a control primer pair not spanning the break site showed stable signals over 
the time course (Figure 3d-e; Supplementary Figure S3g). We obtained similar results when 
probing the other end of the same DSB (15.6 ± 2.2 h, n = 3; Supplementary Figure S3b-e, h-i). 
Furthermore, the parameter sweep shows that when k
p
/(k
p
+k
m
) approaches 1, the predicted 
amount of broken DNA at peak time becomes so low (<1%) that we would be unable to 
measure it by ligation-mediated PCR (Supplementary Figure S2d). Thus, a model consisting 
of a very rapid cycle of cutting and perfect repair with only occasional imperfect repair is 
not compatible with our ability to detect broken DNA. 
Two repair pathways active at one locus
Next, we took a closer look at the indels that were generated. Repair of Cas9-induced 
DSBs produces non-random indel patterns that are specific for the sgRNA (11, 30). In our 
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experiments sgRNA-LBR2 yielded predominantly a deletion of 7 bp or an insertion of 1 
bp (Figure 4a). After 60 hours of Cas9 induction the +1 insertions reached a frequency of 
59.6 ± 4.2%, while the -7 deletions accumulated to 18.0 ± 2.3% of the total indel pool (Figure 4c). 
Analysis of 20 clonal lines derived from single cells in which Cas9/sgRNA-LBR2 had been 
transiently active indicated that the +1 insertion is the predominant mutation but can 
co-occur with the -7 deletion on other alleles in the same cell (Supplementary Figure S4a).
Different indels can be the result of different repair pathways, e.g. C-NHEJ or MMEJ (11, 33). 
To explore whether this may be the case for the -7 and +1 indels, we added an inhibitor of 
DNA-PKcs (NU7441) to the cells. DNA-PKcs plays an essential role in the C-NHEJ pathway 
but not in MMEJ (34). We found that in the presence of 1 µM NU7441 the proportion of the 
-7 deletion events increased by 3-fold while the +1 insertion diminished by about 2-fold 
(Figure 4a-c). The presence of NU7441 inhibitor did not affect cell viability (Supplementary 
Figure S4c). These results indicate that the +1 insertion is the result of C-NHEJ, while the 
-7 deletion is not. MMEJ makes use of microhomologies near the broken ends (18, 35). 
Sequence analysis revealed that the -7 deletion fraction consists of two types of deletions 
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Figure 3: Measurement of broken fraction. 
(A) Schematic view of the LM-PCR assay to detect 
the broken ends after DSB induction. See text for 
explanation. (B) Representative agarose gel of the 
LM-PCR products of a time series. The expected 
product is 205 bp in size. (C) The broken fraction 
measured as band intensities (data from 8 LM-PCR 
experiments from 4 independent time series; values 
are arbitrary units [a.u.]; mean ± SD). Solid blue 
line shows an ODE curve fit to the LM-PCR data to 
determine τ (blue shading, mean ± SD). (D,E) Same 
as b-c, but with primers 2 and 3 that do not span the 
break site. The expected product is 163 bp in size. 
Values are in arbitrary units, mean ± SD, based on 
7 PCR experiments from three independent time series). 
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that occur in an approximate ratio of 1:2 (Figure 4d). Both types can be explained by 
recombination through 3-nucleotide microhomologies, which strongly points to MMEJ as the 
responsible pathway for the formation of the -7 indel. We conclude that at least two different 
repair pathways are active and lead to distinct types of mutations at one specific break site.
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Figure 4: Multiple repair pathways active at one locus. (A,B) The spectrum of indels and their frequencies at the 
LBR2 locus at time point t = 60 h, in cells cultured without (A) or with (B) 1 µM NU7441. A representative experiment is 
shown. Light-blue bar: wild-type sequence; dark-blue bars: indels. (C) Frequencies of -7 and +1 indels in the presence 
(black, n=7) and absence (grey, n=4) of NU7441. All series are normalized to the total indel fraction. Asterisks indicate 
P-values according to Student's t-test: * P<0.05, ** P<0.005, *** P<0.0005. (D) The -7 deletions consist of two types; 
red nucleotides mark the deleted DNA. Shaded nucleotides show possible models for microhomology-mediated 
repair. Percentages indicate the proportion of observed -7 sequence reads. (E) TIDE analysis of +1 insertion and 
-7 deletion indels after exposure of the cells to 10 Gy of IR at the time of Cas9 induction.
Interestingly, we found that the ratio between the +1 and -7 indels changes in favour of the 
+1 insertion when 10 Gy of ionizing radiation (IR) damage was administered just prior to Cas9 
induction. In particular, the -7 deletion fraction decreased about 2-fold (Figure 4e). Cell viability 
did not differ between the control and irradiated sample (Supplementary Figure S4d). The shift 
in pathway utilization can be either due to additional breaks elsewhere in genome (which may 
sequester components of the MMEJ pathway), a cell cycle arrest, or a combination thereof. 
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Delayed activity of MMEJ 
Having established that two types of indels are largely the result of separate pathways, we 
decided to study the kinetics of these pathways in more detail by tracking the +1 and -7 indel 
frequencies over time. We modified the ODE model by incorporating separate km rate 
constants for each type of indel (Figure 5a). We then fitted this model to the +1 and -7 indel 
time series data. This yielded a good fit of the +1 curve (mean R2 = 0.99), but a poorer fit of 
the -7 curve (mean R2 = 0.93; Figure 5c). The deviation of the fitted curve is mostly due to a 
delay in the -7 indel appearance (Figure 5b). As a consequence, our estimate of the km for 
the -7 indel is less accurate, but we can conclude that the MMEJ pathway exhibits a delayed 
onset compared to C-NHEJ. Thus, the k-7 rate appears to increase over time, rather than 
be constant. Possibly the MMEJ pathway is only activated when C-NHEJ fails to be repair a 
DSB, as has been proposed previously (13, 21, 35).  
We then tested whether the model could be improved by explicitly including such a 
delayed onset. For simplicity we assumed a linear increase in the production rate of the 
-7 deletion over time, starting with a rate k
-7,t=0h
 immediately after Cas9 induction and 
increasing to k
-7,t=60h
 at the end of the time course (Figure 5d). Indeed, a better fit of the 
-7 indel curve (mean R2 = 0.99) was obtained (Figure 5e). The model fitting estimates 
k
-7
 to be nearly zero at the onset of Cas9 induction, while at the end of the time course it is 
0.09 ± 0.09h-1, which approaches the activity of the +1 indel repair (0.12 ± 0.10 h-1; Figure 5f). 
These results strongly suggest gradual activation of MMEJ over time. 
Interplay between C-NHEJ and MMEJ
We wondered whether this gradual increase in MMEJ rate is somehow due to competition 
with the C-NHEJ pathway. To test this, we performed time course experiments in the presence 
of NU7441 and repeated the computational modelling. As expected, in the presence of the 
inhibitor k
+1
 is reduced dramatically (~6-fold; Figure 5f; Supplementary Table 3), while the 
cutting rate k
c
 as well as the perfect repair rate k
p
 are virtually unaltered. Strikingly, in the 
presence of NU7441 k
-7,t=0h
 became about 7-fold higher than in the absence of the inhibitor, 
while k
-7,t=60h
 remained largely unaffected. Thus, inhibition of DNA-PKcs leads to a more rapid 
engagement of MMEJ soon after the DSB is introduced. 
However, in the presence of NU7441, MMEJ does not fully compensate for the loss of C-NHEJ. 
The total repair rate is lower, as k
m
 is reduced and k
p
 remains close to zero (Figure 5f). A 
logical prediction is that it takes more time for DSBs to be repaired. The model as well as 
actual measurements show that in the presence of NU7441 the peak time of DSBs is delayed 
(compare Figure 3c & 5g), although this is not statistically significant for the measured data.
Cutting and repair rates in three other loci
To investigate whether the rate constants are locus-specific, we performed kinetics 
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experiments for three additional loci. We designed a sgRNA (sgRNA-LBR8) targeting 
another sequence in the LBR gene that is 169 bp upstream from sgRNA-LBR2; a previously 
reported sgRNA to target the AAVS1 gene (4); and a sgRNA that targets an intergenic 
locus on chromosome 11 (chr11). Each target locus shows a different indel spectrum after 
60 hours (Supplementary Figure S6b, h, k). For each sgRNA we conducted multiple time 
series measurements (Figure 6a-h). 
For the three new loci the indel frequency did not fully reach a plateau at the end of 
the time course (Figure 6c, e, g). This compromised the robustness of the rate constant 
estimates, since our algorithm used this plateau to estimate the transfection efficiency 
of individual experiments. We therefore employed a slightly modified computational 
strategy. We combined the data of all replicate experiments and performed parameter 
fitting in two iterations. In the first iteration, we conducted a parameter sweep for the 
transfection efficiency. We chose the efficiency that yielded the lowest residuals (see 
Methods). In the second iteration, we used this value and applied a standard 1,000-fold 
bootstrapping approach in order to estimate confidence intervals for each parameter of 
the kinetic model. The results are summarized in Figure 6a-h & Supplementary Table 4. 
The confidence intervals of the fitted rate constants are relatively large, and hence the 
results should be interpreted with some caution. Nevertheless, for the LBR2 locus, this 
alternative computational strategy yielded parameter estimates that were similar to those 
from the original strategy. Across the four loci, the estimated cutting rates (kc) varied only 
about 2-fold. The overall repair rates (perfect and imperfect repair combined) vary over an 
~8-fold range and correspond to half-lives of approximately 8.8 h (LBR8), 1.4 h (AAVS1) and 
10.7 h (chr11), as compared to 3.9 h for the LBR2 locus. These values indicate that repair 
rates of Cas9-induced DSBs are variable and often slow. 
Like for LBR2, the estimated rates of perfect repair (k
p
) are very low for AAVS1 and chr11. In 
contrast, perfect repair in locus LBR8 is frequent, making up 76% of all repair events. For LBR8 
the fitted models predicted a slower clearance of broken DNA compared to LBR2 (Figure 6b, d). 
Directly measured time courses of the LBR8 broken state are in agreement with this, with a 
τ of 28.9 ± 17.8 h for LBR8 compared to 14.7 ± 2.1 h for LBR2 (mean ± SD; measurements for both 
ends combined; P = 0.005, Wilcoxon test) (Supplementary Figure S6d-f). Together, these results 
indicate that the error rate of the repair of Cas9-induced DSBs is locus-dependent and often high.
Tight binding of Cas9 after cutting may explain erroneous and slow repair
We sought an explanation for the relatively erroneous and slow repair that we observed. 
It was reported that the Cas9 can remain attached to the broken DNA ends after cutting 
in vitro (36), but it is not known how general this behaviour is. We therefore tested this 
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Figure 5: MMEJ has slower repair kinetics than C-NHEJ. (A) Kinetic model of Cas9-induced DSB repair assuming 
that each type of indel is generated with a specific repair rate. (B) +1 insertion and -7 deletion accumulation in a 
representative time series. Dashed lines show a Gompertz sigmoid fit. (C) Same measurements as in (B) with the multi-
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time dependency of the k
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+1 insertion (top) and -7 deletion (bottom) as proposed in (D). (F) Rate constants without (black) and with (grey) 
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m
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 at the start and end of the time series, respectively. n indicates the 
number of time series. Asterisks indicate P-values according to Wilcoxon test: * P<0.05, ** P<0.005, *** P<0.0005. 
(G) Broken fraction measurements in presence of NU7441 of 2 independent time series, similar to Figure 3b-c.
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directly for three DNA loci for which we had determined the kinetic rate constants. By PCR 
we first produced double-stranded DNA fragments of 600-1,000 bp consisting of precisely 
the same sequences as the three loci. We then incubated each fragment in vitro with the 
respective Cas9/sgRNA complex to induce DSBs, and investigated the reaction products 
by agarose electrophoresis (Figure 6i, j). 
The PCR product treated with Cas9/sgRNA-LBR2 showed the expected digestion products, 
but the smallest fragment was underrepresented while a broad smear indicated aberrant 
migration of the DNA. After heat denaturation of Cas9/sgRNA the smear disappeared and 
the smaller digestion product became clearly visible. For sgRNA-AAVS1 and sgRNA-chr11 
even more pronounced effects were observed: without denaturation the digested DNA 
appeared largely unbroken and the bands were shifted upwards, but after heat treatment 
it became clear that most of the DNA was in fact correctly digested. Together, these results 
indicate that the Cas9/sgRNA complex remains bound to the DNA ends after cutting, even 
when incubated overnight (Figure 6j). In the case of sgRNA-LBR2 it appears that this binding 
occurs primarily at one DSB end, while for the other two sgRNAs Cas9 remains bound to 
both ends. As has been suggested (37), post-cutting adherence of Cas9 to the DNA ends 
may impair the repair process, which could explain the slow and erroneous repair.
Repair fidelity after double cutting 
Finally, we investigated the fidelity of DSB repair upon induction of Cas9 in combination 
with two co-transfected sgRNAs that target adjacent sequences. If the two cuts are made 
simultaneously then the intermediate fragment may be lost, after which the two remaining 
ends are joined by the DSB repair machinery. We amplified the resulting junctions by PCR 
and sequenced them in order to determine the error rate of the repair process, i.e., the 
frequency at which indels occur at the junction. Such a double-cut strategy has been used 
previously in combination with I-SceI (35, 38). Importantly, once the two ends are joined 
perfectly, they cannot be cut again because the new junction is not recognized by either 
of the two sgRNAs. This assay therefore complements our kinetic modelling of single-cut 
repair, in which cycles of repeated cutting and perfect repair were theoretically possible.  
We designed five sgRNAs targeting a second DSB site ~110-300 bp upstream or downstream 
of the sgRNA-LBR2 target site. One of these was sgRNA-LBR8. We co-transfected each 
sgRNA together with sgRNA-LBR2, induced Cas9 expression and harvested cells after 
60 hours. PCR amplification followed by next generation sequencing uncovered all 
intermediates and end-products that could be expected, such as junctions resulting from 
excision events as well as indels at one or both of the two cutting sites (Figure 7a-b). 
In those DNA molecules in which excision was successfully followed by repair, re-joining had 
occurred with highly varying degrees of fidelity. Depending on the combination of sgRNAs 
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tested, we found that 25-95% of these junctions were imperfect (Figure 7c), as indicated by 
the occurrence of indels that ranged from 1 to ~20 bp in size. In 4 out of 5 tested double-cut 
combinations we detected at least 2-fold more excised fragments than indels at single 
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Figure 6: ODE modelling of DSBs at additional loci; Cas9 remains bound to broken ends. (A-H) Time series of 
Cas9 cutting and repair at four loci (LBR2 (A,B), LBR8 (C,D), AAVS1 (E,F), intergenic region on chromosome 11 (G,H)). 
(A,C,E,G) Indel abundance of all individual replicates are shown in small dots where each replicate has an unique 
color. The mean of each time point is shown as big red dots. Fitted models are shown as red curves. (B,D,F,H) Predicted 
broken fraction curves. (I,J) In vitro digestion of DNA fragments by Cas9 and one of the sgRNAs targeting LBR (orange), 
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(I) or overnight (J) in the absence (uncut) or presence (cut) of Cas9/sgRNA. In some samples Cas9 was subsequently 
denatured by two different heat treatment protocols as indicated. The expected band for the intact DNA is marked by 
an arrowhead and the expected digestion products are marked by asterisks. 
116
Chapter 5
break sites (Figure 7b). This implies that the second cut typically occurred before the first 
cut had been repaired. This is in agreement with our modelling results indicating that repair 
of Cas9-induced breaks is often a relatively slow process.
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Because the combination sgRNA-LBR2/sgRNA-LBR8 yielded an exceptionally high 
frequency of perfect excisions (~75%), we studied these repair events in more detail by 
generating time course data (Figure 7d). This revealed that accumulation of excisions took 
approximately 15 hours to reach 50% of the plateau level. This underscores again that 
repair of breaks induced by Cas9 at these sites is slow. Furthermore, indels at the LBR8 site 
alone were virtually undetectable throughout the time course, while indels at both sites 
or at the LBR2 site alone did accumulate. In part, this may be explained by the relatively 
high frequency of perfect repair that we estimated for LBR8 in the single-cut kinetics 
experiments. Another, not mutually-exclusive, explanation may be that repair of the LBR2 
site is quicker than at the LBR8 site, which is also consistent with our parameter estimates 
based on single cuts (Supplementary Table S4).
DISCUSSION
DNA repair kinetics
Our measurements and modelling of the kinetics of re-joining of broken DNA ends after 
a Cas9-induced lesion indicate that the rate of DSB repair is variable and relatively slow. 
Moreover, our results indicate that the repair process tends to be error-prone. A recent 
study using a novel inducible Cas9 system also reported diverse kinetics profiles, but did 
not determine rate constants (39).
Across the four tested loci, we observed repair half-life times of 1.4, 3.9, 8.8 and 10.7 h. 
The latter three of these estimates are much slower than previous estimates based on bulk 
detection of DSBs after ionizing irradiation, which rarely exceeded 1 hour (see Introduction). 
Most of these previous studies were performed after a pulse of ionizing radiation ranging 
from 1-40 Gy, which creates dozens to hundreds of DSBs. Here, we introduce only a few DSBs 
per cell. We cannot rule out that large numbers of simultaneous DSBs accelerate the repair 
process. However, this seems not very likely because in the presence of 10 Gy IR damage 
in addition to the Cas9-induced DSB, we see only a small shift in repair pathway choice 
towards the faster C-NHEJ pathway. 
Another factor that could contribute to the difference in repair rates is the possible 
adherence of Cas9 to the DNA ends after cleavage, which could prevent access by the 
repair machinery (37). In accordance with previous studies (36, 37, 40) our in vitro data show 
that Cas9 remains tightly bound to one or both DNA ends after cutting, and detachment 
could only be achieved by protein denaturation. In vivo, catalytically inactive Cas9 was 
also found to tightly bind to its target DNA (41), with a dwell time of about 2 hours (42). 
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DNA repair fidelity
It has been suggested that the genome in a human cell may be hit by as many as 10-50 DSBs 
per day (6, 43). Yet, in the genome of skin cells of a 55-year old individual only about 
2000 small indels were detected by deep sequencing (44). In yeast and fly genomes 
indels accumulate at frequencies of roughly 10−11/base/generation (45, 46). These data 
suggest that repair of naturally occurring DSBs is highly precise. Ligation of mammalian 
V(D)J recombination junctions has also been found to have low error rates (7, 47). In this 
light, our estimated error rates in the range of 20-100% per break event seem rather 
high. This raises the possibility that repair of Cas9-induced DSBs is not representative for 
naturally occurring DSBs. 
Repair fidelity could be affected by the adherence of Cas9 to broken ends, but also by the 
structure of the DNA ends themselves. High precision of C-NHEJ was found when DNA 
breaks were introduced by the I-SceI nuclease (35). I-SceI makes a staggered cut and leaves 
a 3’ overhang, while Cas9 generates blunt ends (2-4). Blunt ends were shown in vitro and 
in wild-type yeast to be preferentially joined imprecisely (48, 49). Variants of Cas9 protein 
that generate DSBs with different overhangs (the nickases N863A and D10A) also resulted 
in differences in repair (10, 50). Thus, the high rates of imperfect repair that we observe 
may in part be related to the blunt ends created by Cas9. Furthermore, the local chromatin 
environment of the targeted loci may affect the repair outcome, because recruitment of 
repair factors is dependent on the chromatin environment (51).
The low rates of perfect repair that we observed also imply that HR plays only a minor role 
in the repair of Cas9-induced breaks, even though K562 cells are proficient in HR (52). 
HR frequencies in combination with Cas9 have been estimated to be up to 4-15% (10, 50), 
but these frequencies are likely to represent an overestimate because they were measured 
in the presence of a donor template that was either closely linked in cis or provided in 
excess by transient transfection. This also indicates that the accuracy of our broken fraction 
assay is unlikely to be compromised by substantial amounts of extensively resected ends 
that could escape detection in this assay.
Repair fidelity at double DSBs
The proportion of perfect junctions in our double-cut assays was also variable, and 
depending on the precise combination of sgRNAs used. In combination with sgRNA-LBR2, 
we observed the lowest error rate for sgRNA-LBR8, which also triggers mostly perfect 
repair when used in a single-cut kinetics assay. We note that repair of two nearby breaks 
may be more complex than of a single break. For example, the first break may trigger local 
chromatin changes such as phosphorylation of H2AX, which may in turn alter events at 
the second site, such as cutting rate and the recruitment of specific repair complexes. 
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Furthermore, Cas9 may linger on one or both of the ends that are to be joined. This may 
depend on the orientation of the PAM sites, or on other sequence features of the sgRNA 
used, but we have not been able to identify a predictive feature in the pairs of sgRNAs 
that we tested. Others have observed that sgRNA pairs resulted in high levels of precision 
repair (53, 54), although Geisinger et al. considered some single nucleotide indels as 
perfect repair and may have underestimated error rates.  
Different repair pathways
We found that at one single genomic location (LBR2) both C-NHEJ and MMEJ can repair 
DSBs with different kinetics. Overall, MMEJ operates with lower rates than C-NHEJ. This 
is in agreement with previous findings that indicate that C-NHEJ is the primary repair 
pathway (55). We observe that the lower rate is mainly because MMEJ exhibits a delayed 
onset compared to C-NHEJ, rather than a reduced activity. Possibly the C-NHEJ system 
initially prevents access of the MMEJ pathway to the DSB; only after several hours, if 
C-NHEJ has failed to repair the break, the MMEJ pathway is allowed to engage. In contrast, 
upon inhibition of DNA-PKcs the MMEJ has immediate access and an increased rate of 
activity. These results are consistent with a previously proposed model in which MMEJ acts 
as a backup system for C-NHEJ (13, 21, 35). 
Modeling of DSB repair kinetics and fidelity: outlook
Our methodology to determine rate constants may be improved further. We found that 
activation of Cas9 was relatively slow. We accommodated this by taking the gradual 
accumulation of Cas9 activity into account, but instant activation of Cas9 would simplify 
and improve the modelling. A recently reported chemically inducible variant of Cas9 (39) 
may serve this purpose. Stable integration of a sgRNA-expressing vector, rather than 
transient transfection, would ensure that 100% of the cells express the sgRNA, thus 
removing the need to include transfection efficiency as a fitting parameter. This would 
also circumvent any dilution of intranuclear plasmids due to cell division, ensuring that 
the expression level of the sgRNA remains stable over prolonged time course experiments. 
However, stable transfection will only be feasible with an inducible sgRNA expression 
system with very low background activity, otherwise indels may accumulate before the 
start of the time course measurements.
Our measurements and modelling did not include possible differences in pathway activity 
over the cell cycle. The modelling also did not take into account that cells with a DSB 
undergo a transient cell cycle arrest, although it seems unlikely that this has a major 
impact on the estimates of the kinetic parameters (see Methods). Certainly, we did not 
sample the full diversity of sequence contexts and chromatin environments, and it will be 
interesting to investigate the repair kinetics and fidelity of many more loci in the genome. 
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MATERIAL & METHODS
Cell culture and transfection 
We established K562#17, which is a clonal cell line of the female K562 cells (American 
Type Culture Collection) stably expressing DD-Cas9. K562#17 cells were cultured in 
RPMI 1640 (Life Technologies) supplemented with 10% fetal bovine serum (FBS, HyClone®), 
1% penicillin/streptomycin. Mycoplasma tests were negative. For transient transfection, 
6 x 106 K562 cells were resuspended in self-made transfection buffer (100 mM KH
2
PO
4
, 
15 mM NaHCO
3
, 12 mM MgCl
2
, 8 mM ATP, 2 mM glucose (pH 7.4)) (56). After addition of 
3.0 µg plasmid DNA, the cells were electroporated in an Amaxa 2D Nucleofector using 
program T-016. DD-Cas9 was induced with a final concentration of 500 nM Shield-1 (Aobious). 
For kinetics experiments, 18 x 106 cells were transfected and divided over 12-well plates, 
one well for each time point and each well carrying 1 x 106 cells. Cas9 was activated 
24 hours after nucleofection and cells were collected at the indicated time points after 
Cas9 induction. As controls, cells without Shield-1 were collected at various time points.
DNA-PKcs inhibitor NU7441 (Cayman) (final concentration 1 µM) or DMSO (control) was 
added to K562#17 at the same time when the cells were supplemented with Shield-1 to induce 
DD-Cas9. 10 Gy of IR was administered by Cs source Gammacell®40 Exactor (Best Theratronics). 
Constructs
The sgRNA oligos (Supplementary Table 1) were cloned into expression vector pBluescript 
with the sgRNA cassette of PX330 (Addgene plasmid 42230) and transfected into K562#17. 
The sgRNAs were designed using CHOPCHOP (57). The pLenti-Cas9-T2A-Neo expression 
vector (58) was a kind gift of Dr. Bastiaan Evers, NKI. In the expression vector, the ubiquitin 
promoter was exchanged for the hPGK promoter and a destabilization domain (DD) (28) 
was added at the N-terminus of the Cas9 gene, to generate DD-Cas9.
Cell viability
Cell viability was measured using a CellTiter-Blue Cell Viability Assay (Promega). 
CellTiter-Blue Reagent was 1:5 diluted in RPMI 1640 (Life Technologies) supplemented 
with 10% fetal bovine serum, 20 µL of this diluted CellTiter-Blue Reagent was added to 
100 µL cell suspension. After a 3 hours incubation at 37°C in a 96 well tissue culture plate, 
fluorescence (560
Ex
/590
Em
) was measured on an EnVision Multilabel Plate Reader (Perkin 
Elmer). Results of one CellTiter-Blue Cell Viability Assay per experiment are shown. Cell 
viability was measured 45 hours after Shield-1.
Next Generation Sequencing
Cells were collected by centrifugation (300xg, 5 min) and the genomic DNA was isolated 
using the ISOLATE II Genomic DNA Kit (Bioline). PCR was performed in two steps; PCR1 
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with ~100 ng genomic DNA and site specific barcoded primers (See Supplementary Table 2). 
PCR2 used 2 µL of each PCR1 product with Illumina PCR Index Primers Sequences 1-12. 
Each sample was generated with a unique combination of a barcode and index. Both PCR 
reactions were carried out with 25 µL MyTaqTM Red mix (Bioline), 4 µM of each primer and 
50 µL final volume in a 96 well plate. PCR conditions were 1 min at 95°C, followed by 
15 sec at 95°C, 15 sec at 58°C and 1 min at 72°C (15x). 20 µL of 8 samples were pooled and 
100 µL was loaded onto a 1% agarose gel. PCR product was cut from gel to remove the 
primer dimers and cleaned with ISOLATE II PCR and Gel Kit (Bioline). The isolated samples 
were sequenced by Illumina MiSeq. In this study, we only amplified the sgRNA on-target 
sequences. The effect of possible off-target activity of Cas9/sgRNA was ignored and is 
considered to be equal between the different experiments. 
LM-PCR
Genomic DNA (350 ng, determined by Qubit assay, Thermo Fisher Scientific) was incubated 
with 0.1 µM extension primer (EB479 or EB551) (See Supplementary Table 2) and Phusion 
High Fidelity DNA polymerase (Thermo Fisher Scientific) for 5 min at 95°C, 30 sec at 55°C 
and 30 sec at 72°C, to extend the non-blunt DNA ends near the break site. Subsequently, 
0.16 µM dsDamID adaptor (59) was ligated to the blunted broken ends at 16°C overnight 
using T4 ligase (5 U/µL, Roche). Ligase was heat inactivated for 20 min at 65°C. To detect 
broken DNA a PCR was performed on the adaptor-broken DNA ligation product with 
3 μM adaptor primer, EB486 and broken primer (EB487 or EB553). Note that this assay may not 
detect a fraction of the broken ends that have undergone large resection near the break site 
to prepare for HR. In parallel an internal standard PCR was performed with the same samples 
using 3 μM primers EB488 and EB487 or EB555 and EB553 that are both located downstream 
of the sgRNA break site. PCR conditions were 4 min at 95°C, followed by 33 cycles of 
10 sec at 95°C, 10 sec at 58°C, and 10 sec at 72°C. During preparation the samples were 
always kept at 4°C. The PCR products were analysed on a 1.5% agarose gel and imaged with 
ChemiDocTM Imaging Systems (BioRad). A box with a fixed volume was set over the appropriate 
LM-PCR band for each sample and the intensities within each box were determined in arbitrary 
units. The signal without sgRNA was considered background and was subtracted from all other 
time point samples. To correct for the arbitrary intensity values between different time series, 
each sample was divided by the sum of all values in one experiment. Subsequently the data was 
scaled to the maximum value within the time series. For the input PCR two boxes where set 
with similar volume at and under the PCR band for each sample. These values were subtracted 
to correct for background signal, divided by the sum of all values in one experiment and scaled 
to the maximum value within the time series. The mean of biological replicates is shown 
± standard deviation (SD). The peak time (τ), when the broken fraction reaches a maximum, 
is determined by fitting the band intensity values of the time points with the expected curve 
shape from the three-state Ordinary Differential Equations (ODE) model.
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TIDE method
The TIDE method was performed as described in (30). Briefly, PCR reactions were carried 
out with ~100 ng genomic DNA in MyTaqTM Red mix (Bioline) and purified using the 
ISOLATE II PCR and Gel Kit (Bioline). About 100-200 ng DNA from purified PCR samples 
was prepared for sequencing using BigDye terminator v3.1. Samples were analysed by an 
Applied Biosystems 3730x1 DNA Analyzer. The data obtained was analysed using the TIDE 
software (http://tide.nki.nl). The decomposition window used for TIDE was set to indels of 
size 0-10 bp.
In vitro digestion with Cas9
PCR fragments of the target regions were amplified with MyTaqTM (Bioline) according 
to manufacturer’s instructions. See Supplementary Table 2 for the used primers. In vitro 
transcribed sgRNA was generated by T7 promoter driven transcription using the Ribomax 
kit (Promega) and the RNA was purified with the MEGAclear kit (Life Technologies). 
1.5 µL Cas9 (NEB), 50 µg sgRNA and 200 ng PCR fragment were incubated for 2 hours or 
overnight at 37°C. For denaturation of the Cas9, samples were either incubated for 20 min 
at 80°C or for 3 min at 96°C and slowly cooled down to 20°C (1°C/min).
Flow cytometry
K562#17 cells were collected 1 day after nucleofection and directly analysed for 
fluorescence using a BD FACSCalibur. Viable cells were gated on size and shape using 
forward and side scatter. 
For cell cycle profiles, cells were fixed with 5 mL of 70% ethanol at 4°C overnight. After 
fixation, cells were washed with PBS and then incubated in PBS containing propidium 
iodide (PI) and RNase for 30 min at 37°C in the dark. GFP & PI expression were measured 
using a 488 nm laser for excitation. 
Western blotting
Whole-cell extracts of ~0.5 x 106 cells were prepared by washing cultures in PBS and lysing 
with 50 µL lysis buffer (Tris pH 7.6, 10% SDS, Roche proteinase inhibitor). Samples were 
pulse sonicated for 2 min and protein concentrations were determined using the Pierce 
BCA protein assay (Thermo Fisher Scientific). Samples containing 40 μg of total protein 
were separated by SDS-PAGE on 8% acrylamide gels and transferred to a nitrocellulose 
membrane through electroblotting. The membranes were blocked for 1 hour in 
PBS/Tween-20 0.1% containing 5% low fat milk. After washing twice with PBS/Tween20 0.1% 
the membranes were incubated with 1:2,000 α-Cas9 7A9 (Thermo Fisher Scientific) or 
γ-tubulin (T6557, Sigma) for 2 hours at room temperature with mild shaking. Subsequently, 
the membranes were washed again and incubated with a secondary antibody, 
1:10,000 α-mouse IR800 (Li-Cor) at 37°C for 1 hour with shaking. The antibody was 
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detected by Odyssey scanner. The gel was analysed by setting boxes with a fixed volume 
over the signals in each sample. The intensity within a set box was determined by Image 
Studio Version 2.0. Sample t = 60 h was loaded on every gel and used to normalize for the 
intensity of the signal in the different gels. The mean of three biological replicates is shown 
± standard deviation (SD).
The relative activity of CRISPR/Cas9 is calculated by fitting the DD-Cas9 protein abundance 
from the quantified signals. The model employed for fitting describes stabilization of 
DD-Cas9 upon introduction of Shield-1, with the unit-less relative activity:
where hl is the protein half-life of DD-Cas9 with Shield-1 determined as 6.4 h, and t is time 
after introduction of Shield-1. The model assumes that DD-Cas9 is very unstable without 
Shield-1, which is confirmed by the virtual absence of indel accumulation in the absence 
of stabilization (Figure 1e).
NGS data analysis
In each sequence read, the distance between a fixed sequence at the start and at the 
end are determined and used to calculate a score, defined as the difference between 
the measured distance in the read and the expected distance in a wild-type sequence. 
Insertions and deletions have score >0 and <0, respectively. A point mutation has 
score=0, but some bases in the sgRNA target site differ from the wild-type sequence. 
The intact type specifies reads identical to wild-type sequences. 
Per time point, the ratio of each type over the total of reads is calculated. We observed only 
2-6.5% sequence reads in which we could not find a match with the constant parts and 
we discarded these reads in subsequent analyses. The called point mutations (score = 0) 
showed a very similar kinetic profile as the intact sequence (wild-type), indicating that 
they are mostly sequencing errors. We therefore assigned them as intact sequence 
in the analysis. Insertion and deletion levels at time point t = 0 h were considered as 
background and subtracted from all time points.
In the double-cut assays, paired end sequencing was performed. The forward and 
reverse read were matched by the unique sequence ID of a pair of reads. The deletion 
events were divided into two types: (i) perfectly excised DNA, and (ii) excised DNA with 
an indel when the deletion was larger than the expected excised product or up to 5 
nucleotides smaller.
To determine the untransfected fraction, a standard sigmoid fit was applied to the 
 
𝑅𝑅(𝑡𝑡) = 1 − 2−
𝑡𝑡
ℎ𝑙𝑙      (1) 
 
𝑦𝑦(𝑡𝑡) = 1 −
𝑈𝑈
1 + 𝑒𝑒−𝑎𝑎(𝑡𝑡−𝑏𝑏)
          (2) 
 
𝑃𝑃(𝑡𝑡) + 𝐵𝐵(𝑡𝑡) + 𝑀𝑀(𝑡𝑡) = 1         (3) 
 
{
𝑑𝑑𝑃𝑃(𝑡𝑡)
𝑑𝑑𝑡𝑡
= −𝑘𝑘𝑐𝑐𝑅𝑅(𝑡𝑡)𝑃𝑃(𝑡𝑡) + 𝑘𝑘𝑝𝑝𝐵𝐵(𝑡𝑡) = −𝑘𝑘𝑐𝑐𝑅𝑅(𝑡𝑡)𝑃𝑃(𝑡𝑡) + 𝑘𝑘𝑝𝑝(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡))  
𝑑𝑑𝑀𝑀(𝑡𝑡)
𝑑𝑑𝑡𝑡
= 𝑘𝑘𝑚𝑚𝐵𝐵(𝑡𝑡) = 𝑘𝑘𝑚𝑚(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡)) 
        (4) 
 
𝑃𝑃𝑟𝑟(𝑡𝑡) =
𝑈𝑈 + 𝑃𝑃(𝑡𝑡)
𝑈𝑈 + 𝑃𝑃(𝑡𝑡) + 𝑀𝑀(𝑡𝑡)
          (5) 
 
V(i) =
𝑘𝑘𝑝𝑝
𝑘𝑘𝑝𝑝 + 𝑘𝑘𝑚𝑚
=  
iW0
iW0 + (1 −W0)2i−1
          (6) 
 
𝑘𝑘𝑝𝑝 =
𝑘𝑘𝑚𝑚V( )
1 − V(i)
=
i21−iW0𝑘𝑘𝑚𝑚 
(1 −W0) 
          (7) 
 
{
𝑑𝑑𝑀𝑀+1(𝑡𝑡)
𝑑𝑑𝑡𝑡
= 𝑘𝑘+1𝐵𝐵(𝑡𝑡) = 𝑘𝑘+1(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡))  
𝑑𝑑𝑀𝑀−7(𝑡𝑡)
𝑑𝑑𝑡𝑡
= 𝑘𝑘−7𝐵𝐵(𝑡𝑡) = 𝑘𝑘−7(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡)) 
          (8)  
 
{
 
 
 
 𝑀𝑀𝑟𝑟,+1(𝑡𝑡) =
𝑀𝑀+1(𝑡𝑡)
𝑈𝑈 + 𝑃𝑃(𝑡𝑡) + 𝑀𝑀(𝑡𝑡)
   
𝑀𝑀𝑟𝑟,−7(𝑡𝑡) =
𝑀𝑀−7(𝑡𝑡)
𝑈𝑈 + 𝑃𝑃(𝑡𝑡) + 𝑀𝑀(𝑡𝑡)
          (9) 
 
𝑘𝑘−7(t) = 𝑘𝑘−7,𝑡𝑡=0ℎ +
𝑘𝑘−7,𝑡𝑡=60ℎ − 𝑘𝑘−7,𝑡𝑡=0ℎ
𝑇𝑇
𝑡𝑡          (10) 
 
{
𝑑𝑑𝑀𝑀+1(𝑡𝑡)
𝑑𝑑𝑡𝑡
= 𝑘𝑘+1(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡))  
𝑑𝑑𝑀𝑀−7(𝑡𝑡)
𝑑𝑑𝑡𝑡
= (𝑘𝑘−7,𝑡𝑡=0ℎ +
𝑘𝑘−7,𝑡𝑡=60ℎ − 𝑘𝑘−7,𝑡𝑡=0ℎ
𝑇𝑇
𝑡𝑡 )(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡)) 
          (11) 
 
𝑓𝑓(𝑥𝑥) = 1 + 0.5 √𝑥𝑥 
 
𝑅𝑅(𝑡𝑡) = 1 − 2−
𝑡𝑡
ℎ𝑙𝑙      (1) 
 
𝑦𝑦(𝑡𝑡) = 1 −
𝑈𝑈
1 + 𝑒𝑒−𝑎𝑎(𝑡𝑡−𝑏𝑏)
          (2) 
 
𝑃𝑃(𝑡𝑡) + 𝐵𝐵(𝑡𝑡) + 𝑀𝑀(𝑡𝑡) = 1         (3) 
 
{
𝑑𝑑𝑃𝑃(𝑡𝑡)
𝑑𝑑𝑡𝑡
= −𝑘𝑘𝑐𝑐𝑅𝑅(𝑡𝑡)𝑃𝑃(𝑡𝑡) + 𝑘𝑘𝑝𝑝𝐵𝐵(𝑡𝑡) = −𝑘𝑘𝑐𝑐𝑅𝑅(𝑡𝑡)𝑃𝑃(𝑡𝑡) + 𝑘𝑘𝑝𝑝(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡))  
𝑑𝑑𝑀𝑀(𝑡𝑡)
𝑑𝑑𝑡𝑡
= 𝑘𝑘𝑚𝑚𝐵𝐵(𝑡𝑡) = 𝑘𝑘𝑚𝑚(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡)) 
        (4) 
 
𝑃𝑃𝑟𝑟(𝑡𝑡) =
𝑈𝑈 + 𝑃𝑃(𝑡𝑡)
𝑈𝑈 + 𝑃𝑃(𝑡𝑡) + 𝑀𝑀(𝑡𝑡)
          (5) 
 
V(i) =
𝑘𝑘𝑝𝑝
𝑘𝑘𝑝𝑝 + 𝑘𝑘𝑚𝑚
=  
iW0
iW0 + (1 −W0)2i−1
          (6) 
 
𝑘𝑘𝑝𝑝 =
𝑘𝑘𝑚𝑚V(i)
1 − V(i)
=
i21−iW0𝑘𝑘𝑚𝑚 
(1 −W0) 
          (7) 
 
{
𝑑𝑑𝑀𝑀+1(𝑡𝑡)
𝑑𝑑𝑡𝑡
= 𝑘𝑘+1𝐵𝐵(𝑡𝑡) = 𝑘𝑘+1(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡))  
𝑑𝑑𝑀𝑀−7(𝑡𝑡)
𝑑𝑑𝑡𝑡
= 𝑘𝑘−7𝐵𝐵(𝑡𝑡) = 𝑘𝑘−7(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡)) 
          (8)  
 
{
 
 
 
 𝑀𝑀𝑟𝑟,+1(𝑡𝑡) =
𝑀𝑀+1(𝑡𝑡)
𝑈𝑈 + 𝑃𝑃(𝑡𝑡) + 𝑀𝑀(𝑡𝑡)
   
𝑀𝑀𝑟𝑟,−7(𝑡𝑡) =
𝑀𝑀−7(𝑡𝑡)
𝑈𝑈 + 𝑃𝑃(𝑡𝑡) + 𝑀𝑀(𝑡𝑡)
          (9) 
 
𝑘𝑘−7(t) = 𝑘𝑘−7,𝑡𝑡=0ℎ +
𝑘𝑘−7,𝑡𝑡=60ℎ − 𝑘𝑘−7,𝑡𝑡=0ℎ
𝑇𝑇
𝑡𝑡          (10) 
 
{
𝑑𝑑𝑀𝑀+1(𝑡𝑡)
𝑑𝑑𝑡𝑡
= 𝑘𝑘+1(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡))  
𝑑𝑑𝑀𝑀−7(𝑡𝑡)
𝑑𝑑𝑡𝑡
= (𝑘𝑘−7,𝑡𝑡=0ℎ +
𝑘𝑘−7,𝑡𝑡=60ℎ − 𝑘𝑘−7,𝑡𝑡=0ℎ
𝑇𝑇
𝑡𝑡 )(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡)) 
          (11) 
 
𝑓𝑓(𝑥𝑥) = 1 + 0.5 √𝑥𝑥 
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time lapse curve of intact sequences according to the following equation.  
Where a, b and U are parameters that determine the shape of the curve. The fitting is 
done by the nls package of R by minimization of the Gaussian dispersion. U describes 
the asymptotic plateau, that is, the untransfected fraction
 
Mathematical modeling
I. Modeling the kinetics of total indels
The three fractions of intact (P), broken (B) and total indels (M) of a locus at any given time (t) 
after cutting by CRISPR/Cas9 must adhere to the principle of conservation
 
𝑅𝑅(𝑡𝑡) = 1 − 2−
𝑡𝑡
ℎ𝑙𝑙      (1) 
 
𝑦𝑦(𝑡𝑡) = 1 −
𝑈𝑈
1 + 𝑒𝑒−𝑎𝑎(𝑡𝑡−𝑏𝑏)
          (2) 
 
𝑃𝑃(𝑡𝑡) + 𝐵𝐵(𝑡𝑡) + 𝑀𝑀(𝑡𝑡) = 1         (3) 
 
{
𝑑𝑑𝑃𝑃(𝑡𝑡)
𝑑𝑑𝑡𝑡
= −𝑘𝑘𝑐𝑐𝑅𝑅(𝑡𝑡)𝑃𝑃(𝑡𝑡) + 𝑘𝑘𝑝𝑝𝐵𝐵(𝑡𝑡) = −𝑘𝑘𝑐𝑐𝑅𝑅(𝑡𝑡)𝑃𝑃(𝑡𝑡) + 𝑘𝑘𝑝𝑝(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡))  
𝑑𝑑𝑀𝑀(𝑡𝑡)
𝑑𝑑𝑡𝑡
= 𝑘𝑘𝑚𝑚𝐵𝐵(𝑡𝑡) = 𝑘𝑘𝑚𝑚(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡)) 
        (4) 
 
𝑃𝑃𝑟𝑟(𝑡𝑡) =
𝑈𝑈 + 𝑃𝑃(𝑡𝑡)
𝑈𝑈 + 𝑃𝑃(𝑡𝑡) + 𝑀𝑀(𝑡𝑡)
          (5) 
 
V(i) =
𝑘𝑘𝑝𝑝
𝑘𝑘𝑝𝑝 + 𝑘𝑘𝑚𝑚
=  
iW0
iW0 + (1 −W0)2i−1
          (6) 
 
𝑘𝑘𝑝𝑝 =
𝑘𝑘𝑚𝑚V(i)
1 − V(i)
=
i21−iW0𝑘𝑘𝑚𝑚 
(1 −W0) 
          (7) 
 
{
𝑑𝑑𝑀𝑀+1(𝑡𝑡)
𝑑𝑑𝑡𝑡
= 𝑘𝑘+1𝐵𝐵(𝑡𝑡) = 𝑘𝑘+1(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡))  
𝑑𝑑𝑀𝑀−7(𝑡𝑡)
𝑑𝑑𝑡𝑡
= 𝑘𝑘−7𝐵𝐵(𝑡𝑡) = 𝑘𝑘−7(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡)) 
          (8)  
 
{
 
 
 
 𝑀𝑀𝑟𝑟,+1(𝑡𝑡) =
𝑀𝑀+1(𝑡𝑡)
𝑈𝑈 + 𝑃𝑃(𝑡𝑡) + 𝑀𝑀(𝑡𝑡)
   
𝑀𝑀𝑟𝑟,−7(𝑡𝑡) =
𝑀𝑀−7(𝑡𝑡)
𝑈𝑈 + 𝑃𝑃(𝑡𝑡) + 𝑀𝑀(𝑡𝑡)
          (9) 
 
𝑘𝑘−7(t) = 𝑘𝑘−7,𝑡𝑡=0ℎ +
𝑘𝑘−7,𝑡𝑡=60ℎ − 𝑘𝑘−7,𝑡𝑡=0ℎ
𝑇𝑇
𝑡𝑡          (10) 
 
{
𝑑𝑑𝑀𝑀+1(𝑡𝑡)
𝑑𝑑𝑡𝑡
= 𝑘𝑘+1(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡))  
𝑑𝑑𝑀𝑀−7(𝑡𝑡)
𝑑𝑑𝑡𝑡
= (𝑘𝑘−7,𝑡𝑡=0ℎ +
𝑘𝑘−7,𝑡𝑡=60ℎ − 𝑘𝑘−7,𝑡𝑡=0ℎ
𝑇𝑇
𝑡𝑡 )(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡)) 
          (11) 
 
𝑓𝑓(𝑥𝑥) = 1 + 0.5 √𝑥𝑥 
We assumed the cutting and repair kinetics is of first-order and the overall activity of 
CRISPR/Cas9 is proportional to the abundance of Cas9 that is modelled in equation (1). 
As shown in the diagram (Figure 1a) and taking equation (3) into account, the kinetics of 
the intact fraction (P) and the total indels (M) is determined by a nonlinear ODE
 
𝑅𝑅(𝑡𝑡) = 1 − 2−
𝑡𝑡
ℎ𝑙𝑙      (1) 
 
𝑦𝑦(𝑡𝑡) = 1 −
𝑈𝑈
1 + 𝑒𝑒−𝑎𝑎(𝑡𝑡−𝑏𝑏)
          (2) 
 
𝑃𝑃(𝑡𝑡) + 𝐵𝐵(𝑡𝑡) + 𝑀𝑀(𝑡𝑡) = 1         (  
 
{
𝑑𝑑𝑃𝑃(𝑡𝑡)
𝑑𝑑𝑡𝑡
= −𝑘𝑘𝑐𝑐𝑅𝑅(𝑡𝑡)𝑃𝑃(𝑡𝑡) + 𝑘𝑘𝑝𝑝𝐵𝐵(𝑡𝑡) = −𝑘𝑘𝑐𝑐𝑅𝑅(𝑡𝑡)𝑃𝑃(𝑡𝑡) + 𝑘𝑘𝑝𝑝(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡))  
𝑑𝑑𝑀𝑀(𝑡𝑡)
𝑑𝑑𝑡𝑡
= 𝑘𝑘𝑚𝑚𝐵𝐵(𝑡𝑡) = 𝑘𝑘𝑚𝑚(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡)) 
        (4) 
𝑃𝑃𝑟𝑟(𝑡𝑡) =
𝑈𝑈 + 𝑃𝑃(𝑡𝑡)
𝑈𝑈 + 𝑃𝑃(𝑡𝑡) + 𝑀𝑀(𝑡𝑡)
          (5)
 
V(i) =
𝑘𝑘𝑝𝑝
𝑘𝑘𝑝𝑝 + 𝑘𝑘𝑚𝑚
=  
i 0
iW0 + (1 −W0)2i−1
          (6) 
 
𝑘𝑘𝑝𝑝 =
𝑘𝑘𝑚𝑚V(i)
1 − V(i)
=
i21−iW0𝑘𝑘𝑚𝑚 
(1 −W0) 
          (7  
 
{
𝑑𝑑𝑀𝑀+1(𝑡𝑡)
𝑑𝑑𝑡𝑡
= 𝑘𝑘+1𝐵𝐵(𝑡𝑡) = 𝑘𝑘+1(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡))  
𝑑𝑑𝑀𝑀−7(𝑡𝑡)
𝑑𝑑𝑡𝑡
= 𝑘𝑘−7𝐵𝐵(𝑡𝑡) = 𝑘𝑘−7(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡)) 
          (8)  
 
{
 
 
 
 𝑀𝑀𝑟𝑟,+1(𝑡𝑡) =
𝑀𝑀+1(𝑡𝑡)
𝑈𝑈 + 𝑃𝑃(𝑡𝑡) + 𝑀𝑀(𝑡𝑡)
   
𝑀𝑀𝑟𝑟, (𝑡𝑡) =
𝑀𝑀−7(𝑡𝑡)
𝑈𝑈 + 𝑃𝑃(𝑡𝑡) + 𝑀𝑀(𝑡𝑡)
          (9) 
 
𝑘𝑘−7(t) = 𝑘𝑘−7,𝑡𝑡=0ℎ +
𝑘𝑘−7,𝑡𝑡=60ℎ − 𝑘𝑘−7,𝑡𝑡=0ℎ
𝑇𝑇
𝑡𝑡          (10) 
 
{
𝑑𝑑𝑀𝑀+1(𝑡𝑡)
𝑑𝑑𝑡𝑡
= 𝑘𝑘+1(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡))  
𝑑𝑑𝑀𝑀−7(𝑡𝑡)
𝑑𝑑𝑡𝑡
= (𝑘𝑘−7,𝑡𝑡=0ℎ +
𝑘𝑘−7,𝑡𝑡=60ℎ − 𝑘𝑘−7,𝑡𝑡=0ℎ
𝑇𝑇
𝑡𝑡 )(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡)) 
          (11) 
 
𝑓𝑓(𝑥𝑥) = 1 + 0.5 √𝑥𝑥 
 
whereby k
c
 stands for the maximal Cas9 cutting rate, k
p
 for perfect repair rate and k
m
 for 
mutagenic repair rate that gives rise to indels, all of which are in h-1.
Because broken DNA is not detected in amplicons across the break site, the measured 
intact fraction (P
r
) is the ratio between the abundance of intact sequences and the sum 
of the abundance of intact and indel sequences. Including the untransfected fraction (U) 
from equation (2) as a part in the intact fraction, the measured intact fraction is
 
𝑅𝑅(𝑡𝑡) = 1 − 2−
𝑡𝑡
ℎ𝑙𝑙      (1) 
 
𝑦𝑦(𝑡𝑡) = 1 −
𝑈𝑈
1 + 𝑒𝑒−𝑎𝑎(𝑡𝑡−𝑏𝑏)
          (2) 
 
𝑃𝑃(𝑡𝑡) + 𝐵𝐵(𝑡𝑡) + 𝑀𝑀(𝑡𝑡) = 1         (3) 
 
{
𝑑𝑑𝑃𝑃(𝑡𝑡)
𝑑𝑑𝑡𝑡
= −𝑘𝑘𝑐𝑐𝑅𝑅(𝑡𝑡)𝑃𝑃(𝑡𝑡) + 𝑘𝑘𝑝𝑝𝐵𝐵(𝑡𝑡) = −𝑘𝑘𝑐𝑐𝑅𝑅(𝑡𝑡)𝑃𝑃(𝑡𝑡) + 𝑘𝑘𝑝𝑝(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡))  
𝑑𝑑𝑀𝑀(𝑡𝑡)
𝑑𝑑𝑡𝑡
= 𝑘𝑘𝑚𝑚𝐵𝐵(𝑡𝑡) = 𝑘𝑘𝑚𝑚(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡)) 
        (4) 
 
𝑃𝑃𝑟𝑟(𝑡𝑡) =
𝑈𝑈 + 𝑃𝑃(𝑡𝑡)
𝑈𝑈 + 𝑃𝑃(𝑡𝑡) + 𝑀𝑀(𝑡𝑡)
          (5) 
 
V(i) =
𝑘𝑘𝑝𝑝
𝑘𝑘𝑝𝑝 + 𝑘𝑘𝑚𝑚
=  
iW0
iW0 + (1 −W0)2i−1
          (6) 
 
𝑘𝑘𝑝𝑝 =
𝑘𝑘𝑚𝑚V(i)
1 − V(i)
=
i21−iW0𝑘𝑘𝑚𝑚 
(1 −W0) 
          (7) 
 
{
𝑑𝑑𝑀𝑀+1(𝑡𝑡)
𝑑𝑑𝑡𝑡
= 𝑘𝑘+1𝐵𝐵(𝑡𝑡) = 𝑘𝑘+1(1 − 𝑃𝑃 𝑡𝑡 − 𝑀𝑀(𝑡𝑡))  
𝑑𝑑𝑀𝑀−7(𝑡𝑡)
𝑑𝑑𝑡𝑡
= 𝑘𝑘−7𝐵𝐵(𝑡𝑡) = 𝑘𝑘−7(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡)) 
          (8)  
 
{
 
 
 
 𝑀𝑀𝑟𝑟,+1(𝑡𝑡) =
𝑀𝑀+1(𝑡𝑡)
𝑈𝑈 + 𝑃𝑃(𝑡𝑡) + 𝑀𝑀(𝑡𝑡)
   
𝑀𝑀𝑟𝑟,−7(𝑡𝑡) =
𝑀𝑀−7(𝑡𝑡)
𝑈𝑈 + 𝑃𝑃(𝑡𝑡) + 𝑀𝑀(𝑡𝑡)
          (9) 
 
𝑘𝑘−7(t) = 𝑘𝑘−7,𝑡𝑡=0ℎ +
𝑘𝑘−7,𝑡𝑡=60ℎ − 𝑘𝑘−7,𝑡𝑡=0ℎ
𝑇𝑇
𝑡𝑡          (10) 
 
{
𝑑𝑑𝑀𝑀+1(𝑡𝑡)
𝑑𝑑𝑡𝑡
= 𝑘𝑘+1(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡))  
𝑑𝑑𝑀𝑀−7(𝑡𝑡)
𝑑𝑑𝑡𝑡
= (𝑘𝑘−7,𝑡𝑡=0ℎ +
𝑘𝑘−7,𝑡𝑡=60ℎ − 𝑘𝑘−7,𝑡𝑡=0ℎ
𝑇𝑇
𝑡𝑡 )(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡)) 
          (11) 
 
𝑓𝑓(𝑥𝑥) = 1 + 0.5 √𝑥𝑥 
Taking equations (1), (2) and (4) together and a set of randomly chosen initial values for k
c
, k
p
, k
m
, 
the P(t), B(t) and M(t) were modelled. P
r
(t) was calculated with equation (5), to demonstrate 
simulation outcomes as shown in Supplementary Figure 1. Then, we estimated the optimal 
values of kinetic parameters by minimizing the difference between the modelled P
r
(t) and 
experimentally measured intact fraction using the Levenberg-Marquardt algorithm (LMA) 
using Package FME in R. The estimated rates were used to deduce the P(t), B(t) and M(t) 
fractions according to equation (3). The time point of the highest value of B(t) is τ. 
The time course spans multiple cell divisions. Because cells with broken DNA may enter a 
transient cell cycle arrest, this could lead to under-representation of the broken fraction, 
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as is provides cells without broken DNA with a relative growth advantage in the cell pool. 
However, because of three reasons combined, we believe that the impact of this bias on 
our parameter estimates is minor. First, we found that the percentage of arrested cells is 
no more than ~10% at 16 hours after Cas9 activation, and even less at earlier and later 
time points (Supplementary Figure S5). Second, because K562 cells are approximately 
tetraploid (Supplementary Figure S4), arrested cells are likely to also harbour intact or 
indel DNA; hence a cell cycle arrest will not only reduce the broken fraction, but also 
the intact and indel fractions. Third, our kinetic modelling is based on the measured 
indel/(indel+intact) ratios, not on measurements of broken DNA. A modest 
underrepresentation of broken DNA in the cell pool does not significantly affect this ratio.
For Figure 6, we performed the fitting for each sgRNA, using the measurements from 
all time series combined. We first inferred the transfection efficiency from these data 
by conducting a series of model fits while varying the transfection efficiency value from 
60 to 90% in steps of 1%. The transfection efficiency value that yielded the lowest sum 
of residuals squared was chosen. For LBR2, LBR8 and chr11 this resulted in estimated 
transfection efficiencies of 72%%, 69% and 75%, respectively, which is in close agreement 
with efficiencies observed by flow cytometry analysis (see Results). For AAVS1 this value 
was ~85% but the residual errors did not converge to a clear minimum; we therefore 
decided to use the average estimate of the other three loci, i.e. 72%. Next, the model fitting 
was carried out on the data points of all replicates combined, using a standard 1,000-fold 
bootstrapping by random sampling of the data with replacement.  
II. Testing the robustness of the modelled perfect repair rate at LBR2
For the parameter sweep analysis testing the robustness of the rate of perfect repair, k
p
 
(Figure 2e, corresponding text), we restricted the ratio of k
p
 to the total repair rate (k
p
+k
m
) 
as a sweeping factor
 
𝑅𝑅(𝑡𝑡) = 1 − 2−
𝑡𝑡
ℎ𝑙𝑙      (1) 
 
𝑦𝑦(𝑡𝑡) = 1 −
𝑈𝑈
1 + 𝑒𝑒−𝑎𝑎(𝑡𝑡−𝑏𝑏)
          (2) 
 
𝑃𝑃(𝑡𝑡) + 𝐵𝐵(𝑡𝑡) + 𝑀𝑀(𝑡𝑡) = 1         (3) 
 
{
𝑑𝑑𝑃𝑃(𝑡𝑡)
𝑑𝑑𝑡𝑡
= −𝑘𝑘𝑐𝑐𝑅𝑅(𝑡𝑡)𝑃𝑃(𝑡𝑡) + 𝑘𝑘𝑝𝑝𝐵𝐵(𝑡𝑡) = −𝑘𝑘𝑐𝑐𝑅𝑅(𝑡𝑡)𝑃𝑃(𝑡𝑡) + 𝑘𝑘𝑝𝑝(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡))  
𝑑𝑑𝑀𝑀(𝑡𝑡)
𝑑𝑑𝑡𝑡
= 𝑘𝑘𝑚𝑚𝐵𝐵(𝑡𝑡) = 𝑘𝑘𝑚𝑚(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡)) 
        (4) 
 
𝑃𝑃𝑟𝑟(𝑡𝑡) =
𝑈𝑈 + 𝑃𝑃(𝑡𝑡)
𝑈𝑈 + 𝑃𝑃(𝑡𝑡) + 𝑀𝑀(𝑡𝑡)
          (5) 
 
V(i) =
𝑘𝑘𝑝𝑝
𝑘𝑘𝑝𝑝 + 𝑘𝑘𝑚𝑚
=  
iW0
iW0 + (1 −W0)2i−1
          (6) 
 
𝑘𝑘𝑝𝑝 =
𝑘𝑘𝑚𝑚V(i)
1 − V(i)
=
i21−iW0𝑘𝑘𝑚𝑚 
(1 −W0) 
          (7) 
 
{
𝑑𝑑𝑀𝑀+1(𝑡𝑡)
𝑑𝑑𝑡𝑡
= 𝑘𝑘+1𝐵𝐵(𝑡𝑡) = 𝑘𝑘+1(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡))  
𝑑𝑑𝑀𝑀−7(𝑡𝑡)
𝑑𝑑𝑡𝑡
= 𝑘𝑘−7𝐵𝐵(𝑡𝑡) = 𝑘𝑘−7(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡)) 
          (8)  
 
{
 
 
 
 𝑀𝑀𝑟𝑟,+1(𝑡𝑡) =
𝑀𝑀+1(𝑡𝑡)
𝑈𝑈 + 𝑃𝑃(𝑡𝑡) + 𝑀𝑀(𝑡𝑡)
   
𝑀𝑀𝑟𝑟,−7(𝑡𝑡) =
𝑀𝑀−7(𝑡𝑡)
𝑈𝑈 + 𝑃𝑃(𝑡𝑡) + 𝑀𝑀(𝑡𝑡)
          (9) 
 
𝑘𝑘−7(t) = 𝑘𝑘−7,𝑡𝑡=0ℎ +
𝑘𝑘−7,𝑡𝑡=60ℎ − 𝑘𝑘−7,𝑡𝑡=0ℎ
𝑇𝑇
𝑡𝑡          (10) 
 
{
𝑑𝑑𝑀𝑀+1(𝑡𝑡)
𝑑𝑑𝑡𝑡
= 𝑘𝑘+1(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡))  
𝑑𝑑𝑀𝑀−7(𝑡𝑡)
𝑑𝑑𝑡𝑡
= (𝑘𝑘−7,𝑡𝑡=0ℎ +
𝑘𝑘−7,𝑡𝑡=60ℎ − 𝑘𝑘−7,𝑡𝑡=0ℎ
𝑇𝑇
𝑡𝑡 )(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡)) 
          (11) 
 
𝑓𝑓(𝑥𝑥) = 1 + 0.5 √𝑥𝑥 
varying from W
0
=0.75 downwards by i times from 1 to 32, spanning 10 orders of magnitude. 
The incentive of introducing i as a term of multiplication is to test more carefully at 
high k
p
 and a broad dynamic range with virtually equal step size at the low end. Therefore, 
we can represent k
p
 as
 
𝑅𝑅(𝑡𝑡) = 1 − 2−
𝑡𝑡
ℎ𝑙𝑙      (1) 
 
𝑦𝑦(𝑡𝑡) = 1 −
𝑈𝑈
1 + 𝑒𝑒−𝑎𝑎(𝑡𝑡−𝑏𝑏)
          (2) 
 
𝑃𝑃(𝑡𝑡) + 𝐵𝐵(𝑡𝑡) + 𝑀𝑀(𝑡𝑡) = 1         (3) 
 
{
𝑑𝑑𝑃𝑃(𝑡𝑡)
𝑑𝑑𝑡𝑡
= −𝑘𝑘𝑐𝑐𝑅𝑅(𝑡𝑡)𝑃𝑃(𝑡𝑡) + 𝑘𝑘𝑝𝑝𝐵𝐵(𝑡𝑡) = −𝑘𝑘𝑐𝑐𝑅𝑅(𝑡𝑡)𝑃𝑃(𝑡𝑡) + 𝑘𝑘𝑝𝑝(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡))  
𝑑𝑑𝑀𝑀(𝑡𝑡)
𝑑𝑑𝑡𝑡
= 𝑘𝑘𝑚𝑚𝐵𝐵(𝑡𝑡) = 𝑘𝑘𝑚𝑚(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡)  
        (4) 
 
𝑃𝑃𝑟𝑟(𝑡𝑡) =
𝑈𝑈 + 𝑃𝑃(𝑡𝑡)
𝑈𝑈 + 𝑃𝑃(𝑡𝑡) + 𝑀𝑀(𝑡𝑡)
          (5) 
 
V(i) =
𝑘𝑘𝑝𝑝
𝑘𝑘𝑝𝑝 + 𝑘𝑘𝑚𝑚
=  
iW0
iW0 + (1 −W0)2i−1
          (6) 
 
𝑘𝑘𝑝𝑝 =
𝑘𝑘𝑚𝑚V(i)
1 − V(i)
=
i21−iW0𝑘𝑘𝑚𝑚 
(1 −W0) 
          (7) 
 
{
𝑑𝑑𝑀𝑀+1(𝑡𝑡)
𝑑𝑑𝑡𝑡
= 𝑘𝑘+1𝐵𝐵(𝑡𝑡) = 𝑘𝑘+1(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡))  
𝑑𝑑𝑀𝑀−7(𝑡𝑡)
𝑑𝑑𝑡𝑡
= 𝑘𝑘−7𝐵𝐵(𝑡𝑡) = 𝑘𝑘−7(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡)) 
          (8)  
 
{
 
 
 
 𝑀𝑀𝑟𝑟,+1(𝑡𝑡) =
𝑀𝑀+1(𝑡𝑡)
𝑈𝑈 + 𝑃𝑃(𝑡𝑡) + 𝑀𝑀(𝑡𝑡)
   
𝑀𝑀𝑟𝑟,−7(𝑡𝑡) =
𝑀𝑀−7(𝑡𝑡)
𝑈𝑈 + 𝑃𝑃(𝑡𝑡) + 𝑀𝑀(𝑡𝑡)
          (9) 
 
𝑘𝑘−7(t) = 𝑘𝑘−7,𝑡𝑡=0ℎ +
𝑘𝑘−7,𝑡𝑡=60ℎ − 𝑘𝑘−7,𝑡𝑡=0ℎ
𝑇𝑇
𝑡𝑡          (10) 
 
{
𝑑𝑑𝑀𝑀+1(𝑡𝑡)
𝑑𝑑𝑡𝑡
= 𝑘𝑘+1(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡))  
𝑑𝑑𝑀𝑀−7(𝑡𝑡)
𝑑𝑑𝑡𝑡
= (𝑘𝑘−7,𝑡𝑡=0ℎ +
𝑘𝑘−7,𝑡𝑡=60ℎ − 𝑘𝑘−7,𝑡𝑡=0ℎ
𝑇𝑇
𝑡𝑡 )(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡)) 
          (11) 
 
𝑓𝑓(𝑥𝑥) = 1 + 0.5 √𝑥𝑥 
Taking equations (1), (2), (4), (5) and (7) together, we performed the model fitting with LMA.
Given a fixed ratio V(i) of perfect repair, the F-test was applied to examine the statistical 
significance for the difference in performance between restricted and optimal fittings, by 
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the standard approach that takes the degree of freedom, which is the number of time 
points of the experiment minus 2 (the number of parameters in the model) and the fold 
difference in the deviance of fittings. A cut-off at p = 0.1 is applied to determine the upper 
bound of deviance and thereafter the upper bound of the ratio of perfect repair (V) is 
calculated accordingly (Figure 2e).
Taking a similar approach of parameter sweep, we tested the robustness of k
c
, and 
calculated the corresponding deviation of model fit (Supplementary Figure S2f).
III. Modeling the kinetics of individual indels
To model +1 (M
+1
) and -7 (M
-7
) indels individually, we introduced the kinetic terms k
+1
 and k
-7
 
correspondingly for each mutant. As shown in the diagram (Figure 5a), the kinetics of 
individual indels can be written as
 
𝑅𝑅(𝑡𝑡) = 1 − 2−
𝑡𝑡
ℎ𝑙𝑙      (1) 
 
𝑦𝑦(𝑡𝑡) = 1 −
𝑈𝑈
1 + 𝑒𝑒−𝑎𝑎(𝑡𝑡−𝑏𝑏)
          (2) 
 
𝑃𝑃(𝑡𝑡) + 𝐵𝐵(𝑡𝑡) + 𝑀𝑀(𝑡𝑡) = 1         (3) 
 
{
𝑑𝑑𝑃𝑃(𝑡𝑡)
𝑑𝑑𝑡𝑡
= −𝑘𝑘𝑐𝑐𝑅𝑅(𝑡𝑡)𝑃𝑃(𝑡𝑡) + 𝑘𝑘𝑝𝑝𝐵𝐵(𝑡𝑡) = −𝑘𝑘𝑐𝑐𝑅𝑅(𝑡𝑡)𝑃𝑃(𝑡𝑡) + 𝑘𝑘𝑝𝑝(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡))  
𝑑𝑑𝑀𝑀(𝑡𝑡)
𝑑𝑑𝑡𝑡
= 𝑘𝑘𝑚𝑚𝐵𝐵(𝑡𝑡) = 𝑘𝑘𝑚𝑚(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡)) 
        (4) 
 
𝑃𝑃𝑟𝑟(𝑡𝑡) =
𝑈𝑈 + 𝑃𝑃(𝑡𝑡)
𝑈𝑈 + 𝑃𝑃(𝑡𝑡) + 𝑀𝑀(𝑡𝑡)
          (5) 
 
V(i) =
𝑘𝑘𝑝𝑝
𝑘𝑘𝑝𝑝 + 𝑘𝑘𝑚𝑚
=  
iW0
iW0 + (1 −W0)2i−1
          (6) 
 
𝑘𝑘𝑝𝑝 =
𝑘𝑘𝑚𝑚V(i)
1 − V(i)
=
i21−iW0𝑘𝑘𝑚𝑚 
(1 −W0) 
          (7) 
 
{
𝑑𝑑𝑀𝑀+1(𝑡𝑡)
𝑑𝑑𝑡𝑡
= 𝑘𝑘+1𝐵𝐵(𝑡𝑡) = 𝑘𝑘+1(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡))  
𝑑𝑑𝑀𝑀−7(𝑡𝑡)
𝑑𝑑𝑡𝑡
= 𝑘𝑘−7𝐵𝐵(𝑡𝑡) = 𝑘𝑘−7(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡)) 
          (8)  
 
{
 
 
 
 𝑀𝑀𝑟𝑟,+1(𝑡𝑡) =
𝑀𝑀+1(𝑡𝑡)
𝑈𝑈 + 𝑃𝑃(𝑡𝑡) + 𝑀𝑀(𝑡𝑡)
   
𝑀𝑀𝑟𝑟,−7(𝑡𝑡) =
𝑀𝑀−7(𝑡𝑡)
𝑈𝑈 + 𝑃𝑃(𝑡𝑡) + 𝑀𝑀(𝑡𝑡)
          (9) 
 
𝑘𝑘−7(t) = 𝑘𝑘−7,𝑡𝑡=0ℎ +
𝑘𝑘−7,𝑡𝑡=60ℎ − 𝑘𝑘−7,𝑡𝑡=0ℎ
𝑇𝑇
𝑡𝑡          (10) 
 
{
𝑑𝑑𝑀𝑀+1(𝑡𝑡)
𝑑𝑑𝑡𝑡
= 𝑘𝑘+1(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡))  
𝑑𝑑𝑀𝑀−7(𝑡𝑡)
𝑑𝑑𝑡𝑡
= (𝑘𝑘−7,𝑡𝑡=0ℎ +
𝑘𝑘−7,𝑡𝑡=60ℎ − 𝑘𝑘−7,𝑡𝑡=0ℎ
𝑇𝑇
𝑡𝑡 )(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡)) 
          (11) 
 
𝑓𝑓(𝑥𝑥) = 1 + 0.5 √𝑥𝑥 
 
Similar to the measured intact fraction (P
r
), the measured fraction of individual indels (M
r,+1
,M
r,-7
) 
can be represented as
 
𝑅𝑅(𝑡𝑡) = 1 − 2−
𝑡𝑡
ℎ𝑙𝑙      (1) 
 
𝑦𝑦(𝑡𝑡) = 1 −
𝑈𝑈
1 + 𝑒𝑒−𝑎𝑎(𝑡𝑡−𝑏𝑏)
          (2) 
 
𝑃𝑃(𝑡𝑡) + 𝐵𝐵(𝑡𝑡) + 𝑀𝑀(𝑡𝑡) = 1         (3) 
 
{
𝑑𝑑𝑃𝑃(𝑡𝑡)
𝑑𝑑𝑡𝑡
= −𝑘𝑘𝑐𝑐𝑅𝑅(𝑡𝑡)𝑃𝑃(𝑡𝑡) + 𝑘𝑘𝑝𝑝𝐵𝐵(𝑡𝑡) = −𝑘𝑘𝑐𝑐𝑅𝑅(𝑡𝑡)𝑃𝑃(𝑡𝑡) + 𝑘𝑘𝑝𝑝(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡))  
𝑑𝑑𝑀𝑀(𝑡𝑡)
𝑑𝑑𝑡𝑡
= 𝑘𝑘𝑚𝑚𝐵𝐵(𝑡𝑡) = 𝑘𝑘𝑚𝑚(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡)) 
        (4) 
 
𝑃𝑃𝑟𝑟(𝑡𝑡) =
𝑈𝑈 + 𝑃𝑃(𝑡𝑡)
𝑈𝑈 + 𝑃𝑃(𝑡𝑡) + 𝑀𝑀(𝑡𝑡)
          (5) 
 
V(i) =
𝑘𝑘𝑝𝑝
𝑘𝑘𝑝𝑝 + 𝑘𝑘𝑚𝑚
=  
iW0
iW0 + (1 −W0)2i−1
          (6) 
 
𝑘𝑘𝑝𝑝 =
𝑘𝑘𝑚𝑚V(i)
1 − V(i)
=
i21−iW0𝑘𝑘𝑚𝑚 
(1 −W0) 
          (7) 
 
{
𝑑𝑑𝑀𝑀+1(𝑡𝑡)
𝑑𝑑𝑡𝑡
= 𝑘𝑘+1𝐵𝐵(𝑡𝑡) = 𝑘𝑘+1(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡)   
𝑑𝑑𝑀𝑀−7(𝑡𝑡)
𝑑𝑑𝑡𝑡
= 𝑘𝑘−7𝐵𝐵(𝑡𝑡) = 𝑘𝑘−7(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡)) 
          (8)  
 
{
 
 
 
 𝑀𝑀𝑟𝑟,+1(𝑡𝑡) =
𝑀𝑀+1(𝑡𝑡)
𝑈𝑈 + 𝑃𝑃(𝑡𝑡) + 𝑀𝑀(𝑡𝑡)
   
𝑀𝑀𝑟𝑟,−7(𝑡𝑡) =
𝑀𝑀−7(𝑡𝑡)
𝑈𝑈 + 𝑃𝑃(𝑡𝑡) + 𝑀𝑀(𝑡𝑡)
          (9) 
 
𝑘𝑘−7(t) = 𝑘𝑘−7,𝑡𝑡=0ℎ +
𝑘𝑘−7,𝑡𝑡=60ℎ − 𝑘𝑘−7,𝑡𝑡=0ℎ
𝑇𝑇
𝑡𝑡          (10) 
 
{
𝑑𝑑𝑀𝑀+1(𝑡𝑡)
𝑑𝑑𝑡𝑡
= 𝑘𝑘+1(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡))  
𝑑𝑑𝑀𝑀−7(𝑡𝑡)
𝑑𝑑𝑡𝑡
= (𝑘𝑘−7,𝑡𝑡=0ℎ +
𝑘𝑘−7,𝑡𝑡=60ℎ − 𝑘𝑘−7,𝑡𝑡=0ℎ
𝑇𝑇
𝑡𝑡 )(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡)) 
          (11) 
 
𝑓𝑓(𝑥𝑥) = 1 + 0.5 √𝑥𝑥 
Taking equations (1), (2), (4), (5) and (8) together, we estimated the kinetic parameters by 
minimizing a gradient of differences between the modelled P
r
 (t), M
r,+1
 (t) and M
r,-7
 (t) and 
experimentally measured sequence data of the intact, +1 and -7 fraction by LMA.
IV. Adjustment of the modeling of the -7 indel kinetics
Following the modelling of individual indels, we discovered inconsistency between the 
fitted curve of the -7 indel and the experimental data (Figure 5c), suggesting the repair 
rate for the -7 indel is not a constant. Assuming a linear change of -7 repair rate over 
time, we adjusted the model by introducing a starting rate (k
-7,t=0h
) and an end rate (k
-7,t=60h
) 
(Figure 5d), and the non-constant -7 repair rate can be described as
 
𝑅𝑅(𝑡𝑡) = 1 − 2−
𝑡𝑡
ℎ𝑙𝑙      (1) 
 
𝑦𝑦(𝑡𝑡) = 1 −
𝑈𝑈
1 + 𝑒𝑒−𝑎𝑎(𝑡𝑡−𝑏𝑏)
          (2) 
 
𝑃𝑃(𝑡𝑡) + 𝐵𝐵(𝑡𝑡) + 𝑀𝑀(𝑡𝑡) = 1         (3) 
 
{
𝑑𝑑𝑃𝑃(𝑡𝑡)
𝑑𝑑𝑡𝑡
= −𝑘𝑘𝑐𝑐𝑅𝑅(𝑡𝑡)𝑃𝑃(𝑡𝑡) + 𝑘𝑘𝑝𝑝𝐵𝐵(𝑡𝑡) = −𝑘𝑘𝑐𝑐𝑅𝑅(𝑡𝑡)𝑃𝑃(𝑡𝑡) + 𝑘𝑘𝑝𝑝(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡))  
𝑑𝑑𝑀𝑀(𝑡𝑡)
𝑑𝑑𝑡𝑡
= 𝑘𝑘𝑚𝑚𝐵𝐵(𝑡𝑡) = 𝑘𝑘𝑚𝑚( 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡)) 
        (4) 
 
𝑃𝑃𝑟𝑟(𝑡𝑡) =
𝑈𝑈 𝑃𝑃(𝑡𝑡)
𝑈𝑈 + 𝑃𝑃(𝑡𝑡) + 𝑀𝑀(𝑡𝑡)
          (5) 
 
V(i) =
𝑘𝑘𝑝𝑝
𝑘𝑘𝑝𝑝 + 𝑘𝑘𝑚𝑚
=  
iW0
iW0 + (1 −W0)2i−1
         (6) 
 
𝑘𝑘𝑝𝑝 =
𝑘𝑘𝑚𝑚V(i)
1 − V(i)
=
i21−iW0𝑘𝑘𝑚𝑚 
(1 −W0) 
          (7) 
 
{
𝑑𝑑𝑀𝑀+1 𝑡𝑡
𝑑𝑑𝑡𝑡
= 𝑘𝑘+1𝐵𝐵(𝑡𝑡) = 𝑘𝑘+1(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡))  
𝑑𝑑𝑀𝑀−7(𝑡𝑡)
𝑑𝑑𝑡𝑡
= 𝑘𝑘−7𝐵𝐵(𝑡𝑡) = 𝑘𝑘−7(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡)) 
          (8)  
 
{
 
 
 
 𝑀𝑀𝑟𝑟,+1(𝑡𝑡) =
𝑀𝑀+1(𝑡𝑡)
𝑈𝑈 + 𝑃𝑃(𝑡𝑡) + 𝑀𝑀(𝑡𝑡)
   
𝑀𝑀𝑟𝑟,−7(𝑡𝑡) =
𝑀𝑀−7(𝑡𝑡)
𝑈𝑈 + 𝑃𝑃(𝑡𝑡) + 𝑀𝑀(𝑡𝑡)
          (9) 
 
𝑘𝑘−7(t) = 𝑘𝑘−7,𝑡𝑡=0ℎ +
𝑘𝑘−7,𝑡𝑡=60ℎ − 𝑘𝑘−7,𝑡𝑡=0ℎ
𝑇𝑇
𝑡𝑡          (10) 
 
{
𝑑𝑑𝑀𝑀+1(𝑡𝑡)
𝑑𝑑𝑡𝑡
= 𝑘𝑘+1(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡))  
𝑑𝑑𝑀𝑀−7(𝑡𝑡)
𝑑𝑑𝑡𝑡
= (𝑘𝑘−7,𝑡𝑡=0ℎ +
𝑘𝑘−7,𝑡𝑡=60ℎ − 𝑘𝑘−7,𝑡𝑡=0ℎ
𝑇𝑇
𝑡𝑡 )(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡)) 
          (11) 
 
𝑓𝑓(𝑥𝑥) = 1 + 0.5 √𝑥𝑥 
 
whereby T is 60 h, the duration of experiment. 
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Adjusting equation (8) by equation (10), we have
 
𝑅𝑅(𝑡𝑡) = 1 − 2−
𝑡𝑡
ℎ𝑙𝑙      (1) 
 
𝑦𝑦(𝑡𝑡) = 1 −
𝑈𝑈
1 + 𝑒𝑒−𝑎𝑎(𝑡𝑡−𝑏𝑏)
          (2) 
 
𝑃𝑃(𝑡𝑡) + 𝐵𝐵(𝑡𝑡) + 𝑀𝑀(𝑡𝑡) = 1         (3) 
 
{
𝑑𝑑𝑃𝑃(𝑡𝑡)
𝑑𝑑𝑡𝑡
= −𝑘𝑘𝑐𝑐𝑅𝑅(𝑡𝑡)𝑃𝑃(𝑡𝑡) + 𝑘𝑘𝑝𝑝𝐵𝐵(𝑡𝑡) = −𝑘𝑘𝑐𝑐𝑅𝑅(𝑡𝑡)𝑃𝑃(𝑡𝑡) + 𝑘𝑘𝑝𝑝(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡))  
𝑑𝑑𝑀𝑀(𝑡𝑡)
𝑑𝑑𝑡𝑡
= 𝑘𝑘𝑚𝑚𝐵𝐵(𝑡𝑡) = 𝑘𝑘𝑚𝑚(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡)) 
        (4) 
 
𝑃𝑃𝑟𝑟(𝑡𝑡) =
𝑈𝑈 + 𝑃𝑃(𝑡𝑡)
𝑈𝑈 + 𝑃𝑃(𝑡𝑡) + 𝑀𝑀(𝑡𝑡)
          (5) 
 
V(i) =
𝑘𝑘𝑝𝑝
𝑘𝑘𝑝𝑝 + 𝑘𝑘𝑚𝑚
=  
iW0
iW0 + (1 −W0)2i−1
          (6) 
 
𝑘𝑘𝑝𝑝 =
𝑘𝑘𝑚𝑚V(i)
1 − V(i)
=
i21−iW0𝑘𝑘𝑚𝑚 
(1 −W0) 
          (7) 
 
{
𝑑𝑑𝑀𝑀+1(𝑡𝑡)
𝑑𝑑𝑡𝑡
= 𝑘𝑘+1𝐵𝐵(𝑡𝑡) = 𝑘𝑘+1(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡))  
𝑑𝑑𝑀𝑀−7(𝑡𝑡)
𝑑𝑑𝑡𝑡
= 𝑘𝑘−7𝐵𝐵(𝑡𝑡) = 𝑘𝑘−7(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡)) 
          (8)  
 
{
 
 
 
 𝑀𝑀𝑟𝑟,+1(𝑡𝑡) =
𝑀𝑀+1(𝑡𝑡)
𝑈𝑈 + 𝑃𝑃(𝑡𝑡) + 𝑀𝑀(𝑡𝑡)
   
𝑀𝑀𝑟𝑟,−7(𝑡𝑡) =
𝑀𝑀−7(𝑡𝑡)
𝑈𝑈 + 𝑃𝑃(𝑡𝑡) + 𝑀𝑀(𝑡𝑡)
          (9) 
 
𝑘𝑘−7(t) = 𝑘𝑘−7,𝑡𝑡=0ℎ +
𝑘𝑘−7,𝑡𝑡=60ℎ − 𝑘𝑘−7,𝑡𝑡=0ℎ
𝑇𝑇
𝑡𝑡          (10) 
 
{
𝑑𝑑𝑀𝑀+1(𝑡𝑡)
𝑑𝑑𝑡𝑡
= 𝑘𝑘+1(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡))  
𝑑𝑑𝑀𝑀−7(𝑡𝑡)
𝑑𝑑𝑡𝑡
= (𝑘𝑘−7,𝑡𝑡=0ℎ +
𝑘𝑘−7,𝑡𝑡=60ℎ − 𝑘𝑘−7,𝑡𝑡=0ℎ
𝑇𝑇
𝑡𝑡 )(1 − 𝑃𝑃(𝑡𝑡) − 𝑀𝑀(𝑡𝑡)) 
          (11) 
 
𝑓𝑓(𝑥𝑥) = 1 + 0.5 √𝑥𝑥 
Taking equations (1), (2), (4), (5), (9) and (11) together, we performed the model fitting with LMA.
Data and Software Availability
Raw image files are deposited on Mendeley Data (https://data.mendeley.com/datasets/
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Sequence files are deposited in NCBI’s Gene Expression Omnibus and are accessible 
through GEO Series accession number GSE113129 (https://www.ncbi.nlm.nih.gov/geo/
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Supplementary Figure S1. (A-C) Simulations of the ODE model showing the relative abundance of the three states 
(intact, broken, indel) over time for various sets of rate constants. (D,E) Representative flow cytometry plots of a 
transfection of a control plasmid (D) or GFP expression plasmid (E) in same experiment as sgRNA-LBR2 transfection 
for a time series. Cells were collected 48 hours after transfection with indicated plasmid. Histograms of GFP 
fluorescence intensity is plotted. Proportions of GFP-negative and GFP-positive cells are indicated. (F) Separate flow 
cytometry experiment of a transfection of GFP plasmid, imaged 16, 80 or 120 hours after transfection (n=1). Note 
that the proportion of GFP-positive cells is virtually stable. (G-J) Various tested ODE models that differ in the assumed 
onset and accumulation curve of Cas9 activity over time: (G) instant onset at t = 0 h; (H) instant onset at t = 4 h; 
(I) instant onset at t = 8 h; (J) gradual onset quantified by Western blots. The latter is the model used in all analyses. 
Relative abundances of the intact and indel fractions are plotted (dots) together with the model fit (solid lines). Broken 
fraction is estimated from the model.
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Supplementary Figure S2. Changes of the parameters k
c,max
 (A), k
m
 (B), the amount predicted broken fraction (C,D) 
and τ (E) in a parameter sweep survey in which we imposed different fixed perfect/mutagenic repair ratios. Optimal 
fit is shown in black and significant upper bound in red (P < 0.1, F-test). Within this confidence interval the parameters 
show only modest changes. (F) Residuals of the fit to the data points are plotted for a parameter sweep survey of a 
fixed k
c,max
 and changing k
p
 and k
m
 rates. 
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Supplementary Figure S3. (A) Schematic view of the LM-PCR assay to detect the 5 prime broken ends after DSB 
induction. (B) Representative agarose gel of the LM-PCR products of a time series. The expected product is 609 bp 
in size. (C) The broken fraction measured as band intensities (data from three LM-PCR experiments spanning three 
different time series; values are mean ± SD). Solid blue line shows an ODE curve fit to the LM-PCR data to determine 
τ (blue shading, mean ± SD). (D) Representative agarose gel of the input PCR products of a time series. The expected 
product is 350 bp in size. (E) The input PCR fraction measured as band intensities (data from 2 PCR experiments 
spanning 2 different time series; values are mean ± SD). (F-I) Test of the linearity of the used primer pairs, indicated in 
the figure. T=16 h sample was diluted to range of concentrations. Agarose gel and quantification is plotted. 
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Supplementary Figure S4. (A) Indel spectra determined by TIDE in twelve out of twenty cell clones derived from 
sgRNA-LBR2 treated cells that gained a mutation. Note that K562 cells are tri- to tetraploid, hence the individual 
cell clones can have multiple peaks for allele specific mutations. (B) Three cell clones with already acquired indels by 
sgRNA-LBR2 were re-transfected with or without a sgRNA-LBR2 expressing plasmid. The panels show the distribution 
and frequencies of indels as determined by TIDE 60 hours after Cas9/sgRNA induction. (C) Cell viability assay for the 
cells 48 hours after addition of Shield-1 and either DMSO or NU7441. (D) Cell viability assay for the cells without a 
sgRNA, with sgRNA-LBR2 and with additional damage by 10 Gy. Data in (C,D) are mean ± standard deviation from 
two technical replicates.
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Supplementary Figure S5. 
Flow cytometry DNA content 
profiles of K562#17 transfected 
with sgRNA-LBR2 in the absence 
and presence of NU7441 to 
investigate whether a cell cycle 
arrest is triggered by Cas9-
induced DSB. As a positive 
control, cells were treated with 
10 Gy of ionizing radiation 
(right-hand column). Time 
points after Cas9 induction 
are indicated. Horizontal 
axis (‘FL3-A’) indicates DNA 
content. Bottom row shows 
indel spectra of the same cell 
pools at t = 60 h, confirming 
that DSBs were formed and 
repaired in these cells. 
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Supplementary Figure S6. Time series 
experiments of three additional loci; 
an additional sequence in the LBR gene 
using sgRNA-LBR8 (A-E), AAVS1 gene (G-I) and 
an intergenic region on chromosome 11 (J-L). 
(A,G,J) Relative fractions of intact (red) and 
indel (green) as a function of time. The dashed 
lines show sigmoid fits of the data points. Indel 
fraction in absence of Shield-1 is shown in grey. 
n indicates the number of time series per 
locus and error bars represent the SD. (B,H,K) 
Distribution of the type of indels as determined 
by next generation sequencing at t = 60 h. 
(C,I,L) Nucleotide compositions of particularly 
abundant indels. (D,E) Broken fraction detection 
in a time series experiment in presence of sgRNA-
LBR8 of the 3’ (D) and 5’ end (E) of the break. 
(F) Comparison of measured broken fractions 
for sgRNA-LBR2 (n=7) and sgRNA-LBR8 (n=5) 
(average of all 3’ and 5’ measurements 
combined).
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Supplementary Table 1, Related to Methods
Name Sequence Location (hg38) Targeting strand
LBR guide #2 5’ GCCGATGGTGAAGTGGTAAG 3’ Chr 1: 225424038-
225424057
-
LBR guide #5 5’ GTATTTTAGTGATCAGCCTG 3’ Chr 1: 225424155-
225424174 
-
LBR guide #6 5’ AGGCTACATTCAATCTCATT 3’ Chr 1: 225424215-
225424234
+
LBR guide #7 5’ GAGATTGAATGTAGCCTTTC 3’ Chr 1: 225424212-
225424231 
-
LBR guide #8 5’ AGAGTGTGTTTACAGTAAGT 3’ Chr 1: 225423869-
225423888
-
LBR guide #9 5’ GTGTGAGCTTCTTGGGAACA 3’ Chr 1: 225423715-
225423734 
+
Intergenic 
guide
5’ TGGTCTCCTTGTCTGTGTGG 3’ Chr 11: 5561098- 
5561117
+
AAVS1 (4) 5’ GTCCCCTCCACCCCACAGTG 3’ Chr 19: 55115771- 
55115790
-
LBR2 without NU7441 (n=7) LBR2 with NU7441 (n=4)
k
c,max 
(h-1) 0.11 ± 0.02 0.10 ± 0.004
k
p 
(h-1) 1.3 ± 2.3 x 10-6 8.6 ± 5.5 x 10-6
k
m 
(h-1) 0.17 ± 0.12 0.06 ± 0.01
k
+1 
(h-1) 0.11 ± 0.08 0.02 ± 0.006
k
-7,t=0h 
(h-1) 3.0 ± 5.8 x 10-3 0.02 ± 0.004
k
-7,t=60h 
(h-1) 0.09 ± 0.09 0.05 ± 0.005
Supplementary Table 3, Related to Figure 5. Fitted parameter values for the LBR2 locus in the absence or presence 
of NU7441. Parameters were fitted for +1 as well as -7 indels, including different start (t=0h) and end (t=60h) rates for 
the -7 deletion to model the delayed accumulation. Average values ± standard deviations are shown for n independent 
time courses, each fitted individually.
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Supplementary Table 2, Related to Methods
Name Number Oligo*
Adaptor primer EB486 5' GCGTGGTCGCGGCCGAGGA 3'
Extension 
primer 3’
EB479 5' TGGGTGGTTGGCAGAGTTAC 3'
Broken primer 
3’ EB487 5' GAATGTAGCCTTTCTGGCCCTAAAATCCTG 3'
Standard 
primer 3’
EB488 5' TCCTACTTGGCATTTTCTATAATTAACCTGA 3'
Extension 
primer 5’
EB551 5' CCCTTGGGCATGGAATATAA 3'
Broken primer 
5’ EB553 5' CCTTCCAGCACTTGGCTGACTGTGT 3'
Standard 
primer 5’
EB555 5' GATTGAGCTCTTGCTTTGGGTCACATAC 3'
LBR2-fw EB279 5' AAATGGCTGTCTTTCCCAGTAA 3'
LBR2-rv EB361 5' ACGCAGTGGCTAAATCATCC 3'
AAVS1-fw EB326 5' GCTTCTCCTCTTGGGAAGTGTA 3'
AAVS1-rv EB415 5' TTTCTGTCTGCAGCTTGTGG 3'
chr11-fw EB333 5' AGGAAGACGATGGAGAAGACAG 3'
chr11-rv EB416 5' CTTTCCTGCCCATGTTGATT 3'
LBR2-
5-6-7-fw-bc
EB386-EB392,
EB396-EB398,
EB417-EB421
5' ACACTCTTTCCCTACACGACGCTCTTCCGATCTNNNNNNTA
AAGCTGGGAGGTGCTGTC 3'
LBR8-fw-bc
EB511, 
EB518-EB519
5' ACACTCTTTCCCTACACGACGCTCTTCCGATCTNNNNNNAG
CTCAATCCTCTGCCTTCA 3'
Lbr9-fw-bc EB512 5' ACACTCTTTCCCTACACGACGCTCTTCCGATCTTTAGGTAGTAAACCCAGGGGACCAAC 3'
LBR2-
5-6-7-8-9-rv1 EB393
5' GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTACGCAGT
GGCTAAATCATCC 3'
LBR2-
5-6-7-8-9-rv2 EB449
5' GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTGTAGCCT
TTCTGGCCCTAAAAT 3'
LBR8-rv EB517 5' GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTGCCTGTGGAAAAAGACGAAT 3'
AAVS1-fw-bc EB451-EB460 5' ACACTCTTTCCCTACACGACGCTCTTCCGATCTNNNNNNAAGGAGGAGGCCTAAGGATG 3'
AAVS1-rv EB450 5' GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTCTTGCTTTCTTTGCCTGGAC 3'
Chr11-fw-bc EB462-EB471 5' ACACTCTTTCCCTACACGACGCTCTTCCGATCTNNNNNNCAGCATGGAGAGGAAAAGGT 3'
Chr11-rv EB461 5' GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTTAACCTGAGCTCATTGAGGGTT 3'
Illmunia-fw EB354 5' AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCT 3'
Illumina-rv 5' CAAGCAGAAGACGGCATACGAGATNNNNNNGTGACTGGAGTTCAGACGTGTGCTCTTCCGATC 3'
*N’s are the barcode or index sequences
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LBR2a
(n=7)
LBR2b
(n=7)
LBR8b
(n=6)
AAVS1b
(n=6)
chr11b
(n=5)
k
c,max 
 (h-1)
0.11 ± 0.01 0.084
[0.077 – 
0.187]
0.111
[0.017 – 
0.246]
0.053
[0.005 – 
0.153]
0.066
[0.047 – 
0.121]
k
p 
 (h-1)
1.6 ± 1.6 x 10-5 0.002
[1.1 x 10-10 – 
0.053]
0.060
[2.0 x 10-10 – 
0.091]
2.8 x 10-7
[3.3 x 10-9 – 
1.901]
2.4 x 10-7
[2.9 x 10-11 – 
0.014]
k
m 
 (h-1)
0.15 ± 0.11 0.174
[0.050 – 
0.217]
0.019
[0.005  – 
0.226]
0.443
[0.150 – 
8.850]
0.051
[0.022  – 
0.100]
k
p
 /(k
p
+k
m
)
1.1 x 10-4 0.011
[9.6 x 10-10 – 
0.377]
0.758
[3.8 x 10-9 – 
0.805]
1.1 x 10-7
[1.4 x 10-8 – 
0.580]
6.2 x 10-10
[5.8 x 10-10 – 
0.261]
Supplementary Table 4, Related to Figure 2 & Figure 6. Summary of estimated parameter values. (a) Average 
values ± standard deviations for the LBR2 locus, based on 7 independent time courses, each fitted individually. 
k
p
 fraction show the proportion of perfect repair of the overall repair rate (k
p
/(k
p
+k
m
). (b) Values estimated by a single 
model fit using the all data points from n datasets (see Methods). 5-95% confidence margins are indicated in brackets 
below each value and were obtained by bootstrapping (1,000 cycles).
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Chapter 7
GENERAL DISCUSSION
Chapter 7 General Discussion
7ABSTRACT
When DNA breaks occur in the genome, DNA repair is activated. Cells employ various 
mechanisms to repair breaks, such as the classical 
non-homologous end joining pathway, the alternative 
end joining pathway or the homology directed 
repair. The choice for a particular repair pathway 
is regulated, however not all contributing factors 
are completely understood. Chromatin structure 
and its dynamic changes seem to play a role in the 
choice and kinetics of DNA repair. Currently, genome 
editing tools that utilize DNA repair mechanisms of 
the host cell to introduce mutations in the genome 
are widely used by researchers. In anticipation of 
adapting these techniques for therapeutic use, it 
is important to unravel the mechanism behind the 
choice and kinetics of repair. We review the work in 
this thesis and outline new research strategies.
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UNDERSTANDING CRISPR/CAS9
CRISPR is a perfect example that studying a biological process can (unexpectedly) lead to a 
landslide of practical applications and emphasizes the importance of fundamental research. 
The now well-known CRISPR was described for the first time quite recently (1993) (1). 
Mojica et al. found that previously reported dissimilar repeats in genomes of prokaryotes, 
actually shared some repetitive motifs. These regions were named Clustered Regularly 
Interspaced Short Palindromic Repeats (2). Later it was reported that the spacer regions 
between the repeating CRISPR units corresponded to pre-existing sequences from 
bacteriophage genomes. The presence of external DNA elements in bacteria protected 
them from infection by spacer-carrying phage strains. Therefore CRISPR was suggested 
to function as an adaptive immune system against bacteriophages (3, 4). Several years of 
study led to the discovery of all essential elements of the CRISPR/Cas9 system, including; 
crRNAs, tracrRNA, DNA target molecule, PAM sequence and the Cas9 nuclease that 
actually introduces the DSB (5-9). By using the natural properties of the CRISPR system 
it was proven that Cas9 could be experimentally redirected to a locus of choice just 
by changing the crRNA spacer sequence (10, 11). The CRISPR/Cas9 system was then 
engineered rapidly to function in mammalian cells and it was shown that DNA at targeted 
locations in genome could be successfully edited (12, 13). 
Applications of this technique continue to evolve at lightning speed. At present, the 
CRISPR/Cas9 technology has passed the National Institutes of Health’s first safety review 
for human use and a small clinical trial for cancer treatment may get under way in the 
United States before the end of 2018 (14). Approval from the Food and Drug Administration 
is still pending. However, ethical questions about the best use of CRISPR and for what 
case are still unsettled. Many scientific questions remain to be solved; e.g. uncertainties 
concerning off-target or unintended effects during gene editing and safe delivery of the 
system into every cell. Solutions for these issues are essential for successful gene editing 
treatment. 
To contribute to the applicability and understanding of the CRISPR system, we developed 
several methods to rapidly monitor genome editing experiments based on sequence 
trace decomposition (15, 16). In addition, we developed an approach to measure single-
locus DSB repair kinetics after Cas9-induced breaks and to access the contribution of 
different repair pathways (17). We continued to measure the repair pathway preference at 
thousands of loci in the genome to investigate how the chromatin is influencing the repair 
process. For this discussion, we elaborate on how these tools can be utilized to gain more 
insights in the CRISPR system.
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CRISPR AS A TOOL TO STUDY DNA DAMAGE RESPONSE
The development of CRISPR as a genome editing tool would have never developed so fast 
if we did not have an extensive knowledge of DNA repair in cells already. Since homologous 
sequences were known to be used to repair DSBs, cells can be provided with exogenous 
DNA homologous to an endonuclease target site to be used for homology directed DNA 
repair (HDR) (18-23). In addition, it was found that DSBs introduced by designer nucleases 
based on zinc finger proteins were repaired in a similar way as by locus-specific HDR (22, 23). 
Furthermore, it was observed that in absence of a homology template, the target site exhibited 
insertion or deletion mutations introduced by the non-homologous end joining (NHEJ) 
repair pathway (24). These studies showed that both DSB-induced repair pathways (HDR 
and NHEJ) are capable of editing the genome at a DNA break site (25-28). 
No detectable rapid cycling of break and repair
Nowadays many groups have started to use CRISPR as a tool to study DNA repair at precise 
locations in the genome. For example by targeting specific heterochromatin repeats in the 
genome to study repair in these chromatin domains (29, 30). A drawback for using Cas9 
to study DNA repair is that active Cas9 will keep cutting the target DNA continuously. As 
a consequence it cannot be excluded that in S and G2 phase of the cell cycle Cas9 may 
cut the target site in both sister chromatids at the same time, thereby frustrating DNA 
repair by HR. In addition, in case of a perfect repair event, the repaired break becomes a 
substrate for Cas9 again, resulting in a cycle of cutting and perfect repair events that only 
terminates when an imperfect repair occurs (31). Such a scenario is not representative for 
naturally occurring DSBs.
Nonetheless, our quantitative modelling of CRISPR repair kinetics of four independent 
endogenous loci revealed that CRISPR induced breaks are predominantly repaired in an 
error prone fashion. Our data does not support evidence for a model with rapid cycling 
between repetitive cutting and repair. Although, the estimated kinetics for perfect repair 
events in the LBR8 locus may allow several rounds of cutting and repair the contribution 
is low considering that the estimated half-lives for perfect repair are ~10 h and ~6 h for 
cutting. All in all, our model is most consistent with slow repair of Cas9 induced DSB (both 
for mutagenic and perfect repair).
Slow repair after Cas9-induced breaks
In our approach we consistently find repair kinetics of Cas9 induced DSBs to be 
considerably slower (average half-life of ~6 h) than observed in studies with bulk DSBs 
introduced by ionizing irradiation, where repair rarely exceeded 1 hour (32-41). The half-life 
times of repair foci are found to vary from 1-3 h (42-45), though these observations may 
overestimate the duration of actual DSB presence since foci may linger on the DNA after 
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the DSB is re-joined. To verify our findings that repair rates of DSBs are slow after Cas9 
cutting, we carried out a double-cut experiment in which two proximal DNA sites were 
targeted by CRISPR in parallel. For an excision repair event (i.e. in which the intermediate 
part has been removed after repair) both guide target sites must be broken before repair 
occurs, which is more likely to happen in case where repair is slower than cutting. Indeed 
we observed a slow but dominant accumulation of the excision product; another indication 
that repair is slow. Several independent observations strengthen our conclusion that Cas9 
induced DSB repair can take several hours. Sternberg et al. reported that in vitro Cas9 
remains bound to the broken ends. Also in living cells catalytically inactive Cas9 has been 
found to have a residence time of up to 2 hours (46-48). Therefore a plausible explanation 
for slow repair of Cas9 induced DSBs might be that the long residence time of the Cas9 
complex at the broken ends has a decisive inhibiting influence on the kinetics of the DNA 
repair process. Live cell imaging of repair proteins after a Cas9 induced break may validate 
at protein level the timing of recruitment to the break site. However the K562 cell line used 
for our kinetics study proved to be difficult to generate conclusive immunofluorescence 
images because of large numbers of background foci. 
Collectively, our data give insights into the kinetics of DSB repair. CRISPR allows the study of 
DNA repair in a controlled manner at precisely defined locations in the genome. However, 
the kinetic data cannot be directly compared to the kinetics of DNA breaks introduced by 
other damaging agents, since the structure of the DNA ends is likely a determining factor 
for the Cas9 induced DSB repair process.
Broken fraction detection
Our quantitative modelling approach to determine the rate constants of breaking 
and repair proved to be robust and is validated by independent assays (17). Although, 
improvements can be made for more accurate modelling if and when the broken ends 
fraction could be quantified in a sensitive way. The semi quantitative LM-PCR we used 
here is optimized for agarose gel detection. However next-generation sequencing (NGS) 
of these samples  suffered from high background adaptor signals, making it unsuitable for 
quantitation. The background may be the result of the processing of genomic DNA during 
isolation, where often additional technical DNA breaks are introduced. These breaks are 
labelled and amplified with our adaptor and primers thereby generating non-informative 
background signals. 
In the last few years, new techniques have been developed that are based on NGS to detect 
both endonuclease-induced DSBs and complex genome-wide DSBs over background 
sequence reads by labelling the breaks in situ. For example the BLESS (49), End-Seq (50) and 
DSBCapture (51). The drawback of these techniques is that they require large amounts of 
input material (typically, in the order of millions of cells) and are labour-intensive. Recently, 
a new variant assay was developed: BLISS, ‘Breaks Labelling in situ and Sequencing’. 
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This assay requires fewer cells and provides more quantitative data by uniquely labeling of 
all individual molecules with a UMI (unique molecule identifier) (52). Using this method for 
our time series samples may provide a more sensitive view of the status of broken ends in 
time which may lead to a more robust modelling. 
PERFORMANCE OF CRISPR EDITING IN THE NUCLEUS
To control and improve the working of CRISPR editing, it is important to understand the 
mechanism behind the variation in cutting and repair kinetics of Cas9-induced DSBs. We 
have observed that the estimated ratios of perfect/imperfect repair rates vary between the 
four tested loci. Remarkably, even sgRNAs located only 169 bp apart (LBR2 and LBR8) exhibit 
marked different rates for perfect repair, suggesting that the fidelity of repair depends 
on the target sequence. This was strengthened by the observations that each target site 
is repaired in a unique but non-random manner. Even guides that are only 4 bp apart 
(LBR1 and LBR2) produce a completely different indel spectrum. The reason why these 
specific indel patterns arise is still a mystery. Multiple factors can play a role, e.g. sequence 
composition, presence of proteins or nucleosome positioning. It would of interest to be 
able to predict this phenomenon, because prior knowledge may greatly enhance effective 
sgRNA design. Our TIDE and TIDER webtools have become increasing popular in the 
last few years. Presently, the web tool hosts >1,000 analysis sessions per week, with a 
cumulative count of >100,000. By collecting data from these analyses, a large data set 
could be readily available for training algorithms to discover trends for specific sequences 
and indel patterns.
Various repair pathways activated by Cas9-induced DSBs
When studying the DNA repair in time by sequencing the repair outcome at nucleotide 
level, we found that the DSBs induced by Cas9/sgRNA-LBR2 are repaired in a way that 
leaves two major indels: a +1 insertion and a -7 deletion. We could link these specific 
indels to the activity of two individual repair pathways, respectively C-NHEJ and MMEJ. 
This finding gave us a great opportunity to study choice of repair pathway by reading the 
+1 insertion and -7 deletion under various conditions, which can be tested by a simple PCR 
reaction followed by sequencing. 
Besides the +1 insertion and -7 deletion mutations, various different indels are introduced 
during LBR2 repair although at low frequency. Some of these indels may arise due to 
technical noise caused by sequencing errors, others that steadily increase in time probably 
originate from a biological process. Cluster analysis of our indel accumulation data in time 
may reveal whether these low abundant mutations behave similarly or differently than the 
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established kinetics of the C-NHEJ and MMEJ pathways. This may connect other indels to 
the aforementioned repair pathways or reveal new kinetic behaviours that originate from 
additional (unknown) repair processes. 
Effect of chromatin status on Cas9-induced DSB repair
The way a DSB is repaired is regulated by multiple factors. Evidence shows that the 
chromatin context where breaks occur is one of these regulation factors (29, 53-55). With 
our newly designed pathway reporter assay explained above we aimed to investigate 
whether the way of repair is affected by the local chromatin status of the break site. To 
answer this question we integrated transposons carrying the CRISPR target site for guide 
LBR2 together with a unique barcode at multiple locations in the genome using the TRIP 
methodology (56) creating the DSB TRIP assay. The sgRNA to target LBR2 was transfected 
in cells carrying the complex TRIP pool to induce the breakage and repair of DNA at 
thousands individual locations in the genome in parallel. Since all integrated transposons 
carry the same target site, the position of the transposon in the genome and nucleus 
are the only variable. Like for the endogenous LBR2 locus the ratio of +1 and -7 indel 
frequencies reflects the preference for a repair pathway for many different loci spread over 
the genome at the same time. We observed that the variation in C-NHEJ-specific +1 and 
MMEJ-specific -7 indel frequencies is greater than expected on the basis of endogenous 
LBR2 site, suggesting a position effect for repair. 
Comparing our data to chromosomal features revealed that reporters integrated in 
nuclear lamina associated domains (LADs) generally have a lower frequency of indels 
than reporters integrated in DNA positioned away from the lamina (inter-LADs, iLADs). 
LADs typically feature heterochromatin properties, e.g. they have low gene density, are 
transcriptionally silent or express at low levels and replicate late (57, 58). In previous TRIP 
experiments, where the GFP gene was randomly integrated in the genome, a 5- to 6-fold 
reduction of expression was found in LADs versus inter-LADs (56). Apparently LADs have 
a transcriptional repressive environment that also affect CRISPR cutting and repair rates. 
This corresponds to the results reported by Guell et al., who finds a positive correlation 
between total indels and DNaseI-accessible regions (59). 
Moreover, our data suggest that nuclear position also influences the preference for a 
repair pathway. Although the C-NHEJ pathway is genome-wide dominant, in LADs the 
contribution of MMEJ repair appears to be higher when compared to iLADs that have a 
relatively higher contribution of the C-NHEJ pathway. A less pronounced but a similar 
effect was observed in DNA covered with H3K27me3, which is associated with a different 
type of repressed chromatin. This pathway preference shift may be due to a different 
recruitment of repair factors in the chromatin micro-environment (29, 53-55, 60, 61). 
For example a DSB induced by endonuclease I-SceI in a mammalian locus near the nuclear 
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lamina was unable to recruit the HR associated factors BRCA1 and Rad51. Proteins of the 
C-NHEJ and A-EJ pathway were associated with the break (53). Our data confirms this in 
genome wide fashion and quantified the contribution of the C-NHEJ and MMEJ pathway 
in LADs and iLADs.
Upon damage, the chromatin near the break will undergo massive remodelling involving 
various histone modifications (62). Recently, it was shown that these modifications vary 
depending on which repair pathways is activated as shown by monitoring 20 chromatin 
features at 80 euchromatic breaks (63). To complement these finding, we showed that the 
pre-existing chromatin state also influences the preference for a repair pathway, whereby 
the classical heterochromatin versus euchromatin seem to have the biggest influence.
To verify our findings with the published data, it would be interesting to monitor the 
recruitment of repair pathway specific proteins by immunofluorescence in the TRIP 
cell pool. Furthermore, determining the rate constants of cutting and repair at all the 
integrated transposons would provide us insights how the chromatin state influences 
Cas9-induced DSB repair. The challenge with this assay is to obtain sufficient coverage 
for each transposon position in the cell pool at each time point. Therefore, the number 
of positions that can be followed in parallel is a limiting factor. As a proof of principle it 
would be informative to monitor the variation in repair kinetics of the C-NHEJ and MMEJ 
pathway specific indels for a handful of loci at the same time. The use of robotics to 
automatically collect time-course samples would greatly improve the collection of data of 
DSB repair at multiple locations in the genome in parallel and make it possible to increase 
the throughput. Our DSB TRIP experiment already gave us a glance on the influence of 
chromatin status on repair pathway preference (LAD vs iLAD). By further developing this 
technique, the complexity can be increased in the future. In addition, extending these 
studies with a broader selection of different sgRNAs targeting the integrated transposon 
may help to draw more general conclusions. 
OUTLOOK TO UNRAVEL MECHANISTIC INSIGHTS IN 
CRISPR-INDUCED BREAKS
High and low complexity TRIP pools
The complex cell pool we have generated by TRIP covers thousands of reporters at different 
locations in the genome making it an ideal platform to search for correlations between 
repair and known chromosomal characteristics, such as chromatin states. However, 
some practical limitations are connected with TRIP pools. Due to divergent growth rates 
between cells, the cell population will drift and an unequal representation of barcodes 
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arises after several cell divisions. To obtain sufficient coverage of a repair distribution at all 
barcodes high sequencing depth is required. Hence for some experiments, low complexity 
or dedicated TRIP pools offer a possibility to more specific questions. Therefore we 
isolated unique cells from the complex TRIP pool that have been grown into a collection 
of cell lines with a small subset of specific transposon integrations. These cell lines with 
specific reporter integrations may be of interest for a screening assay of potential drugs 
or siRNAs targeting specific chromatin factors that change chromatin status. (Figure 1). 
For example, a dedicated pool carrying a set of ten reporters evenly distributed over LADs 
and iLADs is transfected with the LBR2 sgRNA to generate a DSB repair at the target site 
in the presence of drugs or siRNAs of interest. Changes in pathway preference ratio can be 
easily be detected and related to potential LAD or iLAD disrupting drugs/siRNAs and may 
provide mechanistic leads.
Tethering TRIP
Our data revealed that there is a clear difference for repair pathway preference in LAD and 
iLADs. To dissect how chromatin state influences pathway balance further experiments. 
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Figure 1: Repair pathway choice reporter assay. The repair products at the endogenous or integrated target 
site of sgRNA-LBR2 can function as a readout for DNA repair choice. The distinct +1 insertion and -7 deletions are 
shown to be specific for C-NHEJ and MMEJ pathways respectively. Cells can be screened for the change in +1/-7 
ratio in various conditions (e.g. in presence of epigenetics drugs). With barcoded integrated sgRNA-LBR2 target sites 
different chromatin states can be separated (e.g. LADs vs iLADs).
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are necessary. Tethering TRIP is a variant technology that has been already explored in our 
lab to study effects of the chromosome environment on the regulatory activity of HP-1 (64). 
Here, a transposon was constructed with multiple Gal4 binding sites upstream of a promoter 
that drives GFP expression. This configuration offers the possibility to tether Gal4-fusion 
proteins to the integrated transposons. Binding of the Gal4-HP-1 protein was found to 
repress the GFP expression in all integrated transposon reporters, proving that HP-1 is a 
potent and universal transcriptional repressor (64). This tethering strategy has not yet been 
combined with the DSB TRIP, which would give the possibility to change features in the 
local chromatin environment around the DSB-site. Direct effects of factors that define a 
certain chromatin position on DNA repair pathway choice can then be tested. 
To make use of the already available TRIP cell pools, which have sgRNA-LBR2 target 
sites but lack Gal4 tethering sites, TALE-fusion or nuclease dead CRISPR-fusion proteins 
targeting the reporter transposon can be used instead (Figure 2). Unfortunately, for this 
particular DSB TRIP pool dCas9 based fusion proteins are not possible candidates as they 
will interfere with the Cas9 that is used to introduce the DSB. Orthologues like dCpf1 could 
be considered in the future (65). Short catalytically dead guide RNAs with MS2-binding 
loops may also be explored to tether MS2-fusions to the reporter transposons (66). 
Interesting candidates to recruit to the transposon would be proteins known to be present in 
LADs such as the transcriptional repressor KRAB, or the methyl transferase, G9A, that writes 
the H3K9me2 mark (67, 68). The presence of KRAB will result in the spreading of repressive 
histone modification H3K9me3 (69). G9A is identified as a regulator of NL-interactions (70). 
Tethering these proteins to the transposons are likely to change the local chromatin 
environment and may enhance NL interactions of the integration in iLADs. Questions that 
could be answered are: does the generation of an artificial LAD changes the repair pathway 
choice? Is  the localization of the DNA near the NL causal for pathway choice or are other 
regulatory elements near the integration site needed? Conversely, detachment from the NL 
was described for genes in LADs upon activation by the recruitment of an activator domain 
to the promoter (71). Similar movement was observed by the tethering of DELQPASIDP, 
a fortuitously discovered peptide that causes chromatin decondensation but no gene 
activation (71, 72). Delivering this synthetic peptide to the transposons may detach the LADs 
to the nuclear interior and the influence of this movement on repair preference can be studied. 
TALE protein of interest
16nt barcode
DSB recognition site
5’-TR
Figure 2: Thousands of reporters integrated in parallel coupled with targeted recruitment 
of TALE-fused proteins. A transcription activator-like effector is fused to protein of interest 
and designed to recognize a constant part of the transposon cassette used by the PiggyBac 
transposase. The protein fusion will be directed to all integrated transposons in the TRIP assay. 
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Viability TRIP
Several other interesting questions can be studied using the DSB TRIP technology. Vulnerable 
break sites in the genome can be identified. TRIP cells with and without inflicted damage can 
be grown for a couple of generations. Afterwards, the barcodes of the transposon integrations 
can be counted. The dropout barcodes in the damaged condition may have integrations at 
sites that cannot be repaired or drive the cell in (permanent) cell cycle arrest or apoptosis.
Transcription - DSB TRIP
Evidence has been reported that the DSB response is differentially regulated in the 
proximity of a transcription unit. Transcription near a break site is silenced and the break is 
often associated with proteins of the HR pathway (55, 73, 74). To gain more insights on this 
process another TRIP variation could provide new insight on the effect of transcription on 
DNA repair. Two identical libraries can be generated that contain a similar CRISPR target 
sequence but one transposon reporter is carrying an additional GFP expression cassette. 
However, each TRIP cell pool has random transposon integration in the genome, while in 
this experiment identical locations are preferred in the two libraries. A high complexity 
library will deal with this to some extent, but it will be better to introduce a landing pad (LP) 
containing a recombination site and a selectable marker in the transposon (75) (Figure 3).
 In this way one TRIP library can be constructed without GFP cassette but with a LP. Using 
the recombination sites of the LP the CRISPR target sequence can be accompanied with a 
GFP expression cassette. Two different TRIP libraries would be created but with identical 
transposon integration sites. The pathway preference of a DSB near the transcription unit 
can be studied, but also the overall repair efficiency compared to the sites that do not have 
a transcription unit in close proximity. 
Figure 3: TRIP with landing pad for DNA integration. Schematic representation of the loading of a new feature 
into an integrated transposon. The TRIP cassette contains the 5’ and 3’ TR necessary for transponson integration, an 
attP attachment site (landing pad, LP) for the BxB1 recombinase, a constitutive promoter and CRISPR target site. The 
cargo plasmid carries GFP reporter and a puromycin selection marker that are co-expressed using a 2A translation 
skip peptide. BxB1-mediated recombination occurs between the LP’s attP site and the cargo’s attB site, yielding a 
similar TRIP cell pool with extra functionality (e.g. transcription unit). 
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Traffic light reporter screen
To discover new players in the various repair pathways, our sensitive LBR2-based reporter may 
also be used in combination with a CRISPR knock out or mutagenesis screen. For this approach a 
variant of the traffic light reporter will be integrated in a preferably haploid cell line like HAP-1 (76). 
The reporter is constructed of a promoter upstream of the LBR2 target sequence and drives 
the expression of a series of fluorescent proteins that are out of frame (Figure 4a). The first 
fluorescent reporter is GFP carrying a 1 nucleotide out of frame mutation, second is mCherry 
with an out of frame mutation of 2 nucleotides. Then the haploid cell with the integrated reporter 
will be exposed to either a retroviral gene-trap screen (77) or a knock out CRISPR screen (78). 
Hereby, each cell will be knocked out for a specific active gene. In brief, retroviral gene-trap 
will unbiased inactivate genes upon insertion in the transcription unit. A CRISPR knock out 
screen may introduce frame-shift mutations in the genes designed in the sgRNA library. 
 
eGFP (+1) mCherry (+2)T2A (+1)
sgRNA LBR2 
target site
promoter
+1 insertion by C-NHEJ -7 deletion by MMEJ
eGFP
eGFP (+1) mCherry (+2)T2A (+1)
sgRNA LBR2 
target site
promoter
eGFP (+1) mCherry (+2)T2A (+1)
eBFP donor
Gibberish mCherry
+1 insertion by C-NHEJ
eGFP Gibberish mCherry
subsitution & +1 
insertion by HDR
eBFP
-7 deletion by MMEJ
A
B
Figure 4: Screen for proteins that influence repair pathways choice. Adapted from Certo et al. (88). Schematic 
diagram of reporter. The arrow represents the promoter and initial reading frame. The target site of sgRNA-LBR2 
is placed after the promoter and the different genome engineering outcomes following the introduction of a DSB 
will restore the expression of a specific fluorescent protein. (A) If the break undergoes C-NHEJ via a +1 insertion the 
eGFP sequence is restored and the cell will fluoresce green. If the break undergoes microhomology-mediated end 
joining resulting in a -7 deletion and a frameshift to the +2 reading frame, eGFP will be translated out of frame and 
the T2A and mCherry sequences will be translated in frame causing the cells to fluoresce red. (B) The system in (A) 
can be adjusted to detect three repair pathways. A donor template carrying a single Y66H amino acid substitution 
is added to the cells. With the incorporation of donor template via HDR, the resulting protein has a shift in the 
fluorescence excitation and emission spectra of the protein, converting eGFP to eBFP.
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To read the effect of the inactivation of certain genes on the preference for repair by 
C-NHEJ or MMEJ pathway, the mutagenized cell pool would be exposed to Cas9 and the 
sgRNA LBR2 to induce repair by C-NHEJ and MMEJ in the traffic light reporter cassette. 
This will result in a mixture of GFP or mCherry positive cells. For example a hit in a gene 
affecting in C-NHEJ pathway will result in a decrease in the GFP while a hit in a gene of the 
MMEJ pathway will decrease the red signal. FACS sorting on the colours and subsequent 
DNA sequencing of the gene-trap or sgRNAs of the distinct cell pools will give a depletion 
of cells with respectively knockouts in genes involved in C-NHEJ or MMEJ repair. These 
dropouts may reveal potential new proteins essential in one of the two repair pathways.
The traffic light reporter can be even extended with a third colour e.g. BFP surrounding the 
break site that is non-functional due to truncation, similar as the DR-GFP assay (79). This 
protein can be restored by repair with a donor template (Figure 4b).
CURRENT DEVELOPMENTS OF CRISPR
In this thesis, we used an inducible system that limits the activity of Cas9 to a certain period 
of time. However, the regulation of Cas9 activation systems is relatively slow (80, 81). 
More recently, inducible Cas9s have been developed using chemicals or light, which have 
the potential to quickly activate Cas9 (82, 83). Another interesting option is to stop or inhibit 
the nuclease activity of Cas9 after a period of time by the use of anti-Cas9 molecules. Anti-
CRISPR proteins have been extracted from phages that have an active counter-defense 
system. These proteins inactivate the CRISPR-Cas-interference complex in a sequence-
independent way (84). A drawback is that only anti-proteins have been reported for the 
NmeCas9 orthologue thus far (85). Moreover, administration of anti-proteins by means of 
transfection is not very suitable for a quick shutdown of Cas9.
Orthologues of CRISPR proteins are also interesting to study how they behave in time, how 
they are affected by the chromatin state and what repair pathway preferences they have. 
Various new CRISPR systems have been discovered in the last few years. Zetsche et al. 
describe the Cpf1 protein, which is part of a different CRISPR system, but also makes use 
of RNA-guided target cleavage (86). This variant CRISPR system has already been adjusted 
for gene editing in human cells. Interestingly, Cpf1 uses only a crRNA but does not need 
tracrRNA (86). Furthermore, sequence analysis showed that Cpf1 contains a RuvC-like 
cleavage domain and lacks an NHN nuclease domain and therefore generates staggered 
DSBs (86). In addition to Cpf1, new CRISPR effector proteins have been discovered, 
e.g. C2C1, C2C2, C2C5 (87). These findings expand the opportunities for genome editing 
using targeted endonucleases. Perhaps these CRISPR variants do not linger at the DNA 
ends after generation of a DSB and/or exhibit different repair kinetics than SpCas9. Since 
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Cpf1 generates a staggered overhang (86) HDR repair may be more efficient than for 
Cas9-nickases. With the systems we developed these questions can be studied.
Altogether, CRISPR is an extremely versatile technology. Application of CRISPR has the 
potential to engineer food, correct genetic disorders, eliminate microbes that cause 
disease, eradicate dangerous pests or even bring extinct animal species back to life. There 
is still a lot of progress to be made to achieve this and technological and ethical barriers 
have yet to be overcome. CRISPR has already had a tremendous impact in improving 
the development of model systems, both for cell lines and transgenic animals. It enables 
targeted regulation of gene expression and can change a single DNA base. We are only 
beginning to see the full potential of CRISPR and much more is to be expected. Better 
understanding of the cutting and repair processes involved in CRISPR-mediated genome 
editing will further expands the number of tools in the laboratory and bring us closer to 
goals of clinical use.
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SUMMARY
Each individual cell contains DNA, the carrier of the hereditary information that is written 
in a four-letter code. The DNA code contains different elements. For example, a gene is a 
stretch of DNA that codes for a protein, which executes a function inside or outside the 
cell. When the DNA code of a gene is translated, a protein will be produced. Other parts 
of DNA contain different types of information, like a code for the regulation of protein 
expression or the structural folding of the DNA. All this information together makes the 
DNA two meters in size in mammalian cells. To fit it into the nucleus of a cell, it has to be 
tightly folded at several levels. The folding and the presence of proteins and modifications 
on the DNA (together called chromatin) influence the function of the DNA. For example, 
tightly folded DNA is less accessible to be read than more loosely folded DNA. 
Changing the genetic code in cells can lead to changed functionalities. Engineered 
changes could for example lead to beneficial characteristics to farm crops or may disable 
disease causing genes in cancer cells. The development of new technology enables 
genome editing at selected locations in the genomes of many species. Most popular in 
the field of molecular biology to engineer changes are proteins such as CRISPR/Cas9, 
that break DNA at a programmable location. The CRISPR system consists of a guide RNA 
that recognizes a specific sequence in the genome and escorts the Cas9 nuclease to 
this site, which in turn introduces a precisely defined DNA double-strand break (DSB). In 
response the cell will repair this break. The main repair mechanism in mammalian cells is 
non-homologous end joining (NHEJ) which joins broken ends together. This repair is not 
always accurate whereby extra DNA letters (nucleotides) can be inserted or deleted at the 
site of the break, causing a mutation, which are referred to as indels. However, the efficacy 
and the mutation spectrum can vary substantially depending on the efficiency of introducing 
a DSB and on the way it is repaired. Chapter 1 provides an overview of CRISPR/Cas9 
genome editing and the factors that affect the efficiency of this process.
In genome editing experiments with CRISPR/Cas9 it is important to know the frequency 
and the nature of the introduced indel mutations. Since this is difficult to predict, a simple 
and quick assay to accurately characterize and quantify the induced mutations is needed. 
In Chapter 2 we report the TIDE method. This is a fast and easily applicable method that 
accurately identifies and quantifies indels after CRISPR/Cas9 editing. TIDE requires only 
a pair of PCR reactions and two standard Sanger sequencing runs, which is the technique 
to determine the order of nucleotides of a piece of DNA. These sequence traces are then 
analysed by a specially developed decomposition algorithm to identify the individual 
indel mutations. 
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To generate specific mutations by CRISPR/Cas9 genome editing, the DSB can also be 
repaired with the help of a donor DNA. This is a designed sequence that is almost identical 
to the target location except from some desired mutations. In the presence of the donor 
DNA the designed mutations can be introduced in the genome during repair. This process 
is mediated by a different repair mechanism called homology directed repair (HDR) that 
makes use of the overlapping sequence between genomic DNA and the donor DNA for 
repair. This very precise editing strategy is becoming more popular, due to its property 
to create and study specific mutations, or to correct disease-causing nucleotide variants. 
In Chapter 3 we explain our second method, called TIDER, that can estimate the 
incorporation frequency of any type of template-directed mutations. 
For both methods presented in Chapter 2 & 3 we developed interactive web tools that 
greatly facilitate the rapid testing and rational design of genome editing strategies. TIDE 
and TIDER make it easy to test the efficacy of the designed guide and to determine type 
and proportion of mutations that can be expected. Chapter 4 provides a detailed procedure 
and optimization steps to overcome potential problems when using these two methods.
The process of cutting of DNA by CRISPR/Cas9 and the subsequent repair of the DSB is still 
poorly understood. It is unknown how fast these events occur and how accurate DSB repair 
is. We developed a strategy to directly measure the kinetics and fidelity of DNA repair at 
single loci in human cells (Chapter 5). To do so, we constructed a cell line with a tightly 
controlled inducible Cas9 that made it possible to track the formation of DSBs and their 
repair in time for a locus of choice. Intact, broken and repaired DNA fractions are quantified 
by a combination of next generation sequencing and an assay to detect non-repaired 
broken ends. The resulting data are analysed in a mathematical model that estimates the key 
parameters for repair kinetics and fidelity. Our approach revealed that repair rates varied, 
with half-life times up to ~10 h, indicating that the repair is slow. Moreover, our data show 
that repair of the DSBs tends to be error-prone. Interestingly, we found that the spectrum 
of introduced indels is highly dependent on the sequence that is targeted. The same target 
sequence acquired two specific indels each representing the pathway that repairs the DSB. 
By analyzing the sequence and using an inhibitor we were able to designate the pathways, 
as NHEJ and microhomology-mediated end joining (MMEJ). Moreover, we have established 
that these pathways have different repair kinetics. Therefore, this target sequence can be 
used as a reporter for the preference of repair pathways.
In Chapter 6 we investigate the effect of DNA-protein packaging on Cas9 cutting and 
subsequent repair. We inserted the pathway reporter sequence at ~1500 different 
genomic locations. Our data indicate that the chromatin state of the target sequence 
influenced the indel frequency and pathway preference. We found that DSBs positioned 
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close to the periphery of the cell nucleus (LADs) are more often repaired by the MMEJ 
pathway compared to DSBs found closer to the centre of the cell nucleus (inter-LADs). 
In the presence of donor DNA, the participation of the MMEJ pathway is mostly reduced, 
although DSBs in LADs are still repaired with higher frequency by MMEJ than inter-LADs. 
These quantitative analyses contribute to a better understanding of DSB repair and the 
impact of chromatin on this process.
In Chapter 7 the results are discussed in relation to the latest developments in the field 
of genome editing. New research strategies are presented that can contribute to a 
better understanding of the influences of the chromatin environment on the process of 
double-strand break repair.
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Elke individuele cel bevat DNA, de drager van de erfelijke informatie die is geschreven in 
een vierletterige code (het totaal aan DNA in de kern wordt genoom genoemd). De DNA-
code beschrijft verschillende elementen. Een gen is bijvoorbeeld een stuk DNA dat een 
eiwit beschrijft, een molecuul dat een functie in of buiten de cel uitvoert. Wanneer de DNA-
informatie van een gen wordt gelezen, produceert de cel het eiwit. Andere delen van het 
DNA bevatten weer andere informatie, zoals de code voor de regulatie van de eiwitexpressie 
of ruimtelijk vouwing van het DNA. Al deze informatie samen maakt dat het DNA twee 
meter lang is. Om dit in de celkern te passen wordt het strak opgevouwen op meerdere 
niveaus. De vouwing en de aanwezigheid van eiwitten en modificaties op het DNA (samen 
chromatine genoemd) hebben invloed op de functie van het DNA. Bijvoorbeeld, strak 
opgevouwen DNA is minder gemakkelijk te lezen dan losser gevouwen DNA. 
Wijzigen van de  DNA-code in cellen kan leiden tot gewijzigde functies. Deze veranderingen 
kunnen bijvoorbeeld leiden tot gunstige eigenschappen voor landbouwgewassen of 
kunnen ziekmakende genen in kankercellen uitschakelen. De ontwikkeling van nieuwe 
technologieën maakt het mogelijk het DNA van verschillende organismen op geselecteerde 
locaties aan te passen. De populairste techniek in de moleculaire biologie om genetische 
aanpassingen te maken is CRISPR/Cas9. Het CRISPR-systeem bestaat uit een gids-RNA dat 
een specifieke volgorde in het genoom (sequentie) herkent en de Cas9-nuclease die daar 
een nauwkeurig gedefinieerde dubbel-strengsbreuk (DSB) aanbrengt. Als reactie zal de 
cel deze breuk herstellen. In zoogdiercellen is het meest gebruikte reparatiemechanisme 
non-homologous end joining (NHEJ), die de gebroken uiteinden met elkaar verbindt. Deze 
reparatie is niet altijd nauwkeurig waarbij extra DNA-letters (nucleotiden) kunnen worden 
ingevoegd (inserties) of worden verwijderd (deleties) op de plaats van de breuk. Dit soort 
mutaties worden aangeduid als indels. Echter, de effectiviteit en het mutatiespectrum 
kunnen aanzienlijk variëren afhankelijk van de efficiëntie waarmee een DSB wordt 
geïntroduceerd en de manier waarop deze wordt gerepareerd. Hoofdstuk 1 geeft een 
overzicht van de genoombewerking door CRISPR/Cas9 en de factoren die van invloed zijn 
op de efficiëntie van deze methode.
Bij experimenten om het genoom te bewerken met CRISPR/Cas9 is het belangrijk om 
de frequentie van de geïntroduceerde indel-mutaties te kennen. Omdat die moeilijk 
te voorspellen is, is een eenvoudige en snelle test nodig om de geïnduceerde mutaties 
nauwkeurig te karakteriseren en te kwantificeren. In Hoofdstuk 2 beschrijven we de TIDE-
methode. Dit is een snelle en gemakkelijk toepasbare methode die indels nauwkeurig 
identificeert en kwantificeert na een CRISPR/Cas9-bewerking. TIDE vereist slechts een 
paar PCR-reacties en twee standaard Sanger-sequencing reacties, een techniek is om de 
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volgorde van nucleotiden van een stuk DNA af te lezen. De sequentiepatronen worden 
vervolgens geanalyseerd door een speciaal ontwikkeld ontledingsalgoritme om de 
individuele mutaties te identificeren.
Voor het genereren van specifieke mutaties door middel van CRISPR/Cas9-
genoombewerking kan een geïntroduceerde DSB ook hersteld worden met behulp 
van donor-DNA. Dit is een ontworpen sequentie die, op enkele gewenste mutaties na, 
bijna identiek is aan de locatie waar de breuk wordt gemaakt, de doelwitlocatie. In de 
aanwezigheid van het donor-DNA kunnen de ontworpen mutaties tijdens de reparatie in 
het genoom worden geïntegreerd. Dit proces verloopt via een ander reparatiemechanisme 
dat homology directed repair (HDR) wordt genoemd, en het gebruikt daarbij de 
overlappende sequentie tussen het genoom en het donor-DNA. Deze zeer nauwkeurige 
strategie is de laatste tijd steeds populairder geworden, vanwege de mogelijkheid om 
specifieke mutaties te creëren en ze te bestuderen of om ziekteverwekkende mutaties te 
corrigeren. In Hoofdstuk 3 bespreken we een tweede methode, TIDER, die de frequentie 
kan schatten van elke ontworpen mutatie(s).
Voor beide methoden die in Hoofdstuk 2 & 3 zijn gepresenteerd hebben we bijbehorende 
interactieve webtools ontwikkeld die door de snelle analyse rationeel de ontwerpstrategieën 
voor het bewerken van een genoom vergemakkelijken. TIDE en TIDER maken het eenvoudig 
om de werkzaamheid van een ontworpen gids-RNA te testen en om het type, aantal en 
frequentie van de verwachte mutaties te bepalen. Hoofdstuk 4 biedt gedetailleerde 
procedures en optimalisatiestappen om mogelijke problemen bij het gebruik van deze 
twee methoden te ondervangen.
Het is nog niet precies duidelijk hoe het proces van het knippen van het DNA door 
CRISPR/Cas9 en de daaropvolgende reparatie van de DSB verloopt. Hoe snel vinden deze 
gebeurtenissen plaats en hoe nauwkeurig is het DSB-herstel? We hebben een strategie 
ontwikkeld om de kinetiek en betrouwbaarheid van DNA-herstel op enkele locaties in 
menselijke cellen direct te meten (Hoofdstuk 5). Hiervoor hebben we een cellijn gemaakt 
met een nauwkeurig gecontroleerde, induceerbare Cas9 die het mogelijk maakte de 
vorming van DSB’s en hun herstel in de tijd te volgen in een locatie naar keuze. Percentages 
met intact, gebroken en hersteld DNA worden gekwantificeerd door een combinatie van 
DNA-sequencingtechnologie en een test om niet-gerepareerde, gebroken uiteinden 
te detecteren. De resultaten worden geanalyseerd in een wiskundig model dat de 
belangrijkste parameters voor reparatiekinetiek en -nauwkeurigheid schat. Onze aanpak 
onthulde dat reparatiesnelheden varieerden per doelwitsequentie, met halfwaardetijden 
tot ~10 uur, wat aangeeft dat de reparatie traag is. Bovendien laten onze gegevens zien dat 
reparatie van de DSB’s vaak foutief is. Interessant genoeg vonden we dat het spectrum van 
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geïntroduceerde indels tijdens reparatie in hoge mate afhankelijk is van de sequentie van 
het doelwit van de CRISPR. Dezelfde doelsequentie verwierf twee specifieke indels, die elk 
een apart mechanisme representeerde waarmee de breuk wordt hersteld. Door de indel-
sequenties te bestuderen en een remmer te gebruiken konden we de gebruikte routes 
toekennen aan NHEJ en de microhomology-mediated end joining (MMEJ). Bovendien 
hebben we vastgesteld dat deze routes een verschillende reparatiekinetiek hebben. 
Daarom kan deze doelwitsequentie gebruikt worden als een verslaggever (reporter) van 
de voorkeur voor deze twee reparatiemechanismen. 
In Hoofdstuk 6 onderzoeken we het effect van DNA-eiwitpakking op het knippen 
door Cas9 en de daaropvolgende reparatie. We hebben de reportersequentie van de 
reparatiemechanismen ingevoegd op ~1500 verschillende locaties in het genoom. De 
resultaten geven aan dat de chromatinestatus de indel-frequentie en de voorkeur van 
de herstelroute beïnvloedt. We hebben ontdekt dat DSB’s die dichtbij de periferie van de 
celkern gepositioneerd zijn (LAD's), vaker worden hersteld door de MMEJ-route dan DSB’s 
die dichterbij het centrum van de celkern worden gevonden (inter-LADs). In aanwezigheid 
van donor-DNA wordt de deelname aan het MMEJ-route meestal verminderd, hoewel 
DSB's in LAD's nog steeds met een hogere frequentie door MMEJ worden gerepareerd 
dan in inter-LAD's. Deze kwantitatieve analyses dragen bij aan een beter begrip van 
DSB-reparatie en de impact van chromatine op dit proces.
In Hoofdstuk 7 worden de resultaten besproken in het licht van de nieuwste ontwikkeling op 
het gebied van genoombewerking. Nieuwe onderzoeksstrategieën worden gepresenteerd 
die kunnen bijdragen aan een beter begrip van de invloed van de chromatineomgeving op 
het proces van herstel van een breuk in de dubbele streng.
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ABBREVIATIONS
3C  chromosome conformation capture
4-OHT  4-hydroxytamoxifen
A   adenine
A-EJ  alternative end joining
ATM   ataxia telangiectasia-mutated protein 
ATR   ATM and Rad3-related kinase 
BLESS   in situ breaks labelling, enrichment on streptavidin, and next-generation sequencing
BLISS  breaks labelling in situ and sequencing
bp   base pair  
C   cytosine
Cas  CRISPR-associated
ChIP  chromatin immunoprecipitation
C-NHEJ  classical non-homologous end joining
CRISPR  clustered regularly interspaced short palindromic repeat
crRNA   CRISPR RNA 
CtIP  CtBP-interacting protein
dCas9  catalytically dead Cas9
DDR   DNA damage response
DNA-PK  DNA-dependent protein kinase
DNMT  DNA methyltransferase
Dox   doxycycline
DSB  double-strand break
FACS  fluorescence activated cell sorting
G   guanine
gDNA  genomic DNA
GFP  green fluorescent protein
gRNA  guide RNA
H3K4me2 histone H3 dimethylation on lysine 4
H3K9me2 histone H3 dimethylation on lysine 9
H3K9me3 histone H3 trimethylation on lysine 9
H3K27me3 histone H3 trimethylation on lysine 27
H3K36me3  histone H3 trimethylation on lysine 36
H4K20  histone H4 lysine 20
HAT  histone acetyltransferease
HDAC   histone deacetylase
HDM  histone demethylase
HDR  homology directed repair
HMT  histone methyltransferase
HP-1  heterochromatin protein 1
HR  homologous recombination
iLAD  inter lamin associated domain
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indel  insertions and deletions
IR  ionizing radiation
IRES  internal ribosome entry site
KAP-1  KRAB-associated protein 1 
KI  knock in
KO  knock out
KRAB  Kruppel-associated box domain
LAD   lamina associated domain
LP  landing pad
LM-PCR  ligation-mediated PCR
Mb   megabases 
MMEJ  microhomology-mediated end joining 
MRN   Mre11, Rad50, Nbs1
NGS  next generation sequencing
NL   nuclear lamina
Nm  Neisseria meningitidis 
PAM  protospacer adjacent motif
PB  PiggyBac
PuroR  puromycin resistance cassette
RGENs   RNA-guided endonucleases 
RNAi  RNA interference
RPA   replication protein A
RPR  repair pathway reporter
Sa  Staphylococcus aureus
sgRNA  single guide RNA
Sp  Streptococcus pyogenes 
ssDNA  single-stranded DNA
ssODN  single-stranded oligodeoxynucleotides
SSTR  single-stranded template repair
St  Streptococcus thermophiles 
T   thymine
TALEN  transcription-activator-like effector nuclease
TIDE  tracking of indels by decomposition
TIDER   tracking of insertions, deletions and recombination events 
TRIP  thousands of reporters integrated in parallel
U  uracil 
UMI  unique molecular identifier
UTR  untranslated region
tracrRNA  transactivating CRISPR RNA
XLF   XRCC4-like factor
XRCC4  X-ray cross-complementing protein 4
wt   wild-type
ZFN  zinc finger nuclease
Abbreviations
170
Addendum
CURRICULUM VITAE
Eva Karina Brinkman was born March 5, 1987 in Vlaardingen, the Netherlands. She was 
awarded a Atheneum degree at S.G. Spieringshoek in Schiedam in 2005. Eva started to 
study Life Science & Technology at the Delft University of Technology and University Leiden 
in 2005. During her studies Eva did internships in the group of Dr. Claude Backendorf at the 
Molecular Genetics group at the Leiden Institute of Chemistry. She studied the dynamics of 
chromatin-modifying enzyme BRD2 in living cells. Then continued with her Master internship 
at the Molecular Radiation Biology group of Prof. dr. Roland Kanaar at the Department 
of Cell Biology & Genetics at the Erasmus Medical Center. Here, Eva investigated the 
differentially regulated UV damage response in the cell cycle. For a company internship 
she went to DSM Food Specialties in Delft to work on the improvement of microorganisms 
that degrade plant biomass for a more efficient production of second generation biofuels. 
After that she participated in 2010 in a scientific biology student competition, iGEM, where 
my team finished as one of the finalists, earned the best presentation award at MIT, USA 
and won the UfD-E.ON teamwork award at the TU Delft, the Netherlands. She completed 
her Master degree in September 2011. That year she also co-founded Science Matters, 
a company that is engaged in knowledge transfer of life sciences. Projects have been 
developed a.o. H2020 Marie Skłodowska-Curie grants, Boijmans van Beuningen museum 
and the Rathenau Instituut. In 2012 she joined the group of Prof. dr. Bas van Steensel at the 
Netherlands Cancer Institute Antoni van Leeuwenhoek in Amsterdam. Together with co-
inventors Tao Chen and Bas van Steensel, Eva developed the TIDE and TIDER software and 
granted an exclusive license hereof to Desktop Genetics in 2018.
171
&
LIST OF PUBLICATIONS
1. Brinkman, E.K., van Steensel B., Rapid quantitative evaluation of CRISPR genome 
editing by TIDE and TIDER. Springer Nature Methods in Molecular Biology,  (in press)
2. Chen, Y., Zhang Y., Wang Y., Zhang L., Brinkman E.K., Adam S.A., Goldman R., 
van Steensel B., Ma J. et al., Mapping 3D genome organization relative to nuclear 
compartments using TSA-Seq as a cytological ruler. The Journal of cell biology,  (2018).
3. Brinkman, E.K., Chen T., de Haas M., Holland H.A., Akhtar W., van Steensel B., 
Kinetics and Fidelity of the Repair of Cas9-Induced Double-Strand DNA Breaks. 
Molecular cell 70, 801-813 e806 (2018).
4. Brinkman, E.K., Kousholt A.N., Harmsen T., Leemans C., Chen T., Jonkers J., van 
Steensel B., Easy quantification of template-directed CRISPR/Cas9 editing. Nucleic 
acids research,  (2018).
5. Janssen, A., Breuer G.A., Brinkman E.K., van der Meulen A.I., Borden S.V., van Steensel 
B., Bindra R.S., LaRocque J.R., Karpen G.H., A single double-strand break system 
reveals repair dynamics and mechanisms in heterochromatin and euchromatin. 
Genes Dev 30, 1645-1657 (2016).
6. Brinkman, E.K., Chen T., Amendola M., van Steensel B., Easy quantitative assessment of 
genome editing by sequence trace decomposition. Nucleic acids research 42, e168 (2014).
7. Warmerdam, D.O., Brinkman E.K., Marteijn J.A., Medema R.H., Kanaar R., Smits V.A., 
UV-induced G2 checkpoint depends on p38 MAPK and minimal activation of ATR-
Chk1 pathway. J Cell Sci 126, 1923-1930 (2013).
8. Brinkman, E.K., Schipper K., Bongaerts N., Voges M.J., Abate A., Wahl S.A., A toolkit 
to enable hydrocarbon conversion in aqueous environments. J Vis Exp, e4182 (2012).
List of Publications
172
Addendum
PHD PORTFOLIO
Name of the PhD student:  ir. Eva Karina Brinkman
Erasmus MC Dept:  Cell Biology
Graduate School   Onderzoekschool Oncologie Amsterdam
PhD period:    2012-2018
Promoter:   Prof.dr. Bas van Steensel
1. PhD training
Courses
2013  OOA Course: ‘Introduction to R and statistics’, Amsterdam
2013  Summer School: ‘Chromatin and Systems Biology’, Spetses
2014  OOA Course: ‘Replication stress and chromosomal instability’, Amsterdam
2015  OOA Course: ‘Epigenetics and non-coding RNA’, Amsterdam
2015  EMBO Practical Course: ‘Analysis of High-Throughput Sequencing Data’, 
  Cambridge
2016  6th Winterschool of TRR8, Kleinwarsental
Seminars and workshops
2012-2014 OOA PhD student retreat (poster/oral presentation)
2012-2018 NKI research club meetings (oral presentation)
2012-2018 Weekly discussion meetings (oral presentation)
2012-2018 International NKI seminar, lunch meetings with speaker
2014, 2017 1st and 2nd NKI CRISPR meeting (oral presentation)
2016  Erasmus MC & Leids Universitair Medisch Centrum DNA repair meeting 
  (oral presentation)
(Inter-)national conferences
2012-2018 Cancer Genomics Center annual meeting, Amsterdam 
2012-2018 Dutch Chromatin Day, the Netherlands (oral presentation/2e place poster prize)
2013  5th EMBO meeting, Amsterdam
2014  11th EMBL Conference Transcription and Chromatin, Heidelberg (poster)
2015  IMB DNA repair & Genome Stability in a Chromatin Environment, Mainz (poster)
2016  10th Quinquennial Conference on Responses to DNA damage, Egmond aan Zee
  (1e place poster prize)
2016  Genome engineering: The CRISPR-Cas Revolution, Cold Spring Harbor  
  (oral presentation)
173
&
2017  Functional Analysis of Sequence Variants in Hereditary Breast-and Ovarian  
  Cancer Genes, Amsterdam (poster)
2017  4th International TRR81 Symposium on Chromatin Changes in Differentiation
  and Malignancy, Egmond aan Zee (poster)
2017  Keystone Symposia meeting on Genomic Instability and DNA Repair, Santa Fe
  (poster)
2018  Innovation for Health – premier event in Health & Life Sciences, Rotterdam   
  (shared 2e place poster pitch)
2018   EMBO workshop: Chromatin dynamics and nuclear organization in genome 
  maintenance, Strasbourg (shared 1e place poster prize)
2018  Systems Epigenetics: Towards Precision Cancer Medicine, Amsterdam  
  (oral presentation)
2. Teaching
2016   Supervision Master student Oncology of VUmc Amsterdam 
  (8 months of guidance in lab work, presenting, writing)  
2016-2017  Introduction–day first year Bachelor students Molecular Life Sciences of 
  Utrecht University (oral presentation)
2016-2017 EMBO Course on Genome Engineering: CRISPR/Cas, Heidelberg 
  (invited speaker)
2018  Project pitch for second year Biomedical research student of 
  Hogeschool Avans Breda (oral presentation)
PhD Portfolio

